Section 72

EurekaMag PDF full texts Chapter 71,384


Ray, R.; Kumar, S. 2021: COVID-19: facts, figures, estimated relationships and analysis. Indian Economic Review 56(1): 173-214
Hindson, J. 2020: COVID-19: faecal-oral transmission?. Nature Reviews. Gastroenterology and Hepatology 17(5): 259
Loveday, H.; Wilson, J. 2020: COVID-19: fear, explanation, action, unity and ingenuity and World Hand Hygiene day. Journal of Infection Prevention 21(3): 80-82
Chauhan, N.; Jaggi, M.; Chauhan, S.C.; Yallapu, M.M. 2020: COVID-19: fighting the invisible enemy with microRNAs. Expert Review of Anti-Infective Therapy 2020: 1-9
Stoeklé, H.-C.; Ivasilevitch, A.; Hervé, C. 2021: COVID-19: for changing biomedical research standards teaching, is bioethics the solution?. Ethics Medicine and Public Health 16: 100628
The Lancet Public Health 2020: COVID-19: from a PHEIC to a public mental health crisis?. LANCET. Public Health 5(8): E414
Pericàs, J.M.; Hernandez-Meneses, M.; Sheahan, T.P.; Quintana, E.; Ambrosioni, J.; Sandoval, E.; Falces, C.; Marcos, M.A.; Tuset, M.; Vilella, A.; Moreno, A.; Miro, J.M.; Miró, J.M.; Ambrosioni, J.; Pericàs, J.M.; Téllez, A.; Hernandez-Meneses, M.; Garcia-Pares, D.; Moreno, A.ón.; de la Maria, C.G.; Dahl, A.; Garcia-González, J.; Cañas-Pacheco, M.ía.-A.; Almela, M.; Casals, C.; Marco, F.; Vila, J.; Quintana, E.; Sandoval, E.; Falces, C.; Andrea, R.; Pereda, D.; Azqueta, M.; Castel, M.A.; Garcia, A.; Sitges, M.; Farrero, M.; Vidal, B.; Pérez-Villa, F.; Pomar, J.é L.; Castella, M.; Tolosana, J.é M.; Ortiz, J.é; Fita, G.; Rovira, I.; Perissinotti, A.és.; Fuster, D.; Ramírez, J.; Brunet, M.è; Soy, D.; Castro, P.; Llopis, J. 2020: COVID-19: from epidemiology to treatment. European Heart Journal 41(22): 2092-2112
Magnavita, N.; Chirico, F.; Sacco, A. 2021: COVID-19: from hospitals to courts. Lancet 397(10284): 1542
Behrmann, O.; Spiegel, M. 2020: COVID-19: from rapid genome sequencing to fast decisions. LANCET. Infectious Diseases 20(11): 1218
Higgins, V.; Sohaei, D.; Diamandis, E.P.; Prassas, I. 2020: COVID-19: from3 an acute to chronic disease? Potential long-term health consequences. Critical Reviews in Clinical Laboratory Sciences 2020: 1-23
Menzella, F.; Matucci, A.; Vultaggio, A.; Barbieri, C.; Biava, M.; Scelfo, C.; Fontana, M.; Facciolongo, N.C. 2020: COVID-19: general overview, pharmacological options and ventilatory support strategies. Multidisciplinary Respiratory Medicine 15(1): 708
Zoller-Rydzek, B.; Keller, F. 2020: COVID-19: guaranteed Loans and Zombie Firms. Cesifo Economic Studies 66(4): 322-364
De Santiago, J.; Yelo, C.; F Chereguini, M.; Conde, A.; Galipienzo, J.; Salvatierra, D.; Linero, M.; Alonso, S. 2020: COVID-19: gynecologic cancer surgery at a single center in Madrid. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 30(8): 1108-1112
McCartney, M. 2020: COVID-19: has EBM been replaced by hype-based medicine?. Drug and Therapeutics Bulletin 58(7): 99-100
Cavezzi, A.; Troiani, E.; Corrao, S. 2020: COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. a narrative review. Clinics and Practice 10(2): 1271
Sabatino, V.; Sergio, P.; Muri, M.; Zangrandi, I.; Voltini, G.; Bosio, G.; Betti, M.; Baglivo, F.; Martinelli, E.; Pan, A.; Giorgi-Pierfranceschi, M.G.; Corvino, A.; Romanini, L. 2021: COVID-19: high-resolution computed tomography findings in the first 64 patients admitted to the Hospital of Cremona, the epicentre of the pandemic in Europe. Polish Journal of Radiology 86: E172-E176
Cummings, C.L.; Miller, C.S. 2021: COVID-19: how a self-monitoring checklist can empower early intervention and slow disease progression. Environment Systems and Decisions 41(2): 181-183
Donnelly, S.C. 2021: COVID-19: how did China protect their healthcare workers. Qjm: Monthly Journal of the Association of Physicians 114(4): 223
Gaspari, V.; Neri, I.; Misciali, C.; Patrizi, A. 2020: COVID-19: how it can look on the skin. Clinical and pathological features in 20 COVID-19 patients observed in Bologna, north-eastern Italy. Journal of the European Academy of Dermatology and Venereology: Jeadv 34(10): E552-E553
Stolfo, D.; Sinagra, G. 2020: COVID-19: how things change in a short while. European Heart Journal. Cardiovascular PharmacoTherapy 6(5): 280-281
Da Hora Sale S, P.H.; Lopes de Gusmão Sales, P.; da Hora Sales, M.L. 2020: COVID-19: how to decrease the risk of infection in dental practice?. Minerva Stomatologica 69(5): 324-327
Tusman, G.; Campos, M.; Gogniat, E. 2020: COVID-19: how to transform a noninvasive ventilation device in a critical care ventilator. Revista Espanola de Anestesiologia y Reanimacion 67(7): 367-373
Kaspers, G.J.L. 2020: COVID-19: how will this impact children with cancer, now and in the future?. Expert Review of Anticancer Therapy 20(7): 527-529
Yang, L.; Liu, S.; Liu, J.; Zhang, Z.; Wan, X.; Huang, B.; Chen, Y.; Zhang, Y. 2020: COVID-19: immunopathogenesis and Immunotherapeutics. Signal Transduction and Targeted Therapy 5(1): 128
Cao, X. 2020: COVID-19: immunopathology and its implications for therapy. Nature Reviews. Immunology 20(5): 269-270
Gautam, S.; Hens, L. 2020: COVID-19: impact by and on the environment, health and economy. Environment Development and Sustainability 22(6): 4953-4954
Majumder, S.; Biswas, D. 2022: COVID-19: impact on quality of work life in real estate sector. Quality and Quantity 56(2): 413-427
McAlindon, M. 2021: COVID-19: impetus to the adoption of capsule endoscopy as a primary diagnostic tool?. Frontline Gastroenterology 12(4): 263-264
Owopetu, O.; Fasehun, L.-K.; Abakporo, U. 2021: COVID-19: implications for NCDs and the continuity of care in Sub-Saharan Africa. Global Health Promotion 28(2): 83-86
Kronbichler, A.; Gauckler, P.; Windpessl, M.; Il Shin, J.; Jha, V.; Rovin, B.H.; Oberbauer, R. 2020: COVID-19: implications for immunosuppression in kidney disease and transplantation. Nature Reviews. Nephrology 16(7): 365-367
Amberger, P. 2021: COVID-19: implications for larynx, breathing and voice. Revue Medicale Suisse 17(742): 1132-1135
Welti, R.; D'Mello, G.; Ramalingam, L.; Silva, M. 2020: COVID-19: implications for paediatric dental care in the hospital setting. Journal of Paediatrics and Child Health 56(10): 1661-1662
Almeida-Espinosa, A.; Sarmiento-Ardila, J.A. 2020: COVID-19: implications of SARS-CoV-2 in Colombia. Gaceta Medica de Mexico 156(4): 334-338
Sleator, R.D.; Darby, S.; Giltinan, A.; Smith, N. 2020: COVID-19: in the absence of vaccination - 'mask the nation'. Future Microbiology 15: 963-966
Ing, A.J.; Cocks, C.; Green, J.P. 2020: COVID-19: in the footsteps of Ernest Shackleton. Thorax 75(8): 693-694
Lupia, T.; Corcione, S.; De Rosa, F.G. 2020: COVID-19: in the uncertainty, do not try this at home. Internal and Emergency Medicine 15(8): 1599-1600
Bach, J.-F.ço.; Berche, P.; Chatenoud, L.; Costagliola, D.; Valleron, A.-J. 2021: COVID-19: individual and herd immunity. Comptes Rendus Biologies 344(1): 7-18
Dos Santos, M.J.é; Martins, M.S.; Santana, F.L.P.; Furtado, M.C.S.P.C.êa.; Miname, F.C.B.R.éd.; Pimentel, R.R.d.S.; Brito, Ág.N.; Schneider, P.; Dos Santos, E.S.; da Silva, L.H. 2020: COVID-19: instruments for the allocation of mechanical ventilators-a narrative review. Critical Care 24(1): 582
Moreira, R.d.S. 2020: COVID-19: intensive care units, mechanical ventilators, and latent mortality profiles associated with case-fatality in Brazil. Cadernos de Saude Publica 36(5): E00080020
Tang, J.W. 2020: COVID-19: interpreting scientific evidence - uncertainty, confusion and delays. Bmc Infectious Diseases 20(1): 653
Leask, A. 2020: COVID-19: is fibrosis the killer?. Journal of Cell Communication and Signaling 14(2): 255
Leask, A. 2020: COVID-19: is fibrosis the killer?. Journal of Cell Communication and Signaling 2020: 1
Spuntarelli, V.; Luciani, M.; Bentivegna, E.; Marini, V.; Falangone, F.; Conforti, G.; Rachele, E.S.; Martelletti, P. 2020: COVID-19: is it just a lung disease? a case-based review. Sn Comprehensive Clinical Medicine 2(9): 1401-1406
Filardi, T.; Morano, S. 2020: COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?. Journal of Endocrinological Investigation 43(8): 1053-1060
Derbyshire, E.; Delange, J. 2020: COVID-19: is there a role for immunonutrition, particularly in the over 65s?. Bmj Nutrition Prevention and Health 3(1): 100-105
Bulgar, S.N.; Akhmetshin, R.F.; Abdulaeva, E.A.; Rizvanov, A.A. 2021: COVID-19: is transmission through eye contact possible?. Vestnik Oftalmologii 137(4): 104-109
McDonald, G.; Clark, L.L. 2020: COVID-19: it happens to nurses too-a case study. British Journal of Community Nursing 25(12): 594-597
Snaith, J.R.; Greenfield, J.R. 2020: COVID-19: it's changed us. Internal Medicine Journal 50(9): 1162-1163
Parente, M.ír.P.ét.P.D. 2021: COVID-19: its consequences and lessons. Revista Brasileira de Medicina do Trabalho: Publicacao Oficial da Associacao Nacional de Medicina do Trabalho-Anamt 18(4): 369-370
The Lancet 2021: COVID-19: learning as an interdependent world. Lancet 398(10306): 1105
Lu, X.; Xing, Y.; Wong, G.W.-K. 2020: COVID-19: lessons to date from China. Archives of Disease in Childhood 105(12): 1146-1150
Ngiam, J.N.; Tham, S.M.; Vasoo, S.; Poh, K.K. 2020: COVID-19: local lessons from a global pandemic. Singapore Medical Journal 61(7): 341-342
Perkins, G.D.; Couper, K. 2020: COVID-19: long-term effects on the community response to cardiac arrest?. LANCET. Public Health 5(8): E415-E416
Reperant, L.A.; Osterhaus, A.D.M.E. 2020: COVID-19: losing battles or winning the war?. One Health Outlook 2(1): 9
Schiff, G.; Mirica, M. 2020: COVID-19: making the right diagnosis. Diagnosis 7(4): 377-380
Kerbl, R. 2021: COVID-19: masks for children? An estimation by UNICEF and WHO. Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 169(2): 97-98
Donaldsson, S.; Naver, L.; Jonsson, B.; Drevhammar, T. 2020: COVID-19: minimising contaminated aerosol spreading during CPAP treatment. Archives of Disease in Childhood. Fetal and Neonatal Edition 105(6): 669-671
Syed, I.; Khan, S.; Khan, T.; Syed, S.; Khan, T.; Ali, A.; Harries, K.; Capuano, E.; Farrugia, A.; Pittman, M.; Simon, G.; Haider, T.; Ali, F.; Gupta, I.; Malik, Q. 2020: COVID-19: mobilising CT as a frontline management tool. British Journal of Radiology 93(1116): 20200522
Dhamad, A.E.; Abdal Rhida, M.A. 2020: COVID-19: molecular and serological detection methods. Peerj 8: E10180
Touma, M. 2020: COVID-19: molecular diagnostics overview. Journal of Molecular Medicine 98(7): 947-954
Sidaway, P. 2020: COVID-19: more evidence emerges. Nature Reviews. Clinical Oncology 17(8): 451
Riva, G.; Nasillo, V.; Tagliafico, E.; Trenti, T.; Comoli, P.; Luppi, M. 2020: COVID-19: more than a cytokine storm. Critical Care 24(1): 549
Barrero-Castillero, A.; Beam, K.S.; Bernardini, L.B.; Ramos, E.G.Cordova.; Davenport, P.E.; Duncan, A.R.; Fraiman, Y.S.; Frazer, L.C.; Healy, H.; Herzberg, E.M.; Keyes, M.L.; Leeman, K.T.; Leone, K.; Levin, J.C.; Lin, M.; Raju, R.M.; Sullivan, A. 2020: COVID-19: neonatal-perinatal perspectives. Journal of Perinatology: Official Journal of the California Perinatal Association 2020
Yilmaz, U.; Lepper, P.M.; Reith, W. 2020: COVID-19: neurological manifestations : what we know so far. Der Radiologe 60(10): 916-918
Tutelyan, V.A.; Nikityuk, D.B.; Burlyaeva, E.A.; Khotimchenko, S.A.; Baturin, A.K.; Starodubova, A.V.; Kambarov, A.O.; Sheveleva, S.A.; Zhilinskaya, N.V. 2020: COVID-19: new challenges for medical science and practical health. Voprosy Pitaniia 89(3): 6-13
Tarrasó Castillo, J.; Posadas Blázquez, Tás.José.; Lahosa Córdoba, C.; Signes-Costa, J. 2020: COVID-19: new disease, new manifestations. Archivos de Bronconeumologia 56(12): 825-826
Auxilia, F.; Maraschini, A.; Bono, P.; Ungaro, R.; Luconi, E.; Biganzoli, E.; Castaldi, S. 2020: COVID-19: new scenario old problems. Acta Bio-Medica: Atenei Parmensis 91(9-S): 90-91
Morelli, I.; Luceri, F.; Giorgino, R.; Accetta, R.; Perazzo, P.; Mangiavini, L.; Maffulli, N.; Peretti, G.M. 2020: COVID-19: not a contraindication for surgery in patients with proximal femur fragility fractures. Journal of Orthopaedic Surgery and Research 15(1): 285
Schulenburg, J.-M.G.v.d. 2021: COVID-19: not the time for health economists? a plea for more proactive health economic involvement. European Journal of Health Economics: Hepac: Health Economics in Prevention and Care 22(7): 1001-1004
Wang, J.J.; Deng, A.; Tsui, B.C.H. 2020: COVID-19: novel pandemic, novel generation of medical students. British Journal of Anaesthesia 125(3): E328-E330
Ferrandis, R.; Llau, J.V.; Quintana, M.; Sierra, P.; Hidalgo, F.; Cassinello, C.ón.; Gómez-Luque, A. 2020: COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?. Critical Care 24(1): 332
McMaster, D.; Veremu, M.; Santucci, C. 2020: COVID-19: opportunities for professional development and disruptive innovation. Clinical Teacher 17(3): 238-240
Maeckelberghe, E. 2021: COVID-19: opportunities for public health ethics?. Journal of the Royal College of Physicians of Edinburgh 51(S1): S47-S52
Aitken, E. 2021: COVID-19: opportunity to improve crisis responses to homelessness?. Journal of the Royal College of Physicians of Edinburgh 51(S1): S53-S62
Clevers, H. 2020: COVID-19: organoids go viral. Nature Reviews. Molecular Cell Biology 21(7): 355-356
Eshraghi, A.A.; Li, C.; Alessandri, M.; Messinger, D.S.; Eshraghi, R.S.; Mittal, R.; Armstrong, F.D. 2020: COVID-19: overcoming the challenges faced by individuals with autism and their families. LANCET. Psychiatry 7(6): 481-483
Öztürk, R.; Taşova, Y.şi.; Ayaz, A. 2020: COVID-19: pathogenesis, genetic polymorphism, clinical features and laboratory findings. Turkish Journal of Medical Sciences 50(Si-1): 638-657
Azer, S.A. 2020: COVID-19: pathophysiology, diagnosis, complications and investigational therapeutics. New Microbes and new Infections 37: 100738
Wiertz, C.M.H.; Vints, W.A.J.; Maas, G.J.C.M.; Rasquin, S.M.C.; van Horn, Y.Y.; Dremmen, M.P.M.; Hemmen, B.; Verbunt, J.A. 2021: COVID-19: Patient Characteristics in the first Phase of Postintensive Care Rehabilitation. Archives of Rehabilitation Research and Clinical Translation 3(2): 100108
Diener, H.-C.; Berlit, P.; Masjuan, J. 2020: COVID-19: patients with stroke or risk of stroke. European Heart Journal Suppls: Journal of the European Society of Cardiology 22(Suppl Pt T): P25-P28
Roberts, A.; Johnston, G.H.F.; Landells, C. 2021: COVID-19: pivoting from in-person to virtual orthopedic surgical evaluation. Canadian Journal of Surgery. Journal Canadien de Chirurgie 64(1): E101-E102
Faux, S.G.; Eagar, K.; Cameron, I.D.; Poulos, C.J. 2020: COVID-19: planning for the aftermath to manage the aftershocks. Medical Journal of Australia 213(2): 60-61.E1
Younis, N.K.; Zareef, R.O.; Fakhri, G.; Bitar, F.; Eid, A.H.; Arabi, M. 2021: COVID-19: potential therapeutics for pediatric patients. Pharmacological Reports: Pr 73(6): 1520-1538
Simpson, A.H.R.W.; Dall, G.; Haas, J.ür.G. 2020: COVID-19: potential transmission through aerosols in surgical procedures and blood products. Bone and Joint Research 9(4): 200-201
Cheng, L.T.-E.; Heilbrun, M.E.; Sahani, D.; Tan, B.S.; Klein, J.S. 2020: COVID-19: preparing for second surge and getting back on track for radiology. Bjr Open 2(1): 20200045
Biana, H.T.; Biana, R.T. 2021: COVID-19: prioritizing healthcare workers. Journal of Public Health 43(2): E265-E266
Harenberg, J.; Favaloro, E. 2020: COVID-19: progression of disease and intravascular coagulation - present status and future perspectives. Clinical Chemistry and Laboratory Medicine 58(7): 1029-1036
Gillespie, T.R.; Leendertz, F.H. 2020: COVID-19: protect great apes during human pandemics. Nature 579(7800): 497
Wood, C. 2020: COVID-19: protecting the medically vulnerable. British Journal of Nursing 29(12): 660
Georgiou, A.; Li, J.; Pearce, C.; McLeod, A.; Wabe, N.; Hardie, R.-A.; Franco, G.S.; Imai, C.; Sezgin, G.; Thomas, J.; Dai, Z.; Sheikh, M.K.; Proposch, A.; Weeding, S.; Wickham, B.; Badrick, T.; Murgatroyd, D. 2021: COVID-19: protocol for observational studies utilizing near real-time electronic Australian general practice data to promote effective care and best-practice policy-a design thinking approach. Health Research Policy and Systems 19(1): 122
Ripon, R.K.; Mim, S.S.; Puente, A.E.; Hossain, S.; Babor, M.M.H.; Sohan, S.A.; Islam, N. 2020: COVID-19: psychological effects on a COVID-19 quarantined population in Bangladesh. Heliyon 6(11): E05481
Holden, B.; Quinney, A.; Padfield, S.; Morton, W.; Coles, S.; Manley, P.; Wensley, A.; Hutchinson, C.; Lillie, P.J.; Duncan, C.J.A.; Schmid, M.L.; Li, A.; Foster, K.; Anaraki, S.; Dabrera, G.; Zambon, M.; Hughes, G.J.; Gent, M. 2020: COVID-19: public health management of the first two confirmed cases identified in the UK. Epidemiology and Infection 148: E194
Rehman, H.; Ahmad, M.Iftekhar. 2020: COVID-19: quarantine, isolation, and lifestyle diseases. Archives of Physiology and Biochemistry 2020: 1-5
Rouen, A.; Adda, J.; Roy, O.; Rogers, E.; Lévy, P. 2020: COVID-19: relationship between atmospheric temperature and daily new cases growth rate. Epidemiology and Infection 148: E184
Saville, M. 2021: COVID-19: release approved vaccines for trials of new ones. Nature 597(7875): 178
Jaggers, G.K.; Watkins, B.A.; Rodriguez, R.L. 2020: COVID-19: repositioning nutrition research for the next pandemic. Nutrition Research 81: 1-6
King, D.L.; Billieux, Jël.; Delfabbro, P.H. 2021: COVID-19: research on tech habits needs industry support. Nature 589(7841): 198
Boyle, A.A.; Henderson, K. 2020: COVID-19: resetting ED care. Emergency Medicine Journal: Emj 37(8): 458-459
Schwalbe, N.; Lehtimaki, S.; Gutiérrez, J.P. 2020: COVID-19: rethinking risk. LANCET. Global Health 8(8): E974-E975
Zavaleta, C. 2020: COVID-19: review Indigenous peoples' data. Nature 580(7802): 185
Calderón-Larrañaga, A.; Dekhtyar, S.; Vetrano, D.L.; Bellander, T.; Fratiglioni, L. 2020: COVID-19: risk accumulation among biologically and socially vulnerable older populations. Ageing Research Reviews 63: 101149
Schett, G.; Sticherling, M.; Neurath, M.F. 2020: COVID-19: risk for cytokine targeting in chronic inflammatory diseases?. Nature Reviews. Immunology 20(5): 271-272
Flegel, W.A. 2020: COVID-19: risk of infection is high, independently of ABO blood group. Haematologica 105(12): 2706-2708
Matos, A.G.; Sarquis, I.C.; Santos, A.A.N.; Cabral, L.P. 2021: COVID-19: risk of ocular transmission in health care professionals. Revista Brasileira de Medicina do Trabalho: Publicacao Oficial da Associacao Nacional de Medicina do Trabalho-Anamt 19(1): 82-87
Quillerou, B.; Bouchard, J.-P. 2020: COVID-19: risks of psychological trauma for patients in intensive care or for their families. SOINS. Psychiatrie 41(331): 42-44
Riva, G.; Nasillo, V.; Tagliafico, E.; Trenti, T.; Luppi, M. 2020: COVID-19: room for treating T cell exhaustion?. Critical Care 24(1): 229
Contreras, J.L.; Eisen, M.; Peters, D.M. 2020: COVID-19: save lives with open intellectual-property licences. Nature 583(7818): 683
Delgado, C.T.M.P. 2020: COVID-19: scars of the virus and stories caused by social isolation and mourning. Revista da Associacao Medica Brasileira 66(11): 1478-1481
Lewis, P.; Erren, T.C. 2020: COVID-19: science must not be the boy who cried wolf. Journal of Epidemiology and Community Health 74(8): 676
Gattinoni, L.; Marini, J.J.; Chiumello, D.; Busana, M.; Camporota, L. 2020: COVID-19: scientific reasoning, pragmatism and emotional bias. Annals of Intensive Care 10(1): 134
Mehan, A.; Venkatesh, A.; Girish, M. 2020: COVID-19: should oral vaccination strategies be given more consideration?. Therapeutic Advances in Vaccines and ImmunoTherapy 8: 2515135520946503
Sandy-Hodgetts, K. 2020: COVID-19: silver linings for wound care research. Journal of Wound Care 29(8): 429
Tokunbo, O.; Abayomi, T.; Adekomi, D.; Oyeyipo, I. 2021: COVID-19: sitting is the new smoking; the role of exercise in augmenting the immune system among the elderly. African Health Sciences 21(1): 189-193
Najafi, A.; Sadeghniiat-Haghighi, K.; Alemohammad, Z.B.; Akbarpour, S. 2020: COVID-19: sleep research perspectives. Sleep Science 13(3): 184-185
Mulugeta, T.; Tadesse, E.; Shegute, T.; Desta, T.T. 2021: COVID-19: socio-economic impacts and challenges in the working group. Heliyon 7(6): E07307
Shammi, M.; Robi, M.R.; Tareq, S.M. 2020: COVID-19: socio-environmental challenges of Rohingya refugees in Bangladesh. Journal of Environmental Health Science and Engineering 18(2): 1709-1711
Husain-Syed, F.; Ronco, C.; Wiech, T.; Hecker, M.; Seeger, W. 2021: COVID-19: spot urine rather than bronchoalveolar lavage fluid analysis?. Critical Care 25(1): 162
Abbasi, K. 2020: COVID-19: state failure is our misery and their jackpot. Journal of the Royal Society of Medicine 113(11): 419-420
Lexchin, J. 2020: COVID-19: still much to learn. Journal of the Royal Society of Medicine 113(7): 244
Khan, A. 2020: COVID-19: students caught in Pakistan's digital divide. Nature 587(7835): 548
Sundnes, K.O.; Braut, G.S. 2021: COVID-19: systematic learning across boundaries requires a conceptual agreement. Scandinavian Journal of Public Health 49(7): 809-814
Brüssow, H. 2020: COVID-19: test, trace and isolate-new epidemiological data. Environmental Microbiology 22(7): 2445-2456
Patrinely, J.Randall.; Zakria, D.; Berkowitz, S.T.; Johnson, D.B.; Totten, D.J. 2020: COVID-19: the Emerging Role of Medical Student Involvement. Medical Science Educator 2020: 1-3
Goergen, J.; Bavishi, A.; Eimer, M.; Zielinski, A.R. 2021: COVID-19: the Risk to Athletes. Current Treatment Options in Cardiovascular Medicine 23(11): 68
John, J.; Kesner, K. 2020: COVID-19: the androgen hypothesis. African Journal of Urology: the Official Journal of the Pan African Urological Surgeons' Association 26(1): 55
L'Angiocola, P.Diego.; Monti, M. 2020: COVID-19: the critical balance between appropriate governmental restrictions and expected economic, psychological and social consequences in Italy. Are we going in the right direction?. Acta Bio-Medica: Atenei Parmensis 91(2): 35-38
Panthee, B.; Dhungana, S.; Panthee, N.; Paudel, A.; Gyawali, S.; Panthee, S. 2020: COVID-19: the current situation in Nepal. New Microbes and new Infections 37: 100737
Castaldi, S.; Romano, L.; Pariani, E.; Garbelli, C.; Biganzoli, E. 2020: COVID-19: the end of lockdown what next?. Acta Bio-Medica: Atenei Parmensis 91(2): 236-238
Chatterjee, S.; Ghosh, R.; Biswas, P.; Dubey, S.; Guria, R.T.; Sharma, C.B.; Kalra, S. 2020: COVID-19: the endocrine opportunity in a pandemic. Minerva Endocrinologica 45(3): 204-227
Qu, L.; Li, J.; Ren, H. 2020: COVID-19: the epidemiology and treatment. British Journal of Hospital Medicine 81(10): 1-9
Devakumar, D.; Bhopal, S.S.; Shannon, G. 2020: COVID-19: the great unequaliser. Journal of the Royal Society of Medicine 113(6): 234-235
Leal Filho, W.; Azul, A.M.; Wall, T.; Vasconcelos, C.R.P.; Salvia, A.L.; do Paço, A.; Shulla, K.; Levesque, V.; Doni, F.; Alvarez-Castañón, L.; Mac-Lean, C.; Avila, L.V.; Damke, L.I.ês.; Castro, P.; Azeiteiro, U.M.; Fritzen, B.ár.; Ferreira, P.; Frankenberger, F. 2021: COVID-19: the impact of a global crisis on sustainable development research. Sustainability Science 16(1): 85-99
Leal Filho, W.; Price, E.; Wall, T.; Shiel, C.; Azeiteiro, U.M.; Mifsud, M.; Brandli, L.; Farinha, C.S.; Caeiro, S.; Salvia, A.L.; Vasconcelos, C.R.; de Sousa, L.O.; Pace, P.; Doni, F.; Veiga Avila, L.; Fritzen, B.ár.; LeVasseur, T.J. 2021: COVID-19: the impact of a global crisis on sustainable development teaching. Environment Development and Sustainability 23(8): 11257-11278
Ubom, A.E.; Ijarotimi, O.A.; Nyeche, S.; Ikimalo, J.I. 2021: COVID-19: the implications and consequences of prolonged lockdown and COVID-19 vaccine cost in a low-middle income country. Pan African Medical Journal 39: 48
Souza Filho, B.A.B.d.; Tritany, Ér.F. 2020: COVID-19: the importance of new technologies for physical activity as a public health strategy. Cadernos de Saude Publica 36(5): E00054420
Košir, U.; Sørensen, K. 2022: COVID-19: the key to flattening the curve is health literacy. Perspectives in Public Health 142(5): 259-260
Puxeddu, I.; Ferro, F.; Bartoloni, E.; Elefante, E.; Baldini, C.; Scirè, C.A.; Talarico, R.; Migliorini, P.; Mosca, M.; Bombardieri, S. 2021: COVID-19: the new challenge for rheumatologists. one year later. Clinical and Experimental Rheumatology 39(1): 203-213
Sun, S.; Su, W.; Lin, C.Q.; Li, X.; Yan, H.; Tian, B.; Lin, H. 2020: COVID-19: the novel coronavirus disease and its manifestations and management in ophthalmology. Discovery Medicine 29(158): 145-157
Hisham, I.N.; Townsend, G.; Gillard, S.; Debnath, B.; Sin, J. 2021: COVID-19: the perfect vector for a mental health epidemic. Bjpsych Bulletin 45(6): 332-338
Emmanuel, A. 2020: COVID-19: the physician's response in the first phase. Clinical Medicine 20(3): 237
Brown, R.; Coventry, L.; Pepper, G. 2021: COVID-19: the relationship between perceptions of risk and behaviours during lockdown. Zeitschrift für Gesundheitswissenschaften 2021: 1-11
Torres-Castro, R.; Vilaró, J.; Vera-Uribe, R. 2020: COVID-19: the risk of respiratory techniques in healthcare workers. Spinal Cord 58(6): 724-725
Abbasi, K. 2021: COVID-19: the silenced voices of the pandemic that must be heard. Journal of the Royal Society of Medicine 114(6): 283
Cuschieri, S. 2022: COVID-19: the transition towards a new normal-experiences from the European country of Malta. Zeitschrift für Gesundheitswissenschaften 30(11): 2641-2648
Bernard, F.O.; Akaito, J.A.; Joseph, I.; David, K.B. 2020: COVID-19: the trends of conspiracy theories vs facts. Pan African Medical Journal 35(Suppl 2): 147
Bommier, C.; Stœklé, H.-C.; Hervé, C. 2021: COVID-19: the urgent call for academic research in research ethics. Ethics Medicine and Public Health 18: 100679
Teuwen, L-Anne.; Geldhof, V.; Pasut, A.; Carmeliet, P. 2020: COVID-19: the vasculature unleashed. Nature Reviews. Immunology 20(7): 389-391
Ferreira, L.L.; Chagas, A.C.P.; Bernardo, W.M. 2020: COVID-19: the virus in the control of culture?. Revista da Associacao Medica Brasileira 66(3): 242-244
Parisi, S.G.; Viel, G.; Cecchi, R.; Montisci, M. 2020: COVID-19: the wrong target for healthcare liability claims. Legal Medicine 2020: 101718
Nelson, C.W. 2020: COVID-19: time for WHO to reconsider its stance towards Taiwan. Nature 579(7798): 193
Watson, A.; McKinnon, T.; Prior, S-Daisy.; Richards, L.; Green, C.A. 2020: COVID-19: time for a bold new strategy for medical education. Medical Education Online 25(1): 1764741
Salifu, Y.; Atout, M.; Shivji, N.; Khalid, D.S.; Bardi, J.N. 2020: COVID-19: time to rethink palliative care strategy in resource-poor settings. International Journal of Palliative Nursing 26(6): 268-271
Cao, W.; Li, T. 2020: COVID-19: towards understanding of pathogenesis. Cell Research 30(5): 367-369
Knight, J.; Day, M.; Lee, A.C.K.; Morling, J.R. 2021: COVID-19: transferring learning from the pandemic response to non-communicable disease control. Public Health 197: A1-A2
Von Keyserlingk, M.A.G. 2021: COVID-19: transitioning from in class to online teaching in a heartbeat-Research Methods in Applied Biology. Translational Animal Science 5(1): Txab 014
Pullen, L.C. 2020: COVID-19: transplant works toward adaptation. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20(10): 2633-2634
Ai, J.; Li, Y.; Zhou, X.; Zhang, W. 2020: COVID-19: treating and managing severe cases. Cell Research 30(5): 370-371
Janda, A.; Schuetz, C.; Heeg, M.; Minden, K.; Hedrich, C.M.; Kallinich, T.; Hinze, C.; Schulz, A.; Speth, F. 2020: COVID-19: treatment strategies of German-speaking pediatric rheumatologists : Results of an online survey. Zeitschrift für Rheumatologie 79(7): 710-717
Fretheim, A. 2021: COVID-19: underpowered randomised trials, or no randomised trials?. Trials 22(1): 234
Nkengasong, J.N. 2021: COVID-19: unprecedented but expected. Nature Medicine 27(3): 364
Lippi, G.; Sanchis-Gomar, F.; Henry, B.M. 2020: COVID-19: unravelling the clinical progression of nature's virtually perfect biological weapon. Annals of Translational Medicine 8(11): 693
Ertan, D.; El-Hage, W.; Thierrée, S.; Javelot, Hé.; Hingray, C. 2020: COVID-19: urgency for distancing from domestic violence. European Journal of Psychotraumatology 11(1): 1800245
Howard, G.; Bartram, J.; Brocklehurst, C.; Colford, J.M.; Costa, F.; Cunliffe, D.; Dreibelbis, R.; Eisenberg, J.N.S.; Evans, B.; Girones, R.; Hrudey, S.; Willetts, J.; Wright, C.Y. 2020: COVID-19: urgent actions, critical reflections and future relevance of 'WaSH': lessons for the current and future pandemics. Journal of Water and Health 18(5): 613-630
Johnston, B.; Blades, S. 2020: COVID-19: using 'knitted hearts' in end-of-life care to enable continuing bonds and memory making. International Journal of Palliative Nursing 26(8): 391-393
Messina, F.; Giombini, E.; Agrati, C.; Vairo, F.; Ascoli Bartoli, T.; Al Moghazi, S.; Piacentini, M.; Locatelli, F.; Kobinger, G.; Maeurer, M.; Zumla, A.; Capobianchi, M.R.; Lauria, F.N.; Ippolito, G.; Abbate, I.; Agrati, C.; Al Moghazi, S.; Ascoli Bartoli, T.; Bartolini, B.; Capobianchi, M.R.; Capone, A.; Goletti, D.; Rozera, G.; Nisii, C.; Gagliardini, R.; Ciccosanti, F.; Fimia, G.M.; Nicastri, E.; Giombini, E.; Lanini, S.; D'Abramo, A.; Rinonapoli, G.; Girardi, E.; Montaldo, C.; Marconi, R.; Addis, A.; Maron, B.; Bianconi, G.; De Meulder, B.; Kennedy, J.; Khader, S.A.; Luca, F.; Maeurer, M.; Piacentini, M.; Merler, S.; Pantaleo, G.; Sekaly, R.-P.; Sanna, S.; Segata, N.; Zumla, A.; Messina, F.; Vairo, F.; Lauria, F.N.; Ippolito, G. 2020: COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection. Journal of Translational Medicine 18(1): 233
Serrano Gallardo, P. 2021: COVID-19: vulnerability in the eye of the hurricane. Enfermeria Clinica 31: S2-S3
McLeod, M.; Gurney, J.; Harris, R.; Cormack, D.; King, P. 2020: COVID-19: we must not forget about Indigenous health and equity. Australian and New Zealand journal of public health 44(4): 253-256
Fretheim, A.; Flatø, M.; Steens, A.; Flottorp, S.A.; Rose, C.J.; Telle, K.E.; Kinge, J.M.; Schwarze, P.E. 2020: COVID-19: we need randomised trials of school closures. Journal of Epidemiology and Community Health 74(12): 1078-1079
The Lancet Microbe 2020: COVID-19: we will not be returning to the old normal. LANCET. Microbe 1(6): E226
Ionio, C.; Gallese, M.; Fenaroli, V.; Smorti, M.; Greco, A.; Testa, I.; Zilioli, A.; Bonassi, L. 2021: COVID-19: what about pregnant women during first lockdown in Italy?. Journal of Reproductive and Infant Psychology 2021: 1-13
Gorman, D.; Horn, M. 2021: COVID-19: what comes after elimination?. New Zealand Medical Journal 134(1543): 8-11
Gelardi, M.; Iannuzzi, L.; Trecca, E.M.C.; Kim, B.; Quaranta, N.A.A.; Cassano, M. 2020: COVID-19: what happened to all of the otolaryngology emergencies?. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies: Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 277(11): 3231-3232
Gelardi, M.; Iannuzzi, L.; Trecca, E.M.C.; Kim, B.; Quaranta, N.A.A.; Cassano, M. 2020: COVID-19: what happened to all of the otolaryngology emergencies?. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies: Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2020: 1-2
Ho, Y.-L.; Miethke-Morais, A. 2020: COVID-19: what have we learned?. Jornal Brasileiro de Pneumologia: Publicacao Oficial da Sociedade Brasileira de Pneumologia e Tisilogia 46(3): E20200216
Sridhar, D. 2020: COVID-19: what health experts could and could not predict. Nature Medicine 26(12): 1812
Kelman, I. 2020: COVID-19: what is the disaster?. Social Anthropology: the Journal of the European Association of Social Anthropologists 28(2): 296-297
Pougnet, R.; Pougnet, L.; Dewitte, J.-D. 2020: COVID-19: what protection for hospital staff?. Revue de l'Infirmiere 69(266): 29
Montanari Vergallo, G.; Varone, M.Cristina.; Del Rio, A. 2021: COVID-19: when health care resources run short, how to pick who should (not) get treated?. ActaBio-Medica:AteneiParmensis 92(4):E2021372
Bauch, C.T.; Anand, M. 2020: COVID-19: when should quarantine be enforced?. LANCET. Infectious Diseases 20(9): 994-995
De Rosa, F.G.; Lupia, T.; Corcione, S. 2020: COVID-19: where have the lymphocytes gone?. Internal Medicine Journal 50(11): 1436-1437
Bullerdiek, J.ör.; Bock-Steinweg, U. 2021: COVID-19: women with PCO syndrome at higher risk. Gynakologische Endokrinologie 19(4): 319-320
Jayakumar, K. 2020: COVID-19:: An impasse between livelihood and health. Delaware Journal of Public Health 6(3): 81
Mohamadian, M.; Chiti, H.; Shoghli, A.; Biglari, S.; Parsamanesh, N.; Esmaeilzadeh, A. 2021: COVID-19: Virology, biology and novel laboratory diagnosis. Journal of Gene Medicine 23(2): E3303
Nasoodi, A.; Johnston, C.; Fraioli, F. 2020: COVID-19; beyond the obvious: how do we move forward?. European Journal of Nuclear Medicine and Molecular Imaging 47(9): 2070-2071
Saeed, H.; Osama, H.; Madney, Y.M.; Harb, H.S.; Abdelrahman, M.A.; Ehrhardt, C.; Abdelrahim, M.E.A. 2021: COVID-19; current situation and recommended interventions. International Journal of Clinical Practice 75(5): E13886
Bonnet, F. 2020: COVID-19 a few months after the beginning of the first pandemic. Le Praticien en Anesthesie Reanimation 24(4): 177-178
Micallef, J.ël.; Soeiro, T.; Jonville-Béra, A.-P. 2020: COVID-19 and NSAIDs: Primum non nocere. Therapie 75(5): 514-515
Heuser, K.; Berger, T.C.; Henning, O.; Svalheim, S.; Sibeko, J.ør.M.; Nakken, K.O.; Taubøll, E. 2021: COVID-19 and epilepsy. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 141(10)
Hoff, J.M.; Midelfart, A. 2021: COVID-19 and myopia. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 141(9)
Nystad, T.W.; Hufthammer, K.O.; Buanes, E.A.; Bryne, K.; Fevang, B.ør.-T.S. 2021: COVID-19 in patients with chronic inflammatory rheumatic joint disease. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 141(2021-14)
Jacob Alby, V. 2020: COVID-19 victims: to be or not to be ?. Annales Medico-Psychologiques 178(7): 717-721
Marti, J.; Ferro-Luzzi, G. 2021: COVID-19 : a double punishment for vulnerable households in Switzerland. Revue Medicale Suisse 17(724): 248-253
Shanmugam, C.; Mohammed, A.Rafi.; Ravuri, S.; Luthra, V.; Rajagopal, N.; Karre, S. 2020: COVID-2019 - A comprehensive pathology insight. Pathology Research and Practice 216(10): 153222
Liu, L.; Cai, D.; Huang, X.; Shen, Y. 2021: COVID-2019 Associated with Acquired Monocular Blindness. Current Eye Research 2021: 1-4
Lamberghini, F.; Testai, F.D. 2021: COVID-2019 fundamentals. Journal of the American Dental Association 152(5): 354-363
Xin, Y.; Shao, S.; Wang, Z.; Xu, Z.; Li, H. 2021: COVID-2019 lockdown in Beijing: a rare opportunity to analyze the contribution rate of road traffic to air pollutants. Sustainable Cities and Society 75: 102989
Datta, R. 2020: COVID-2019: Experience of setting up quarantine center. Journal of Anaesthesiology Clinical Pharmacology 36(Suppl 1): S14-S18
Ashton, J. 2021: COVID-21: just when you thought it was safe to go back in the water. Journal of the Royal Society of Medicine 114(3): 146-147
Silva, P.ôn.C.L.; Batista, P.V.C.; Lima, H.él.S.; Alves, M.A.; Guimarães, F.G.; Silva, R.C.P. 2020: COVID-ABS: An agent-based model of COVID-19 epidemic to simulate health and economic effects of social distancing interventions. Chaos Solitons and Fractals 139: 110088
Wu, X.; Chen, C.; Zhong, M.; Wang, J.; Shi, J. 2021: COVID-AL: the diagnosis of COVID-19 with deep active learning. Medical Image Analysis 68: 101913
Verdiner, R.E.; Choukalas, C.G.; Siddiqui, S.; Stahl, D.L.; Galvagno, S.M.; Jabaley, C.S.; Bartz, R.R.; Lane-Fall, M.; Goff, K.L.; Sreedharan, R.; Bennett, S.; Williams, G.W.; Khanna, A.K. 2020: COVID-Activated Emergency Scaling of Anesthesiology Responsibilities Intensive Care Unit. Anesthesia and Analgesia 131(2): 365-377
Iqbal, A.; Ramzan, M.; Akhtar, A.; Ahtesham, A.; Aslam, S.; Khalid, J. 2021: COVID-Associated Pulmonary Aspergillosis and its Related Outcomes: a Single-Center Prospective Observational Study. Cureus 13(8): E16982
Afshar, P.; Heidarian, S.; Naderkhani, F.; Oikonomou, A.; Plataniotis, K.N.; Mohammadi, A. 2020: COVID-CAPS: a capsule network-based framework for identification of COVID-19 cases from X-ray images. Pattern Recognition Letters 138: 638-643
Afshar, P.; Heidarian, S.; Enshaei, N.; Naderkhani, F.; Rafiee, M.Javad.; Oikonomou, A.; Fard, F.Babaki.; Samimi, K.; Plataniotis, K.N.; Mohammadi, A. 2021: COVID-CT-MD, COVID-19 computed tomography scan dataset applicable in machine learning and deep learning. Scientific Data 8(1): 121
Al-Waisy, A.S.; Al-Fahdawi, S.; Mohammed, M.A.; Abdulkareem, K.H.; Mostafa, S.A.; Maashi, M.S.; Arif, M.; Garcia-Zapirain, B. 2020: COVID-CheXNet: hybrid deep learning framework for identifying COVID-19 virus in chest X-rays images. Soft Computing 2020: 1-16
Khuzani, A.Z.; Heidari, M.; Shariati, S.A. 2020: COVID-Classifier: An automated machine learning model to assist in the diagnosis of COVID-19 infection in chest x-ray images. Medrxiv: the Preprint Server for Health Sciences 2020
Zargari Khuzani, A.; Heidari, M.; Shariati, S.Ali. 2021: COVID-Classifier: an automated machine learning model to assist in the diagnosis of COVID-19 infection in chest X-ray images. Scientific Reports 11(1): 9887
Saha, I.; Ghosh, N.; Maity, D.; Seal, A.; Plewczynski, D. 2021: COVID-DeepPredictor: Recurrent Neural Network to Predict SARS-CoV-2 and other Pathogenic Viruses. Frontiers in Genetics 12: 569120
Heidarian, S.; Afshar, P.; Enshaei, N.; Naderkhani, F.; Rafiee, M.J.; Babaki Fard, F.; Samimi, K.; Atashzar, S.F.; Oikonomou, A.; Plataniotis, K.N.; Mohammadi, A. 2021: COVID-FACT: a Fully-Automated Capsule Network-Based Framework for Identification of COVID-19 Cases from Chest CT Scans. Frontiers in Artificial Intelligence 4: 598932
Demurtas, J.; Tonelli, R.; Celotto, S.; Veronese, N.; Lagolio, E.; Rossi, F.; Clini, E.; Righi, E.; Meer, A. 2021: COVID-Guide: an app for covid-19 triage and self-assessment. Recenti Progressi in Medicina 112(5): 387-391
Garcia-Gordillo, J.é A.; Camiro-Zúñiga, A.; Aguilar-Soto, M.; Cuenca, D.; Cadena-Fernández, A.; Khouri, L.S.; Rayek, J.N.; Mercado, M. 2021: COVID-IRS: a novel predictive score for risk of invasive mechanical ventilation in patients with COVID-19. Plos one 16(4): E0248357
Elkattawy, S.; Ayad, S.; Younes, I.; Singh, Z.; Alyacoub, R.; Brescia, M.L. 2021: COVID-Induced Spontaneous Pneumothoraxes: Case Series. Cureus 13(4): E14567
Korn, D.; Bobrowski, T.; Li, M.; Kebede, Y.; Wang, P.; Owen, P.; Vaidya, G.; Muratov, E.; Chirkova, R.; Bizon, C.; Tropsha, A. 2020: COVID-KOP: Integrating Emerging COVID-19 Data with the ROBOKOP Database. Chemrxiv: the Preprint Server for Chemistry 2020
Bayrakci, B. 2021: COVID-Lung: the Battlefield. Journal of Pediatric Intensive Care 10(1): 1-3
Trubiano, J.A.; Vogrin, S.; Smibert, O.C.; Marhoon, N.; Alexander, A.A.; Chua, K.Y.L.; James, F.L.; Jones, N.R.L.; Grigg, S.E.; Xu, C.L.H.; Moini, N.; Stanley, S.R.; Birrell, M.T.; Rose, M.T.; Gordon, C.L.; Kwong, J.C.; Holmes, N.E. 2020: COVID-MATCH65-A prospectively derived clinical decision rule for severe acute respiratory syndrome coronavirus 2. Plos one 15(12): E0243414
Richards, D.A.; Sugg, H.V.; Cockcroft, E.; Cooper, J.; Cruickshank, S.; Doris, F.; Hulme, C.; Logan, P.; Iles-Smith, H.; Melendez-Torres, G.J.; Rafferty, A.M.; Reed, N.; Russell, A.-M.; Shepherd, M.; Singh, S.J.; Thompson Coon, J.; Tooze, S.; Wootton, S.; Abbott, R.; Bethel, A.; Creanor, S.; Quinn, L.; Tripp, H.; Warren, F.C.; Whear, R.; Bollen, J.; Hunt, H.A.; Kent, M.; Morgan, L.; Morley, N.; Romanczuk, L. 2021: COVID-NURSE: evaluation of a fundamental nursing care protocol compared with care as usual on experience of care for noninvasively ventilated patients in hospital with the SARS-CoV-2 virus-protocol for a cluster randomised controlled trial. Bmj Open 11(5): E046436
Wang, L.; Lin, Z.Qiu.; Wong, A. 2020: COVID-Net: a tailored deep convolutional neural network design for detection of COVID-19 cases from chest X-ray images. Scientific Reports 10(1): 19549
Alshazly, H.; Linse, C.; Abdalla, M.; Barth, E.; Martinetz, T. 2021: COVID-Nets: deep CNN architectures for detecting COVID-19 using chest CT scans. PEERJ. Computer Science 7: E655
Cascella, M.; Del Gaudio, A.; Vittori, A.; Bimonte, S.; Del Prete, P.; Forte, C.A.; Cuomo, A.; De Blasio, E. 2021: COVID-Pain: Acute and Late-Onset Painful Clinical Manifestations in COVID-19 - Molecular Mechanisms and Research Perspectives. Journal of Pain Research 14: 2403-2412
Rose, A.J.; Ellen, M.E. 2020: COVID-Related Disruption-Finding the Silver Lining. Journal of General Internal Medicine 35(11): 3361-3362
Ross, S.B.; Wilson, M.G.; Papillon-Ferland, L.; Elsayed, S.; Wu, P.E.; Battu, K.; Porter, S.; Rashidi, B.; Tamblyn, R.; Pilote, L.; Downar, J.; Bonnici, A.; Huang, A.; Lee, T.C.; McDonald, E.G. 2020: COVID-SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults. Journal of the American Geriatrics Society 68(8): 1636-1646
Lazarus, J.V.; Ratzan, S.; Palayew, A.; Billari, F.C.; Binagwaho, A.; Kimball, S.; Larson, H.J.; Melegaro, A.; Rabin, K.; White, T.M.; El-Mohandes, A. 2020: COVID-SCORE: a global survey to assess public perceptions of government responses to COVID-19 (COVID-SCORE-10). Plos one 15(10): E0240011
De Lima, C.L.; da Silva, C.C.; da Silva, A.C.G.; Luiz Silva, E.; Marques, G.S.; de Araújo, L.J.B.; Albuquerque Júnior, L.A.ôn.; de Souza, S.B.J.á; de Santana, M.ír.A.új.; Gomes, J.C.; de Freitas Barbosa, V.A.; Musah, A.; Kostkova, P.; Dos Santos, W.P.; da Silva Filho, A.G. 2020: COVID-SGIS: a Smart Tool for Dynamic Monitoring and Temporal Forecasting of Covid-19. Frontiers in Public Health 8: 580815
Gupta, R.; Pandi-Perumal, S.R. 2020: COVID-Somnia: how the Pandemic Affects Sleep/Wake Regulation and how to Deal with it?. Sleep and Vigilance 4(2): 51-53
Zohner, Y.E.; Morris, J.S. 2021: COVID-TRACK: world and USA SARS-COV-2 testing and COVID-19 tracking. Biodata Mining 14(1): 4
Yang, Y.; Anstey, J.; Yastrebov, K.; Nanjayya, V.B.; Orde, S.; Nalos, M.; Costello, C.; Ryan, N.P.G. 2020: COVID-US: a simplified approach to cardiopulmonary ultrasound in suspected and confirmed COVID-19 patients in surge crisis. Australasian Journal of Ultrasound in Medicine 23(2): 96-102
Zhang, S.X.; Balada-Llasat, J.-M.; Pancholi, P.; Sullivan, K.V.; Riedel, S. 2021: COVID-Associated Pulmonary Aspergillosis in the United States: Is it Rare or have we Missed the Diagnosis?. Journal of Clinical Microbiology 59(10): E0113521
Conforti, A.; Marra, E.; Palombo, F.; Roscilli, G.; Ravà, M.; Fumagalli, V.; Muzi, A.; Maffei, M.; Luberto, L.; Lione, L.; Salvatori, E.; Compagnone, M.; Pinto, E.; Pavoni, E.; Bucci, F.; Vitagliano, G.; Stoppoloni, D.; Pacello, M.L.; Cappelletti, M.; Ferrara, F.F.; D'Acunto, E.; Chiarini, V.; Arriga, R.; Nyska, A.; Di Lucia, P.; Marotta, D.; Bono, E.; Giustini, L.; Sala, E.; Perucchini, C.; Paterson, J.; Ryan, K.A.; Challis, A.-R.; Matusali, G.; Colavita, F.; Caselli, G.; Criscuolo, E.; Clementi, N.; Mancini, N.; Groß, R.üd.; Seidel, A.; Wettstein, L.; Münch, J.; Donnici, L.; Conti, M.; De Francesco, R.; Kuka, M.; Ciliberto, G.; Castilletti, C.; Capobianchi, M.R.; Ippolito, G.; Guidotti, L.G.; Rovati, L.; Iannacone, M.; Aurisicchi 2022: COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models. Molecular Therapy: the Journal of the American Society of Gene Therapy 30(1): 311-326
De Carvalho Brito, V.ór.; Dos Santos, P.R.S.; de Sales Carvalho, N.R.; de Carvalho Filho, A.O. 2021: COVID-index: a texture-based approach to classifying lung lesions based on CT images. Pattern Recognition 119: 108083
McLaren, R.A.; Trejo, F.E.; Blitz, M.J.; Bianco, A.; Limaye, M.; Brustman, L.; Bernstein, P.S.; Roman, A.S.; Stone, J.; Minkoff, H. 2021: COVID-related "lockdowns" and birth rates in new York. American Journal of Obstetrics and Gynecology Mfm 3(6): 100476
Ishii, A.; Reinhard, A.; Simon, C.; Schweizer, Vérie.; Todic, J. 2021: COVID-related ENT affections: acute management and issues of rehabilitation strategy. Revue Medicale Suisse 17(753): 1681-1683
Montauk, T.R.; Kuhl, E.A. 2020: COVID-related family separation and trauma in the intensive care unit. Psychological Trauma: Theory Research Practice and Policy 12(S1): S96-S97
Wissemann, K.; Mathes, B.; Meyer, A.; Schmidt, N.B. 2021: COVID-related fear maintains controlling parenting behaviors during the pandemic. Cognitive Behaviour Therapy 2021: 1-15
Tomasik, B.; Braun, M. 2021: COVID-related upsurge in diagnoses of advanced breast cancer-is a disruption in mammography screening the one to be blamed?. Esmo Open 6(3): 100108
Yatim, A.; Gilliet, M. 2021: COVID-toes, a cutaneous sign of innate resistance to SARS-CoV-2. Revue Medicale Suisse 17(732): 646-652
Mallapaty, S.; Ledford, H. 2020: COVID-vaccine results are on the way - and scientists' concerns are growing. Nature 586(7827): 16-17
Gesesew, H.A.; Mwanri, L.; Stephens, J.H.; Woldemichael, K.; Ward, P. 2021: COVID/HIV Co-Infection: a Syndemic Perspective on what to Ask and how to Answer. Frontiers in Public Health 9: 623468
Mulholland, A.J.; Amaro, R.E. 2020: COVID19 - Computational Chemists Meet the Moment. Journal of Chemical Information and Modeling 60(12): 5724-5726
Waddington, G.S. 2020: COVID19 - Moving forward. Journal of Science and Medicine in Sport 23(7): 633
Lee, A.; Morling, J.R.; Bhopal, R.S. 2020: COVID19 - Why open and honest public dialogue is needed. Public Health 188: A1-A2
Ahmed, T.; Ahmed, T.; Karimi, H.; Tolle, L.; Iqbal, M.N. 2021: COVID19 Acute respiratory distress syndrome and extra-corporeal membrane oxygenation; a mere option or ultimate necessity. Perfusion 36(6): 559-563
Ostaszewski, M.; Niarakis, A.; Mazein, A.; Kuperstein, I.; Phair, R.; Orta-Resendiz, A.; Singh, V.; Aghamiri, S.S.; Acencio, M.L.; Glaab, E.; Ruepp, A.; Fobo, G.; Montrone, C.; Brauner, B.; Frishman, G.; Monraz Gómez, L.C.ób.; Somers, J.; Hoch, M.; Kumar Gupta, S.; Scheel, J.; Borlinghaus, H.; Czauderna, T.; Schreiber, F.; Montagud, A.; Ponce de Leon, M.; Funahashi, A.; Hiki, Y.; Hiroi, N.; Yamada, T.G.; Dräger, A.; Renz, A.; Naveez, M.; Bocskei, Z.; Messina, F.; Börnigen, D.; Fergusson, L.; Conti, M.; Rameil, M.; Nakonecnij, V.; Vanhoefer, J.; Schmiester, L.; Wang, M.; Ackerman, E.E.; Shoemaker, J.E.; Zucker, J.; Oxford, K.; Teuton, J.; Kocakaya, E.; Summak, G.ök.çe.Y.ğm.; Hanspers, K.; Kutmon, M.; Coort, S.; Eijssen, L.; Ehrhart, F 2021: COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms. Molecular Systems Biology 17(10): E10387
Stufano, A.; Lisco, S.; Bartolomeo, N.; Marsico, A.; Lucchese, G.; Jahantigh, H.; Soleo, L.; Moretti, M.; Trerotoli, P.; De Palma, G.; Lovreglio, P. 2021: COVID19 outbreak in Lombardy, Italy: An analysis on the short-term relationship between air pollution, climatic factors and the susceptibility to SARS-CoV-2 infection. Environmental Research 198: 111197
Garcia, P.; Anand, S.; Han, J.; Montez-Rath, M.E.; Sun, S.; Shang, T.; Parsonnet, J.; Chertow, G.M.; Schiller, B.; Abra, G. 2022: COVID-19 Vaccine Type and Humoral Immune Response in Patients Receiving Dialysis. Journal of the American Society of Nephrology: Jasn 33(1): 33-37
Dolnicar, S.; Zare, S. 2020: COVID19 and Airbnb - Disrupting the Disruptor. Annals of Tourism Research 83: 102961
Bellini, M.I.; Pengel, L.; Potena, L.; Segantini, L. 2021: COVID-19 and education: restructuring after the pandemic. Transplant International: Official Journal of the European Society for Organ Transplantation 34(2): 220-223
Nieuwenhuijsen, M.J. 2020: COVID19 and the city; from the short term to the long term. Environmental Research 191: 110066
Ragnesola, B.; Jin, D.; Lamb, C.C.; Shaz, B.H.; Hillyer, C.D.; Luchsinger, L.L. 2020: COVID19 antibody detection using lateral flow assay tests in a cohort of convalescent plasma donors. Bmc Research Notes 13(1): 372
Focosi, D.; Franchini, M. 2021: COVID19 immune plasma donation after vaccination: pros and cons. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 60(4): 103151
Gupta, R.; Misra, A. 2020: COVID19 in South Asians/Asian Indians: Heterogeneity of data and implications for pathophysiology and research. Diabetes Research and Clinical Practice 165: 108267
Radhakrishnan, V.; Ovett, J.; Rajendran, A.; Kolluru, S.; Pai, V.; Gnanaguru, V.; Dhanushkodi, M.; Kalaiyarasi, J.Perumal.; Mehra, N.; Selvarajan, G.; Rajan, A.Kumar.; Karunakaran, P.; Kesana, S.; Sagar, T. 2020: COVID19 in children with cancer in low- and middle-income countries: Experience from a cancer center in Chennai, India. Pediatric Hematology and Oncology 2020: 1-7
Ghosh, A.; Gupta, V.; Misra, A. 2020: COVID19 induced acute pancreatitis and pancreatic necrosis in a patient with type 2 diabetes. Diabetes and Metabolic Syndrome 14(6): 2097-2098
Shikdar, S.; Borogovac, A.; Mohamad, E.; Khawandanah, M. 2021: COVID19 infection in a patient undergoing treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH) with Ravulizumab. Thrombosis Journal 19(1): 75
Jawaid Akhtar, M. 2020: COVID19 inhibitors: a prospective therapeutics. Bioorganic Chemistry 101: 104027
Hotez, P.J. 2020: COVID19 meets the antivaccine movement. Microbes and Infection 22(4-5): 162-164
Vecchio, S.; Ramella, R.; Drago, A.; Carraro, D.; Littlewood, R.; Somaini, L. 2020: COVID19 pandemic and people with opioid use disorder: innovation to reduce risk. Psychiatry Research 289: 113047
Aggarwal, A.; Tandon, A.; Bhatt, S.; Aggarwal, A.; Dagar, S.; Bansal, H. 2021: COVID19 pneumonia with cavitation and cystic lung changes: multi-detector computed tomography spectrum of a gamut of etiologies. Bjr Open 3(1): 20210007
Gallagher, T. 2021: COVID19 therapeutics: Expanding the antiviral arsenal. Ebiomedicine 66: 103289
Sucker, C.; Kappert, G.ün.; Koscielny, J.ür. 2020: COVID19 und Versorgung mit Blutkomponenten, aktueller Stand bzgl. Einführung der Telematik-Infrastruktur, GSAV und ASV. Hamostaseologie 40(5): 694-696
Garcia, P.; Anand, S.; Han, J.; Montez-Rath, M.; Sun, S.; Shang, T.; Parsonnet, J.; Chertow, G.M.; Schiller, B.; Abra, G. 2021: COVID19 vaccine type and humoral immune response in patients receiving dialysis. Medrxiv: the Preprint Server for Health Sciences 2021
Lee, A.C.K.; Alwan, N.A.; Morling, J.R. 2020: COVID19, race and public health. Public Health 185: A1-A2
Shakouri, S.; Bakhshali, M.A.; Layegh, P.; Kiani, B.; Masoumi, F.; Ataei Nakhaei, S.; Mostafavi, S.M. 2021: COVID19-CT-dataset: an open-access chest CT image repository of 1000+ patients with confirmed COVID-19 diagnosis. Bmc Research Notes 14(1): 178
Ronaghi, F.; Salimibeni, M.; Naderkhani, F.; Mohammadi, A. 2022: COVID19-HPSMP : COVID-19 adopted Hybrid and Parallel deep information fusion framework for stock price movement prediction. Expert Systems with Applications 187: 115879
Dimai, S.; Semmler, L.; Prabhu, A.; Stachelscheid, H.; Huettemeister, J.; Klaucke, S.C.; Lacour, P.; Blaschke, F.; Kruse, J.; Parwani, A.; Boldt, L.-H.; Bullinger, L.; Pieske, B.M.; Heinzel, F.R.; Hohendanner, F. 2021: COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab. Plos one 16(8): E0255976
LeTourneux, F.éd.ér.; Grandmont, T.; Dulude-de Broin, F.éd.ér.; Martin, M.-C.; Lefebvre, J.ée.; Kato, A.; Bêty, J.ël.; Gauthier, G.; Legagneux, P. 2021: COVID19-induced reduction in human disturbance enhances fattening of an overabundant goose species. Biological Conservation 255: 108968
Kalra, R.Singh.; Kumar, V.; Dhanjal, J.Kaur.; Garg, S.; Li, X.; Kaul, S.C.; Sundar, D.; Wadhwa, R. 2021: COVID19-inhibitory activity of withanolides involves targeting of the host cell surface receptor ACE2: insights from computational and biochemical assays. Journal of Biomolecular Structure and Dynamics 2021: 1-14
Tebé, C.; Valls, J.; Satorra, P.; Tobías, A. 2020: COVID19-world: a shiny application to perform comprehensive country-specific data visualization for SARS-CoV-2 epidemic. Bmc Medical Research Methodology 20(1): 235
Siraj, A.; Hassan, Z.; Khan, M.Shahbaz. 2020: COVID19: A Matter of State and Faith. JournaloftheCollegeofPhysiciansandSurgeons--Pakistan:Jcpsp 30(6): 81
Zhao, Y.; Cui, C.; Zhang, K.; Liu, J.; Xu, J.; Nisenbaum, E.; Huang, Y.; Qin, G.; Chen, B.; Hoffer, M.; Blanton, S.H.; Telischi, F.; Hare, J.M.; Daunert, S.; Shukla, B.; Pahwa, S.G.; Jayaweera, D.T.; Farmer, P.E.; Del Rio, C.; Liu, X.; Shu, Y. 2020: COVID19: a Systematic Approach to Early Identification and Healthcare Worker Protection. Frontiers in Public Health 8: 205
Worsley, P.R.; Spratt, F.; Bader, D.L. 2020: COVID19: Challenging tissue viability in both patients and clinicians. Journal of Tissue Viability 29(3): 153-154
Pappas, N. 2021: COVID19: Holiday intentions during a pandemic. Tourism Management 84: 104287
Platto, S.; Xue, T.; Carafoli, E. 2020: COVID19: an announced pandemic. Cell Death and Disease 11(9): 799
Punjabi, P.P. 2020: COVID19: ethnic, cardiovascular and renal: pandemic causing pandemonium. Perfusion 35(6): 451
Bertoncelli, D.; Guidarini, M.; Della Greca, A.; Ratti, C.; Falcinella, F.; Iovane, B.; Dutto, M.Luigi.; Caffarelli, C.; Tchana, B. 2020: COVID19: potential cardiovascular issues in pediatric patients. Acta Bio-Medica: Atenei Parmensis 91(2): 177-183
Zhang, R.; Guo, Z.; Sun, Y.; Lu, Q.; Xu, Z.; Yao, Z.; Duan, M.; Liu, S.; Ren, Y.; Huang, L.; Zhou, F. 2020: COVID19XrayNet: a Two-Step Transfer Learning Model for the COVID-19 Detecting Problem Based on a Limited Number of Chest X-Ray Images. Interdisciplinary Sciences Computational Life Sciences 12(4): 555-565
Bennett, J. 2020: COVID: its compassionate use. Journal of Vascular Nursing: Official Publication of the Society for Peripheral Vascular Nursing 38(4): 163
Pal, R. 2020: COVID: we need citizen's charter for common folks. Journal of Family Medicine and Primary Care 9(9): 5083-5084
Rauchman, S. 2021: COVID: treatment trials are still urgent. Nature 594(7861): 26
Echeverría, P.; Mas Bergas, M.A.; Puig, J.; Isnard, M.; Massot, M.; Vedia, C.; Peiró, R.; Ordorica, Y.; Pablo, S.; Ulldemolins, M.ía.; Iruela, M.é; Balart, D.; Ruiz, J.é M.ía.; Herms, J.; Clotet Sala, B.; Negredo, E. 2020: COVIDApp as an Innovative Strategy for the Management and Follow-Up of COVID-19 Cases in Long-Term Care Facilities in Catalonia: Implementation Study. Jmir Public Health and Surveillance 6(3): E21163
Abbasi, W.A.; Abbas, S.A.; Andleeb, S.; Ul Islam, G.; Ajaz, S.A.; Arshad, K.; Khalil, S.; Anjam, A.; Ilyas, K.; Saleem, M.; Chughtai, J.; Abbas, A. 2021: COVIDC: An expert system to diagnose COVID-19 and predict its severity using chest CT scans: Application in radiology. Informatics in Medicine Unlocked 23: 100540
Tabik, S.; Gomez-Rios, A.; Martin-Rodriguez, J.L.; Sevillano-Garcia, I.; Rey-Area, M.; Charte, D.; Guirado, E.; Suarez, J.L.; Luengo, J.; Valero-Gonzalez, M.A.; Garcia-Villanova, P.; Olmedo-Sanchez, E.; Herrera, F. 2020: COVIDGR Dataset and COVID-SDNet Methodology for Predicting COVID-19 Based on Chest X-Ray Images. IEEE Journal of Biomedical and Health Informatics 24(12): 3595-3605
Tomaiuolo, R.; Derrico, P.; Ritrovato, M.; Locatelli, M.; Milella, F.; Restelli, U.; Lago, P.; Giuliani, F.; Banfi, G. 2021: COVIDIAGNOSTIX: health technology assessment of serological tests for SARS-CoV-2 infection. International Journal of Technology Assessment in Health Care 37(1): E87
Gunraj, H.; Wang, L.; Wong, A. 2020: COVIDNet-CT: a Tailored Deep Convolutional Neural Network Design for Detection of COVID-19 Cases from Chest CT Images. Frontiers in Medicine 7: 608525
Strohbehn, G.W.; Heiss, B.L.; Rouhani, S.J.; Trujillo, J.A.; Yu, J.; Kacew, A.J.; Higgs, E.F.; Bloodworth, J.C.; Cabanov, A.; Wright, R.C.; Koziol, A.; Weiss, A.; Danahey, K.; Karrison, T.G.; Edens, C.C.; Ventura, I.B.; Pettit, N.N.; Patel, B.; Pisano, J.; Strek, M.E.; Gajewski, T.F.; Ratain, M.J.; Reid, P.D. 2020: COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19. Medrxiv: the Preprint Server for Health Sciences 2020
Nagy, Ád.ám.; Ligeti, B.áz.; Szebeni, J.án.; Pongor, S.án.; Gyrffy, B.áz. 2021: COVIDOUTCOME-estimating COVID severity based on mutation signatures in the SARS-CoV-2 genome. Database: the Journal of Biological Databases and Curation 2021
Seco, M.; Wood, J.; Wilson, M.K. 2020: COVIDSafe thoracic surgery: Minimizing intraoperative exposure to aerosols. Jtcvs Techniques 3: 412-414
Singh, R.K.; Pandey, R.; Babu, R.N. 2021: COVIDScreen: explainable deep learning framework for differential diagnosis of COVID-19 using chest X-rays. Neural Computing and Applications 33(14): 8871-8892
Van der Toorn, W.; Oh, D.-Y.; von Kleist, M. 2021: COVIDStrategyCalculator: a software to assess testing and quarantine strategies for incoming travelers, contact management, and de-isolation. Patterns 2(6): 100264
Elakkiya, R.; Vijayakumar, P.; Karuppiah, M. 2021: COVID_SCREENET: COVID-19 Screening in Chest Radiography Images Using Deep Transfer Stacking. Information Systems Frontiers: a Journal of Research and Innovation 23(6): 1369-1383
Elkorany, A.S.; Elsharkawy, Z.F. 2021: COVIDetection-Net: a tailored COVID-19 detection from chest radiography images using deep learning. Optik 231: 166405
Yamada, Y.; Ćepulić, D-Borna.; Coll-Martín, T.; Debove, Séphane.; Gautreau, G.; Han, H.; Rasmussen, J.; Tran, T.P.; Travaglino, G.A.; Lieberoth, A.; Blackburn, Aélique.M.; Boullu, Lïs.; Bujić, M.; Byrne, G.; Caniëls, M.C.J.; Flis, I.; Kowal, M.; Rachev, N.R.; Reynoso-Alcántara, V.; Zerhouni, O.; Ahmed, O.; Amin, R.; Aquino, S.; Areias, Jão.Carlos.; Aruta, J.Jamir.Benzon.R.; Bamwesigye, D.; Bavolar, J.; Bender, A.R.; Bhandari, P.; Bircan, T.; Cakal, H.; Capelos, T.; Čeněk, Jří.; Ch'ng, B.; Chen, F-Yu.; Chrona, S.; Contreras-Ibáñez, C.C.; Correa, P.Sebastián.; Cr 2021: COVIDiSTRESS Global Survey dataset on psychological and behavioural consequences of the COVID-19 outbreak. Scientific Data 8(1): 3
Satyam, R.; Yousef, M.; Qazi, S.; Bhat, A.M.; Raza, K. 2021: COVIDium: a COVID-19 resource compendium. Database: the Journal of Biological Databases and Curation 2021
Naumov, V.; Putin, E.; Pushkov, S.; Kozlova, E.; Romantsov, K.; Kalashnikov, A.; Galkin, F.; Tihonova, N.; Shneyderman, A.; Galkin, E.; Zinkevich, A.; Cope, S.M.; Sethuraman, R.; Oprea, T.I.; Pearson, A.T.; Tay, S.; Agrawal, N.; Dubovenko, A.; Vanhaelen, Q.; Ozerov, I.; Aliper, A.; Izumchenko, E.; Zhavoronkov, A. 2021: COVIDomic: a multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity. Plos Computational Biology 17(7): E1009183
Menestrina, L.; Cabrelle, C.; Recanatini, M. 2021: COVIDrugNet: a network-based web tool to investigate the drugs currently in clinical trial to contrast COVID-19. Scientific Reports 11(1): 19426
Hajac, M.; Olchowy, C.; Poręba, R.ł; Gać, P.ł 2021: COVID‑19 pathology imaging: a one-year perspective. Dental and Medical Problems 58(3): 377-384
Kim, J. 2020: Learning and Teaching Online During Covid-19: Experiences of Student Teachers in an Early Childhood Education Practicum. International Journal of Early Childhood 52(2): 145-158
Vaish, A.; Jain, V.K.; Iyengar, K.P.; Vaishya, R. 2020: COVID‑19: Current Knowledge and Best Practices for Orthopaedic Surgeons. Indian Journal of Orthopaedics 54(6): 917-918
Wu, J.; Chen, W.; Zhou, J.; Zhao, W.; Sun, Y.; Zhu, H.; Yao, P.; Chen, S.; Jiang, J.; Zhou, Z. 2020: COVIEdb: a Database for Potential Immune Epitopes of Coronaviruses. Frontiers in Pharmacology 11: 572249
Umer, M.; Ashraf, I.; Ullah, S.; Mehmood, A.; Choi, G.S. 2022: COVINet: a convolutional neural network approach for predicting COVID-19 from chest X-ray images. Journal of Ambient Intelligence and Humanized Computing 13(1): 535-547
Ghosh, S.; Shankar, S.; Chatterjee, K.; Chatterjee, K.; Yadav, A.K.; Pandya, K.; Suryam, V.; Agrawal, S.; Ray, S.; Phutane, V.; Datta, R. 2021: COVISHIELD (AZD1222) VaccINe effectiveness among healthcare and frontline Workers of INdian Armed Forces: Interim results of VIN-WIN cohort study. Medical Journal Armed Forces India 77: S264-S270
Sibicky, S.L. 2021: COViD-19 "Long-Haulers": Caring for Older people in the Aftermath of a Global Pandemic. Senior Care Pharmacist 36(8): 361-362
Alderman, C. 2020: COViD-19: Face Mask Effectiveness, Hand Sanitizer Shortages, and Rapid Medication Therapy Trials. Senior Care Pharmacist 35(6): 243-246
Alderman, C. 2021: COViD-19: We're all in this Together - Some more than Others. Senior Care Pharmacist 36(8): 358-360
Wang, K.; Liu, Y.; Mashrur, S.M.; Loa, P.; Habib, K.N. 2021: COVid-19 influenced households' Interrupted Travel Schedules (COVHITS) survey: Lessons from the fall 2020 cycle. Transport Policy 112: 43-62
Simonetti, M.; Zhang, N.; Harbers, L.; Milia, M.Grazia.; Brossa, S.; Huong Nguyen, T.Thu.; Cerutti, F.; Berrino, E.; Sapino, A.; Bienko, M.; Sottile, A.; Ghisetti, V.; Crosetto, N. 2021: COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance. Nature Communications 12(1): 3903
Zhou, W.; Zhang, J.; Toki, S.; Goleniewska, K.; Norlander, A.E.; Newcomb, D.C.; Wu, P.; Boyd, K.L.; Kita, H.; Peebles, R.S. 2020: COX Inhibition Increases Alternaria-Induced Pulmonary Group 2 Innate Lymphoid Cell Responses and IL-33 Release in Mice. Journal of Immunology 205(4): 1157-1166
Hedberg-Oldfors, C.; Darin, N.; Thomsen, C.; Lindberg, C.; Oldfors, A. 2020: COX deficiency and leukoencephalopathy due to a novel homozygous APOPT1/COA8 mutation. NEUROLOGY. Genetics 6(4): E464
Jeyaraj, B. 2007: COX inhibition for tocolysis and its effect on the neonate. Journal of Perinatology: Official Journal of the California Perinatal Association 27(6): 395; Author Response 395-6
Mazhar, D.; Ang, R.; Waxman, J. 2006: COX inhibitors and breast cancer. British Journal of Cancer 94(3): 346-350
Wang, X-M.; Hamza, M.; Gordon, S.M.; Wahl, S.M.; Dionne, R.A. 2008: COX inhibitors downregulate PDE4D expression in a clinical model of inflammatory pain. Clinical Pharmacology and Therapeutics 84(1): 39-42
Mitchell, J.A.; Warner, T.D. 2006: COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs. Nature Reviews. Drug Discovery 5(1): 75-86
Vanhoutte, P.M. 2009: COX-1 and vascular disease. Clinical Pharmacology and Therapeutics 86(2): 212-215
Johnsson, A.-K.; Rönnberg, E.; Fuchs, D.; Kolmert, J.; Säfholm, J.; Claesson, H.-E.; Hamberg, M.; Wheelock, C.E.; Nilsson, G.; Dahlén, S.-E. 2021: COX-1 dependent biosynthesis of 15-hydroxyeicosatetraenoic acid in human mast cells. Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids 1866(5): 158886
Peng, X.; Li, J.; Tan, S.; Xu, M.; Tao, J.; Jiang, J.; Liu, H.; Wu, B. 2017: COX-1/PGE 2 /EP4 alleviates mucosal injury by upregulating β-arr1-mediated Akt signaling in colitis. Scientific Reports 7(1): 1055
Pavon, F.J.; Polis, I.; Stouffer, D.G.; Roberto, M.; Martin-Fardon, R.ém.; Rodriguez de Fonseca, F.; Parsons, L.H.; Serrano, A. 2020: COX-2 Inhibition Antagonizes Intra-Accumbens 2-Arachidonoylglycerol-Mediated Reduction in Ethanol Self-Administration in Rats. Alcoholism Clinical and Experimental Research 44(11): 2158-2165
Suh, J.D.; Hur, K.; Ference, E.H.; Lam, D.D.; Fong, A.; Correa, A.J.; Wrobel, B. 2020: COX-2 Overexpression in Schneiderian Papillomas. Allergy and Rhinology 11: 2152656720973689
Zhang, Y.; Tighe, S.; Zhu, Y.-T. 2020: COX-2 Signaling in the Tumor Microenvironment. Advances in Experimental Medicine and Biology 1277: 87-104
Silveira, T.L.; Pang, L.Y.; Di Domenico, A.; Veloso, E.S.; Silva, I.éf.L.D.; Puerto, H.L.D.; Ferreria, E.; Argyle, D.J. 2021: COX-2 Silencing in Canine Malignant Melanoma Inhibits Malignant Behaviour. Frontiers in Veterinary Science 8: 633170
Quilley, J. 2011: COX-2 and angiotensin II-induced hypertension and oxidative stress. American Journal of Hypertension 24(11): 1188
FitzGerald, G.A. 2003: COX-2 and beyond: Approaches to prostaglandin inhibition in human disease. Nature Reviews. Drug Discovery 2(11): 879-890
Bakhle, Y.S. 2001: COX-2 and cancer: a new approach to an old problem. British Journal of Pharmacology 134(6): 1137-1150
Bazan, N.G. 2001: COX-2 as a multifunctional neuronal modulator. Nature Medicine 7(4): 414-415
Kyzas, P.A.; Stefanou, D.; Agnantis, N.J. 2005: COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 18(1): 153-160
Boland, G.P.; Butt, I.S.; Prasad, R.; Knox, W.F.; Bundred, N.J. 2004: COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ. British Journal of Cancer 90(2): 423-429
Generali, D.; Buffa, F.M.; Deb, S.; Cummings, M.; Reid, L.E.; Taylor, M.; Andreis, D.; Allevi, G.; Ferrero, G.; Byrne, D.; Martinotti, M.; Bottini, A.; Harris, A.L.; Lakhani, S.R.; Fox, S.B. 2014: COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment. British Journal of Cancer 111(1): 46-54
Zhang, Y.-C.; Zhao, H.; Chen, C.; Ali, M.A. 2020: COX-2 gene rs689466 polymorphism is associated with increased risk of colorectal cancer among Caucasians: a meta-analysis. World Journal of Surgical Oncology 18(1): 192
Majumder, M.; Dunn, L.; Liu, L.; Hasan, A.; Vincent, K.; Brackstone, M.; Hess, D.; Lala, P.K. 2018: COX-2 induces oncogenic micro RNA miR655 in human breast cancer. Scientific Reports 8(1): 327
Höcherl, K.; Schmidt, C.; Bucher, M. 2009: COX-2 inhibition attenuates endotoxin-induced downregulation of organic anion transporters in the rat renal cortex. Kidney International 75(4): 373-380
Brooks, P.M.; Day, R.O. 2000: COX-2 inhibitors. Medical Journal of Australia 173(8): 433-436
Lawrie, M.M. 2001: COX-2 inhibitors. Medical Journal of Australia 174(7): 367; Author Reply 368-9
McKeough, G.N. 2001: COX-2 inhibitors. Medical Journal of Australia 174(7): 367; Author Reply 368-9
Jones, D.B. 2001: COX-2 inhibitors. Medical Journal of Australia 174(7): 368; Author Reply 368-9
Becker, R.C. 2005: COX-2 inhibitors. Texas Heart Institute Journal 32(3): 380-383
Elder, D.J.; Paraskeva, C. 1998: COX-2 inhibitors for colorectal cancer. Nature Medicine 4(4): 392-393
Cheung, A.S.; Grossmann, M. 2012: COX-2 inhibitors in prostate cancer treatment--hold your horses?. Asian Journal of Andrology 14(4): 518-519
Raynauld, J-Pierre. 2002: COX-2 inhibitors in the treatment of cardiovascular disease. Cmaj: Canadian Medical Association Journal 167(7): 739; Author Reply 739-40
Seibert, K.; Lefkowith, J.; Tripp, C.; Isakson, P.; Needleman, P. 1999: COX-2 inhibitors--is there cause for concern?. Nature Medicine 5(6): 621-622
Choi, E-Mi.; Kwak, S-June.; Kim, Y-Myeong.; Ha, K-Soo.; Kim, J-Il.; Lee, S.W.; Han, J.A. 2005: COX-2 inhibits anoikis by activation of the PI-3K/Akt pathway in human bladder cancer cells. Experimental and Molecular Medicine 37(3): 199-203
Singh, B.; Berry, J.A.; Shoher, A.; Ayers, G.D.; Wei, C.; Lucci, A. 2007: COX-2 involvement in breast cancer metastasis to bone. Oncogene 26(26): 3789-3796
Kopp, K.L.M.; Dabelsteen, S.; Krejsgaard, T.; Eriksen, K.W.; Geisler, C.; Becker, J.C.; Wasik, M.; Ødum, N.; Woetmann, A. 2010: COX-2 is a novel target in therapy of mycosis fungoides. Leukemia 24(12): 2127-2129
Garg, R.; Blando, J.M.; Perez, C.J.; Lal, P.; Feldman, M.D.; Smyth, E.M.; Ricciotti, E.; Grosser, T.; Benavides, F.; Kazanietz, M.G. 2018: COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer. Oncogene 37(34): 4735-4749
Pereira, Cícero.A.C.; Costa, A.C.; Joaquim, H.P.G.; Talib, L.L.; van de Bilt, M.T.; Loch, A.A.; Gattaz, W.F. 2021: COX-2 pathway is upregulated in ultra-high risk individuals for psychosis. World Journal of Biological Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry 2021: 1-6
Yao, M.; Song, D.H.; Rana, B.; Wolfe, M.M. 2002: COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer. British Journal of Cancer 87(5): 574-579
Chen, C. 2010: COX-2's new role in inflammation. Nature Chemical Biology 6(6): 401-402
Kopp, K.L.M.; Kauczok, C.S.; Lauenborg, B.; Krejsgaard, T.; Eriksen, K.W.; Zhang, Q.; Wasik, M.A.; Geisler, C.; Ralfkiaer, E.; Becker, J.C.; Ødum, N.; Woetmann, A. 2010: COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF). Leukemia 24(6): 1179-1185
Hsieh, P-Shiuan.; Jin, J-Shiaw.; Chiang, C-Fan.; Chan, P-Chi.; Chen, C-Hao.; Shih, K-Chung. 2009: COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. Obesity 17(6): 1150-1157
Timoshenko, A.V.; Chakraborty, C.; Wagner, G.F.; Lala, P.K. 2006: COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer. British Journal of Cancer 94(8): 1154-1163
Yu, Y.; Jiang, J. 2020: COX-2/PGE2 axis regulates hippocampal BDNF/TrkB signaling via EP2 receptor after prolonged seizures. Epilepsia Open 5(3): 418-431
Sharma-Walia, N.; Patel, K.; Chandran, K.; Marginean, A.; Bottero, V.; Kerur, N.; Paul, A.G. 2012: COX-2/PGE2: molecular ambassadors of Kaposi's sarcoma-associated herpes virus oncoprotein-v-FLIP. Oncogenesis 1: E5
Morteau, O. 1999: COX-2: promoting tolerance. Nature Medicine 5(8): 867-868
Zhou, C.; Jiang, X.; Liang, A.; Zhu, R.; Yang, Y.; Zhong, L.; Wan, D. 2020: COX10-AS1 Facilitates Cell Proliferation and Inhibits Cell Apoptosis in Glioblastoma Cells at Post-Transcription Level. Neurochemical Research 45(9): 2196-2203
Deng, B.; Xu, P.; Zhang, B.; Luo, Q.; Song, G. 2021: COX2 Enhances Neovascularization of Inflammatory Tenocytes Through the HIF-1α/VEGFA/PDGFB Pathway. Frontiers in Cell and Developmental Biology 9: 670406
Behling, F.; Suhm, E.; Ries, V.; Gonçalves, V.ít.M.; Tabatabai, G.; Tatagiba, M.; Schittenhelm, J. 2021: COX2 expression is associated with preoperative tumor volume but not with volumetric tumor growth in vestibular schwannoma. Neurological Research and Practice 3(1): 11
Cheng, I.; Liu, X.; Plummer, S.J.; Krumroy, L.M.; Casey, G.; Witte, J.S. 2007: COX2 genetic variation, NSAIDs, and advanced prostate cancer risk. British Journal of Cancer 97(4): 557-561
Xing, Y.; Wang, R.; Chen, D.; Mao, J.; Shi, R.; Wu, Z.; Kang, J.; Tian, W.; Zhang, C. 2015: COX2 is involved in hypoxia-induced TNF-α expression in osteoblast. Scientific Reports 5: 10020
Gonçalves, S.; Yin, K.; Ito, Y.; Chan, A.; Olan, I.; Gough, S.; Cassidy, L.; Serrao, E.; Smith, S.; Young, A.; Narita, M.; Hoare, M. 2021: COX2 regulates senescence secretome composition and senescence surveillance through PGE2. Cell Reports 34(11): 108860
Liu, J.; Han, S.; Ding, J.; Wu, K.; Miao, J.; Fan, D. 2005: COX2-related multicentric mixed-type Castleman's disease in a young man. Nature Clinical Practice. Oncology 2(7): 370-5; Quiz 376
Mao, Y.; Ma, W.; Zhuo, R.; Ye, L.; Xu, D.; Wang, W.; Ning, G.; Sun, F. 2021: COX4I2 is a novel biomarker of blood supply in adrenal tumors. Translational Andrology and Urology 10(7): 2899-2909
Xiyang, Y-Bin.; Liu, R.; Wang, X-Yang.; Li, S.; Zhao, Y.; Lu, B-Tuan.; Xiao, Z-Cheng.; Zhang, L-Feng.; Wang, T-Hua.; Zhang, J. 2020: COX5A Plays a Vital Role in Memory Impairment Associated With Brain Aging via the BDNF/ERK1/2 Signaling Pathway. Frontiers in Aging Neuroscience 12: 215
Zhang, K.; Wang, G.; Zhang, X.; Hüttemann, P.P.; Qiu, Y.; Liu, J.; Mitchell, A.; Lee, I.; Zhang, C.; Lee, J-Sook.; Pecina, P.; Wu, G.; Yang, Z-Quan.; Hüttemann, M.; Grossman, L.I. 2016: COX7AR is a Stress-inducible Mitochondrial COX Subunit that Promotes Breast Cancer Malignancy. Scientific Reports 6: 31742
Ehalt, W. 1964: Coxarthroses. Wiener Klinische Wochenschrift 76: 301
Majchrzak-Celińska, A.; Misiorek, J.O.; Kruhlenia, N.; Przybyl, L.; Kleszcz, R.; Rolle, K.; Krajka-Kuźniak, V. 2021: COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells. Bmc Cancer 21(1): 493
Smith, D.H.; Dollé, J.-P.; Ameen-Ali, K.E.; Bretzin, A.; Cortes, E.; Crary, J.F.; Dams-O'Connor, K.; Diaz-Arrastia, R.; Edlow, B.L.; Folkerth, R.; Hazrati, L.-N.; Hinds, S.R.; Iacono, D.; Johnson, V.E.; Keene, C.D.; Kofler, J.; Kovacs, G.G.; Lee, E.B.; Manley, G.; Meaney, D.; Montine, T.; Okonkwo, D.O.; Perl, D.P.; Trojanowski, J.Q.; Wiebe, D.J.; Yaffe, K.; McCabe, T.; Stewart, W. 2021: COllaborative Neuropathology NEtwork Characterizing ou Tcomes of TBi (CONNECT-TBI). Acta Neuropathologica Communications 9(1): 32
Sablerolles, R.S.G.; Hogenhuis, F.E.F.; Lafeber, M.; van de Loo, B.P.A.; Borgsteede, S.D.; Boersma, E.; Versmissen, J.; van der Kuy, H.M.; Aleman, J.; Nagele, F.; Stemer, G.; Tournoy, J.; derLinden, L.v.; Krusteva, I.; Safipour, Z.; Bengaard, A.K.; Houlind, M.B.; Kerjean, N.P.; Grand, J.L.; Zenico, C.; Berlinghini, S.; Caruso, F.; Peverini, M.; Pieraccini, F.; Bini, K.; Candela, M.; DiCarlo, M.; Grinta, R.; Salaffi, F.; Schimizzi, A.M.; Tardella, M.; Verri, F.; Tessari, R.; Marchesini, F.; Chessa, P.; Gambera, M.; Martignoni, I.; Rametta, G.; Pappalardo, F.; Rossi, L.; Fantini, L.; Maria, E.; Gambarelli, G.; Berlinghini, S.; Martini, G.; Pagliarino, S.; Loche, E.; Agnoletto, L.; Peverini, M.; Boni, G.; Falcao, M.; Farinha, H.; Mendes, D.; R 2020: COvid MEdicaTion (COMET) study: protocol for a cohort study. European Journal of Hospital Pharmacy: Science and Practice 27(4): 191-193
Abras, G.M.; Silva, T.A.B.E.; Lima, L.F.P.N.D.S.; Lopes, M.V.D.R. 2021: CO² filtration during pneumoperitoneum inflation and deflation in patients undergoing laparoscopy during the COVID-19 pandemic. Revista do Colegio Brasileiro de Cirurgioes 48: E20202632
Tang, R.; Li, W-Xia.; Huang, W.; Yan, F.; Chai, W-Min.; Yang, G-Yuan.; Chen, K-Min. 2013: CO₂-based in-line phase contrast imaging of small intestine in mice. Scientific Reports 3: 2313
Zhuo, L.; Mao, J.X.; Chen, J.S.; Song, P.; Lin, S.; Xia, S.H.; Chen, H. 2020: COⅠ and 16S rDNA Sequence Identification of Common Necrophagous Flies in Fujian Province. Fa Yi Xue Za Zhi 36(6): 749-754
Zhang, Y.; Li, X-Xiang.; Ma, Y.; Xu, J.; Zhao, L-Na.; Qian, X-Feng.; Zhang, X-Feng.; Shi, J-Fang.; Han, Q-Zhen. 2017: CP and CP-PGN protect mice against MRSA infection by inducing M1 macrophages. Scientific Reports 7(1): 16877
Wei, X.; Wu, Y.; Tang, H.; Wang, B.; Wang, Y.; Sun, W.; Asenso, J.; Xiao, F.; Wang, C. 2021: CP-25 ameliorates methotrexate induced nephrotoxicity via improving renal apoptosis and methotrexate excretion. Journal of Pharmacological Sciences 146(1): 21-28
Jia, X-Yi.; Chang, Y.; Wei, F.; Dai, X.; Wu, Y-Jing.; Sun, X-Jing.; Xu, S.; Wu, H-Xun.; Wang, C.; Yang, X-Zhi.; Wei, W. 2019: CP-25 reverses prostaglandin E4 receptor desensitization-induced fibroblast-like synoviocyte dysfunction via the G protein-coupled receptor kinase 2 in autoimmune arthritis. Acta Pharmacologica Sinica 40(8): 1029-1039
Yang, X-Zhi.; Wei, W. 2020: CP-25, a compound derived from paeoniflorin: research advance on its pharmacological actions and mechanisms in the treatment of inflammation and immune diseases. Acta Pharmacologica Sinica 41(11): 1387-1394
Chang, Y.; Jia, X.; Wei, F.; Wang, C.; Sun, X.; Xu, S.; Yang, X.; Zhao, Y.; Chen, J.; Wu, H.; Zhang, L.; Wei, W. 2016: CP-25, a novel compound, protects against autoimmune arthritis by modulating immune mediators of inflammation and bone damage. Scientific Reports 6: 26239
Wischhusen, J.; Naumann, U.; Ohgaki, H.; Rastinejad, F.; Weller, M. 2003: CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death. Oncogene 22(51): 8233-8245
Kühne, T.D.; Iannuzzi, M.; Del Ben, M.; Rybkin, V.V.; Seewald, P.; Stein, F.; Laino, T.; Khaliullin, R.Z.; Schütt, O.; Schiffmann, F.; Golze, D.; Wilhelm, J.; Chulkov, S.; Bani-Hashemian, M.H.; Weber, V.ér.; Borštnik, U.; Taillefumier, M.; Jakobovits, A.S.; Lazzaro, A.; Pabst, H.; Müller, T.; Schade, R.; Guidon, M.; Andermatt, S.; Holmberg, N.; Schenter, G.K.; Hehn, A.; Bussy, A.; Belleflamme, F.; Tabacchi, G.; Glöß, A.; Lass, M.; Bethune, I.; Mundy, C.J.; Plessl, C.; Watkins, M.; VandeVondele, J.; Krack, M.; Hutter, J.ür. 2020: CP2K: An electronic structure and molecular dynamics software package - Quickstep: Efficient and accurate electronic structure calculations. Journal of Chemical Physics 152(19): 194103
Li, Y.; Liu, X.; Xia, C.-H.; FitzGerald, P.G.; Li, R.; Wang, J.; Gong, X. 2020: CP49 and filensin intermediate filaments are essential for formation of cold cataract. Molecular Vision 26: 603-612
Wang, H.; Huang, R.; Li, L.; Zhu, J.; Li, Z.; Peng, C.; Zhuang, X.; Lin, H.; Shi, S.; Huang, P. 2021: CPA-seq reveals small nc RNAs with methylated nucleosides and diverse termini. Cell Discovery 7(1): 25
Shao, Q.; Zhang, Z.; Cao, R.; Zang, H.; Pei, W.; Sun, T. 2020: CPA4 Promotes EMT in Pancreatic Cancer via Stimulating PI3K-AKT-mTOR Signaling. Oncotargets and Therapy 13: 8567-8580
Wiggs, J.L. 2020: CPAMD8, a new Gene for Anterior Segment Dysgenesis and Childhood Glaucoma. Ophthalmology 127(6): 767-768
Adegunsoye, A.; Neborak, J.M.; Zhu, D.; Cantrill, B.; Garcia, N.; Oldham, J.M.; Noth, I.; Vij, R.; Kuzniar, T.J.; Bellam, S.K.; Strek, M.E.; Mokhlesi, B. 2020: CPAP Adherence, Mortality, and Progression-Free Survival in Interstitial Lung Disease and OSA. Chest 158(4): 1701-1712
L'Acqua, C.; Meli, A.; Rondello, N.; Polvani, G.; Salvi, L. 2020: CPAP Effects on Oxygen Delivery in One-Lung Ventilation During Minimally Invasive Surgical Ablation for Atrial Fibrillation in the Supine Position. Journal of Cardiothoracic and Vascular Anesthesia 34(11): 2931-2936
Sivanandan, S.; Sankar, M.J. 2020: CPAP Failure in Neonates: Practice, Experience, and Focus do Matter!. Indian Journal of Pediatrics 87(11): 881-882
Hooper, R.G. 2020: CPAP Therapeutic Options for Obstructive Sleep Apnea. Pragmatic and Observational Research 11: 67-76
Wickwire, E.M.; Bailey, M.D.; Somers, V.K.; Oldstone, L.M.; Srivastava, M.C.; Johnson, A.M.; Scharf, S.M.; Albrecht, J.S. 2022: CPAP adherence is associated with reduced inpatient utilization among older adult Medicare beneficiaries with pre-existing cardiovascular disease. Journal of Clinical Sleep Medicine: Jcsm: Official Publication of the American Academy of Sleep Medicine 18(1): 39-45
Wickwire, E.M.; Bailey, M.D.; Somers, V.K.; Srivastava, M.C.; Scharf, S.M.; Johnson, A.M.; Albrecht, J.S. 2021: CPAP adherence is associated with reduced risk for stroke among older adult Medicare beneficiaries with obstructive sleep apnea. Journal of Clinical Sleep Medicine: Jcsm: Official Publication of the American Academy of Sleep Medicine 17(6): 1249-1255
Chen, R-Yu.; Yen, C-Jui.; Lin, Y-Jyh.; Wang, J-Ming.; Tasi, T-Fen.; Huang, Y-Chuan.; Liu, Y-Wen.; Tsai, H-Wen.; Lee, M-Hao.; Hung, L-Yi. 2021: CPAP enhances and maintains chronic inflammation in hepatocytes to promote hepatocarcinogenesis. Cell Death and Disease 12(11): 983
Freire, A.X. 2016: CPAP in Obstructive Sleep Apnea. New England Journal of Medicine 375(23): 2301
Chervin, R.D.; Rosen, I.M.; Watson, N.F. 2016: CPAP in Obstructive Sleep Apnea. New England Journal of Medicine 375(23): 2301-2302
Stevens, D.; Loffler, K.A.; Buman, M.P.; Dunstan, D.W.; Luo, Y.; Lorenzi-Filho, G.; Barbe, F.E.; Anderson, C.S.; McEvoy, R.D. 2021: CPAP increases physical activity in obstructive sleep apnea with cardiovascular disease. Journal of Clinical Sleep Medicine: Jcsm: Official Publication of the American Academy of Sleep Medicine 17(2): 141-148
Tang, C-Ju.C.; Fu, R-Huei.; Wu, K-Sheng.; Hsu, W-Bin.; Tang, T.K. 2009: CPAP is a cell-cycle regulated protein that controls centriole length. Nature Cell Biology 11(7): 825-831
Yang, Y.; Ning, Y.; Wen, W.; Jia, Y.; Chen, X.; Huang, M.; Sara, J.D.; Qin, Y.; Fang, F.; Zhang, H.; Du, Y.; Li, L.; Jiao, X.; Yang, Y.; Han, X.; Zhang, M.; Wei, Y. 2020: CPAP is associated with decreased risk of AF recurrence in patients with OSA, especially those younger and slimmer: a meta-analysis. Journal of Interventional Cardiac Electrophysiology: An International Journal of Arrhythmias and Pacing 58(3): 369-379
Chen, R-Yu.; Yen, C-Jui.; Liu, Y-Wen.; Guo, C-Guo.; Weng, C-Yu.; Lai, C-Hsien.; Wang, J-Ming.; Lin, Y-Jyh.; Hung, L-Yi. 2020: CPAP promotes angiogenesis and metastasis by enhancing STAT3 activity. Cell Death and Differentiation 27(4): 1259-1273
Lastra, A.C.; Masa, J.F.; Mokhlesi, B. 2020: CPAP titration failure is not equivalent to long-term CPAP treatment failure in patients with obesity hypoventilation syndrome: a case series. Journal of Clinical Sleep Medicine: Jcsm: Official Publication of the American Academy of Sleep Medicine 16(11): 1975-1981
Abehsera, S.; Zaccai, S.; Mittelman, B.; Glazer, L.; Weil, S.; Khalaila, I.; Davidov, G.; Bitton, R.; Zarivach, R.; Li, S.; Li, F.; Xiang, J.; Manor, R.; Aflalo, E.D.; Sagi, A. 2018: CPAP3 proteins in the mineralized cuticle of a decapod crustacean. Scientific Reports 8(1): 2430
Ray, K. 2011: CPB2 dampens inflammation in autoimmune arthritis. Nature Reviews. Rheumatology 7(10): 558
Hancocks, S. 2013: CPD -- changing access and raising standards. British Dental Journal 214(10): 483
Rotstein, A.; Charow, R.; Papadakos, T.; Wiljer, D.; Slinger, P. 2020: CPD by the Minute: an innovative mobile application for continuing professional development in medicine. Canadian Journal of Anaesthesia 67(12): 1881-1882
Hancocks, S. 2014: CPD but not as we know it. British Dental Journal 216(4): 145
Sandison, A.G. 2003: CPD requirements--non-clinical registration. South African Medical Journal 93(6): 394
Shah, S. 2008: CPD variety is good. British Dental Journal 204(12): 658
Picó, S.; Parras, A.; Santos-Galindo, M.ía.; Pose-Utrilla, J.; Castro, M.; Fraga, E.; Hernández, I.ó H.; Elorza, A.; Anta, H.éc.; Wang, N.; Martí-Sánchez, L.; Belloc, E.àl.; Garcia-Esparcia, P.; Garrido, J.J.; Ferrer, I.; Macías-García, D.; Mir, P.; Artuch, R.; Pérez, B.én.; Hernández, F.él.; Navarro, P.; López-Sendón, J.é L.; Iglesias, T.; Yang, X.W.; Méndez, R.úl.; Lucas, J.é J. 2021: CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington's disease. Science Translational Medicine 13(613): Eabe 7104
Nagaoka, K.; Udagawa, T.; Richter, J.D. 2012: CPEB-mediated ZO-1 mRNA localization is required for epithelial tight-junction assembly and cell polarity. Nature Communications 3: 675
Nagaoka, K.; Fujii, K.; Zhang, H.; Usuda, K.; Watanabe, G.; Ivshina, M.; Richter, J.D. 2016: CPEB1 mediates epithelial-to-mesenchyme transition and breast cancer metastasis. Oncogene 35(22): 2893-2901
Xu, M.; Fang, S.; Song, J.; Chen, M.; Zhang, Q.; Weng, Q.; Fan, X.; Chen, W.; Wu, X.; Wu, F.; Tu, J.; Zhao, Z.; Ji, J. 2018: CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance. Cell Death and Disease 9(10): 957
Xiaoping, L.; Zhibin, Y.; Wenjuan, L.; Zeyou, W.; Gang, X.; Zhaohui, L.; Ying, Z.; Minghua, W.; Guiyuan, L. 2013: CPEB1, a histone-modified hypomethylated gene, is regulated by miR-101 and involved in cell senescence in glioma. Cell Death and Disease 4: E675
Fang, Y.; Zhong, Q.; Wang, Y.; Gu, C.; Liu, S.; Li, A.; Yan, Q. 2020: CPEB3 functions as a tumor suppressor in colorectal cancer via JAK/STAT signaling. Aging 12(21): 21404-21422
Zhong, Q.; Fang, Y.; Lai, Q.; Wang, S.; He, C.; Li, A.; Liu, S.; Yan, Q. 2020: CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling. Journal of Experimental and Clinical Cancer Research: Cr 39(1): 132
Moore, P.C.; Oakes, S.A. 2017: CPEB4 links the clock and the UPR to protect the liver. Nature Cell Biology 19(2): 79-81
Huang, M.; Wang, Y.; Collins, M.; Graves, L.M. 2004: CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase. Leukemia 18(11): 1857-1863
Lee, K.; Jeong, H-Oh.; Lee, S.; Jeong, W-Ki. 2019: CPEM: Accurate cancer type classification based on somatic alterations using an ensemble of a random forest and a deep neural network. Scientific Reports 9(1): 16927
Xie, J.; Li, Y.; Guo, X.; Rao, J.; Yan, T.; Mou, L.; Wu, X.; Xie, X.; Yang, W.; Zhang, B. 2020: CPF-C1 analog with effective antimicrobial and antibiofilm activities against Staphylococcus aureus including MRSA. Biochimie 176: 1-11
Edwards, M.; McConnell, P.; Schafer, D.A.; Cooper, J.A. 2015: CPI motif interaction is necessary for capping protein function in cells. Nature Communications 6: 8415
Gao, L.; Xu, Z.; Huang, Z.; Tang, Y.; Yang, D.; Huang, J.; He, L.; Liu, M.; Chen, Z.; Teng, Y. 2020: CPI-613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK-ACC signaling. Journal of Experimental and Clinical Cancer Research: Cr 39(1): 73
Zheng, T.; Chen, P.; Huang, Y.; Qiu, J.; Zhou, C.; Wu, Z.; Li, L. 2021: CPI-637 as a Potential Bifunctional Latency-Reversing Agent that Targets Both the BRD4 and TIP60 Proteins. Frontiers in Cellular and Infection Microbiology 11: 686035
Relling, M.V.; Klein, T.E. 2011: CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clinical Pharmacology and Therapeutics 89(3): 464-467
Del Galdo, S.; Fusè, M.; Barone, V. 2020: CPL Spectra of Camphor Derivatives in Solution by an Integrated QM/MD Approach. Frontiers in Chemistry 8: 584
Bazydlo-Guzenda, K.; Buda, P.; Matloka, M.; Mach, M.; Stelmach, F.; Dzida, R.; Smuga, D.; Hucz-Kalitowska, J.; Teska-Kaminska, M.; Vialichka, V.; Dubiel, K.; Kaminska, B.; Wieczorek, M.; Pieczykolan, J. 2021: CPL207280, a Novel G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1-Specific Agonist, Shows a Favorable Safety Profile and Exerts Antidiabetic Effects in Type 2 Diabetic Animals. Molecular Pharmacology 100(4): 335-347
Wang, Y.; Pan, S.; He, X.; Wang, Y.; Huang, H.; Chen, J.; Zhang, Y.; Zhang, Z.; Qin, X. 2021: CPNE1 Enhances Colorectal Cancer Cell Growth, Glycolysis, and Drug Resistance Through Regulating the AKT-GLUT1/HK2 Pathway. Oncotargets and Therapy 14: 699-710
Choi, H.Y.; Park, N.; Lee, B.; Choe, Y.I.; Woo, D.K.; Park, J.-Y.; Yoo, J.C. 2020: CPNE1-mediated neuronal differentiation can be inhibited by HAX1 expression in HiB5 cells. Biochemical and Biophysical Research Communications 533(3): 319-324
Park, Y.-H.; Son, C.; Seo, Y.-M.; Lee, Y.S.; Har, A.; Park, J.-C. 2021: CPNE7-Induced Autophagy Restores the Physiological Function of Mature Odontoblasts. Frontiers in Cell and Developmental Biology 9: 655498
Sloane, T. 2005: CPOE is far from KO'd. JAMA study only proves that no technology cures problems in isolation. Modern Healthcare 35(12): 20
Maigne, L.; Delsol, A.; Fois, G.; Debiton, E.; Degoul, F.; Payno, H. 2021: CPOP: An open source C++ cell POPulation modeler for radiation biology applications. Physica Medica: Pm: An International Journal Devoted to the Applications of Physics to Medicine and Biology: Official Journal of the Italian Association of Biomedical Physics 89: 41-50
Laha, K.; Zhu, M.; Gemperline, E.; Rau, V.; Li, L.; Fanselow, M.S.; Lennertz, R.; Pearce, R.A. 2022: CPP impairs contextual learning at concentrations below those that block pyramidal neuron NMDARs and LTP in the CA1 region of the hippocampus. Neuropharmacology 202: 108846
Oliveira-Mendes, Bárbara.Bruna.Ribeiro.de.; Horta, C.Campolina.Rebello.; do Carmo, A.Oliveira.; Biscoto, G.Lago.; Sales-Medina, D.Ferreira.; Leal, Hênsia.Gomes.; Brandão-Dias, P.Ferreira.Pinto.; Miranda, S.Eustáquio.Mendes.; Aguiar, C.Jeane.; Cardoso, V.Nascimento.; de Barros, Aé.Luis.Branco.; Chávez-Olortégui, C.; Leite, M.Fátima.; Kalapothakis, E. 2018: CPP-Ts: a new intracellular calcium channel modulator and a promising tool for drug delivery in cancer cells. Scientific Reports 8(1): 14739
Daddali, R.; Ojaniemi, M.; Hallman, M.; Rämet, M.; Haapalainen, A.M. 2020: CPPED1-targeting microRNA-371a-5p expression in human placenta associates with spontaneous delivery. Plos one 15(6): E0234403
Pechaksorn, N.; Vattanavanit, V. 2020: CPR Compression Rotation Every one Minute Versus two Minutes: a Randomized Cross-Over Manikin Study. Emergency Medicine International 2020: 5479209
Berger, S. 2020: CPR and AEDs save lives: insuring CPR--AED education and CPR--AED access in schools. Current Opinion in Pediatrics 32(5): 641-645
Otero-Agra, M.ín.; Santiago-Urgal, N.; Hermo-Gonzalo, M.ía.T.; Fernández-Méndez, M.ía.; Fernández-Méndez, F. 2021: CPR by foot. An alternative in special circumstances? a randomized simulation study. American Journal of Emergency Medicine 43: 1-6
Turnbull, J. 1998: CPR for patients in a persistent vegetative state?. Cmaj: Canadian Medical Association Journal 159(1): 18-9; Author Reply 19-20
Jespersen, B.W. 1998: CPR for patients in a persistent vegetative state?. Cmaj: Canadian Medical Association Journal 159(1): 19; Author Reply 19-20
Walker, P. 1998: CPR for patients in a persistent vegetative state?. Cmaj: Canadian Medical Association Journal 159(1): 19; Author Reply 19-20
Gutowski, W.D. 1998: CPR for patients in a persistent vegetative state?. Cmaj: Canadian Medical Association Journal 159(1): 19; Author Reply 19-20
Freer, J.P. 2003: CPR for patients labeled DNR. Annals of Internal Medicine 139(8): 704; Author Reply 705
Puckett, S. 2006: CPR in the box. Jems: a Journal of Emergency Medical Services 31(2): 18; Author Reply 18
Wallner, B.; Moroder, L.; Salchner, H.; Mair, P.; Wallner, S.; Putzer, G.; Strapazzon, G.; Falk, M.; Brugger, H. 2021: CPR with restricted patient access using alternative rescuer positions: a randomised cross-over manikin study simulating the CPR scenario after avalanche burial. Scandinavian Journal of Trauma Resuscitation and Emergency Medicine 29(1): 129
Swanson, R.W.; Ramsden, V.R. 1988: CPR: is there a better method?. Cmaj: Canadian Medical Association Journal 138(10): 888
Persson, R.; Vasilakis-Scaramozza, C.; Hagberg, K.W.; Sponholtz, T.; Williams, T.; Myles, P.; Jick, S.S. 2020: CPRD Aurum database: Assessment of data quality and completeness of three important comorbidities. Pharmacoepidemiology and Drug Safety 29(11): 1456-1464
Kim, J.; Hu, Z.; Cai, L.; Li, K.; Choi, E.; Faubert, B.; Bezwada, D.; Rodriguez-Canales, J.; Villalobos, P.; Lin, Y-Fen.; Ni, M.; Huffman, K.E.; Girard, L.; Byers, L.A.; Unsal-Kacmaz, K.; Peña, C.G.; Heymach, J.V.; Wauters, E.; Vansteenkiste, J.; Castrillon, D.H.; Chen, B.P.C.; Wistuba, I.; Lambrechts, D.; Xu, J.; Minna, J.D.; DeBerardinis, R.J. 2017: CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells. Nature 546(7656): 168-172
Nitzahn, M.; Lipshutz, G.S. 2020: CPS1: Looking at an ancient enzyme in a modern light. Molecular Genetics and Metabolism 131(3): 289-298
Ross, N.T.; Lohmann, F.; Carbonneau, S.; Fazal, A.; Weihofen, W.A.; Gleim, S.; Salcius, M.; Sigoillot, F.; Henault, M.; Carl, S.H.; Rodríguez-Molina, J.B.; Miller, H.R.; Brittain, S.M.; Murphy, J.; Zambrowski, M.; Boynton, G.; Wang, Y.; Chen, A.; Molind, G.J.; Wilbertz, J.H.; Artus-Revel, C.G.; Jia, M.; Akinjiyan, F.A.; Turner, J.; Knehr, J.; Carbone, W.; Schuierer, S.; Reece-Hoyes, J.S.; Xie, K.; Saran, C.; Williams, E.T.; Roma, G.; Spencer, M.; Jenkins, J.; George, E.L.; Thomas, J.R.; Michaud, G.; Schirle, M.; Tallarico, J.; Passmore, L.A.; Chao, J. 2020: CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcoma. Nature Chemical Biology 16(1): 50-59
Lee, K.; Zheng, Q.; Lu, Q.; Xu, F.; Qin, G.; Zhai, Q.; Hong, R.; Chen, M.; Deng, W.; Wang, S. 2021: CPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4. Signal Transduction and Targeted Therapy 6(1): 184
Tan, S.; Zhang, M.; Shi, X.; Ding, K.; Zhao, Q.; Guo, Q.; Wang, H.; Wu, Z.; Kang, Y.; Zhu, T.; Sun, J.; Zhao, X. 2021: CPSF6 links alternative polyadenylation to metabolism adaption in hepatocellular carcinoma progression. Journal of Experimental and Clinical Cancer Research: Cr 40(1): 85
Garside, N.; Zaribafzadeh, H.; Henao, R.; Chung, R.; Buckland, D. 2021: CPT to RVU conversion improves model performance in the prediction of surgical case length. Scientific Reports 11(1): 14169
Voelter, V.; Zouhair, A.; Vuilleumier, H.; Matter, M.; Bouzourene, H.; Leyvraz, S.; Bauer, J.; Coucke, P.; Stupp, R. 2006: CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase II. British Journal of Cancer 95(6): 710-716
Guichard, S.; Terret, C.; Hennebelle, I.; Lochon, I.; Chevreau, P.; Frétigny, E.; Selves, J.; Chatelut, E.; Bugat, R.; Canal, P. 1999: CPT-11 converting carboxylesterase and topoisomerase activities in tumour and normal colon and liver tissues. British Journal of Cancer 80(3-4): 364-370
Jansen, W.J.; Hulscher, T.M.; van Ark-Otte, J.; Giaccone, G.; Pinedo, H.M.; Boven, E. 1998: CPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated protein. British Journal of Cancer 77(3): 359-365
Chen, L-Chun.; Cheng, W-Jie.; Lin, S-Yi.; Hung, M-Tse.; Sheu, M-Thau.; Lin, H-Liang.; Hsieh, C-Ming. 2021: CPT11 with P-glycoprotein/CYP 3A4 dual-function inhibitor by self-nanoemulsifying nanoemulsion combined with gastroretentive technology to enhance the oral bioavailability and therapeutic efficacy against pancreatic adenocarcinomas. Drug Delivery 28(1): 2205-2217
Jariwala, N.; Mehta, G.A.; Bhatt, V.; Hussein, S.; Parker, K.A.; Yunus, N.; Parker, J.S.; Guo, J.Y.; Gatza, M.L. 2021: CPT1A and fatty acid β-oxidation are essential for tumor cell growth and survival in hormone receptor-positive breast cancer. Nar Cancer 3(3): Zcab 035
Mørkholt, A.Skøttrup.; Trabjerg, M.Sloth.; Oklinski, M.Krystian.Egelund.; Bolther, L.; Kroese, L.John.; Pritchard, C.Eliot.Jason.; Huijbers, I.Johan.; Nieland, J.Dirk.Vestergaard. 2019: CPT1A plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis. Scientific Reports 9(1): 13299
Wang, Y-Nan.; Zeng, Z-Lei.; Lu, J.; Wang, Y.; Liu, Z-Xian.; He, M-Ming.; Zhao, Q.; Wang, Z-Xian.; Li, T.; Lu, Y-Xin.; Wu, Q-Nian.; Yu, K.; Wang, F.; Pu, H-Ying.; Li, B.; Jia, W-Hua.; Shi, M.; Xie, D.; Kang, T-Bang.; Huang, P.; Ju, H-Qiang.; Xu, R-Hua. 2018: CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis. Oncogene 37(46): 6025-6040
Roa-Mansergas, X.; Fadó, R.; Atari, M.; Mir, J.F.; Muley, H.; Serra, D.; Casals, Núria. 2018: CPT1C promotes human mesenchymal stem cells survival under glucose deprivation through the modulation of autophagy. Scientific Reports 8(1): 6997
Yuan, Q.; Lv, Y.; Ding, H.; Ke, Q.; Shi, C.; Luo, J.; Jiang, L.; Yang, J.; Zhou, Y. 2021: CPT1α maintains phenotype of tubules via mitochondrial respiration during kidney injury and repair. Cell Death and Disease 12(8): 792
Zhang, X.; Zhang, Z.; Liu, S.; Li, J.; Wu, L.; Lv, X.; Xu, J.; Chen, B.; Zhao, S.; Yang, H. 2021: CPT2 down-regulation promotes tumor growth and metastasis through inducing ROS/NFκB pathway in ovarian cancer. Translational Oncology 14(4): 101023
Li, H.; Chen, J.; Liu, J.; Lai, Y.; Huang, S.; Zheng, L.; Fan, N. 2021: CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism. Experimental Cell Research 409(1): 112892
Whiteaker, J.R.; Halusa, G.N.; Hoofnagle, A.N.; Sharma, V.; MacLean, B.; Yan, P.; Wrobel, J.A.; Kennedy, J.; Mani, D.R.; Zimmerman, L.J.; Meyer, M.R.; Mesri, M.; Rodriguez, H.; Paulovich, A.G.; Abbatiello, S.E.; Boja, E.; Carr, S.A.; Chan, D.W.; Chen, X.; Davies, S.R.; Ellis, M.J.C.; Fenyö, D.; Hiltke, T.; Ketchum, K.A.; Kinsinger, C.; Kuhn, E.; Liebler, D.C.; Lin, D.; Liu, T.; Loss, M.; MacCoss, M.J.; Qian, W-Jun.; Rivers, R.; Rodland, K.D.; Ruggles, K.V.; Scott, M.G.; Smith, R.D.; Thomas, S.; Townsend, R.Reid.; Whiteley, G.; Wu, C.; Zhang, H.; Zhang, Z. 2014: CPTAC Assay Portal: a repository of targeted proteomic assays. Nature Methods 11(7): 703-704
Wang, F.; Marshak, N.; Usher, W.; Burstedde, C.; Knoll, A.; Heister, T.; Johnson, C.R. 2020: CPU Ray Tracing of Tree-Based Adaptive Mesh Refinement Data. Computer Graphics Forum: Journal of the European Association for Computer Graphics 39(3): 1-12
Qi, M-you.; Feng, Y.; Dai, D-zai.; Li, N.; Cheng, Y-si.; Dai, Y. 2010: CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity. Acta Pharmacologica Sinica 31(2): 165-174
Zhang, G-lin.; Yu, F.; Dai, D-zai.; Cheng, Y-si.; Zhang, C.; Dai, Y. 2012: CPU86017-RS attenuate hypoxia-induced testicular dysfunction in mice by normalizing androgen biosynthesis genes and pro-inflammatory cytokines. Acta Pharmacologica Sinica 33(4): 470-478
Xu, X-Li.; Bao, Q-chao.; Jia, J-Min.; Liu, F.; Guo, X-Ke.; Zhang, M-ye.; Wei, J-lian.; Lu, M-chen.; Xu, L-li.; Zhang, X-Jin.; You, Q-Dong.; Sun, H-Peng. 2016: CPUY201112, a novel synthetic small-molecule compound and inhibitor of heat shock protein Hsp90, induces p53-mediated apoptosis in MCF-7 cells. Scientific Reports 6: 19004
Cafaro, A.; Giannini, M.B.; Silimbani, P.; Cangini, D.; Masini, C.; Ghelli Luserna Di Rorà, A.; Simonetti, G.; Martinelli, G.; Cerchione, C. 2020: CPX-351 daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemia. Minerva Medica 111(5): 455-466
Lancet, J.E.; Uy, G.L.; Newell, L.F.; Lin, T.L.; Ritchie, E.K.; Stuart, R.K.; Strickland, S.A.; Hogge, D.; Solomon, S.R.; Bixby, D.L.; Kolitz, J.E.; Schiller, G.J.; Wieduwilt, M.J.; Ryan, D.H.; Faderl, S.; Cortes, J.E. 2021: CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial. LANCET. Haematology 8(7): E481-E491
Thomas, X.; Plesa, A. 2021: CPX-351: an attractive option for the treatment of older patients with high-risk or secondary acute myeloid leukaemia. LANCET. Haematology 8(7): E468-E469
Andrews, J. 2011: CQC outcome for medicines management: an outsider's inside view. British Dental Journal 210(9): 407-409
Iacobucci, G. 2020: CQC says inspections suspended for covid-19 crisis will restart in autumn. Bmj 369: M2467
Limb, M. 2021: CQC's plans to rethink inspection ratings don't go far enough, says BMA. Bmj 373: N1390
Peate, I. 2020: CQC: working in a pandemic. British Journal of Nursing 29(13): 727
Qi, K.; Song, M.; Xie, X.; Wen, Y.; Wang, Z.; Wei, B.; Wang, Z. 2022: CQDs/biochar from reed straw modified Z-scheme MgIn2S4/BiOCl with enhanced visible-light photocatalytic performance for carbamazepine degradation in water. Chemosphere 287(Part 2): 132192
Wen, A.; Rasmussen, L.V.; Stone, D.; Liu, S.; Kiefer, R.; Adekkanattu, P.; Brandt, P.S.; Pacheco, J.A.; Luo, Y.; Wang, F.; Pathak, J.; Liu, H.; Jiang, G. 2021: CQL4NLP: Development and Integration of FHIR NLP Extensions in Clinical Quality Language for EHR-driven Phenotyping. AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science 2021: 624-633
Wang, M.; Delasalle, K.; Feng, L.; Thomas, S.; Giralt, S.; Qazilbash, M.; Handy, B.; Lee, J.J.; Alexanian, R. 2010: CR represents an early index of potential long survival in multiple myeloma. Bone Marrow Transplantation 45(3): 498-504
Ford, C.D.; Asch, J.; Konopa, K.; Petersen, F.B. 2010: CR with lenalidomide in del(5)(q13q33) AML relapsing after allogeneic hematopoietic SCT. Bone Marrow Transplantation 45(2): 403-404
Jeong, T.W.; Singh, P.K.; Scullion, C.; Ahmed, H.; Hadjisolomou, P.; Jeon, C.; Yun, H.; Kakolee, K.F.; Borghesi, M.; Ter-Avetisyan, S. 2017: CR-39 track detector for multi-MeV ion spectroscopy. Scientific Reports 7(1): 2152
Costa, Tássia.R.; Menaldo, D.L.; Zoccal, K.F.; Burin, S.M.; Aissa, A.F.; Castro, Fíola.A.de.; Faccioli, Lúcia.H.; Greggi Antunes, Lânia.M.; Sampaio, S.V. 2017: CR-LAAO, an L-amino acid oxidase from Calloselasma rhodostoma venom, as a potential tool for developing novel immunotherapeutic strategies against cancer. Scientific Reports 7: 42673
Liang, X.; Fang, J.; Li, H.; Yang, X.; Ni, D.; Zeng, F.; Chen, Z. 2020: CR-Unet-Based Ultrasonic Follicle Monitoring to Reduce Diameter Variability and Generate Area Automatically as a Novel Biomarker for Follicular Maturity. Ultrasound in Medicine and Biology 46(11): 3125-3134
Kalaai, S.; van Dun, B.; Boonen, B.; van Haaren, E.H.; Schotanus, M.G.M. 2021: CR-lipped bearing is an adequate functional solution to patients with perioperative excessive laxity in cruciate retaining total knee arthroplasty. Knee 28: 51-56
Zimmerman, P.A.; Fitness, J.; Moulds, J.M.; McNamara, D.T.; Kasehagen, L.J.; Rowe, J.Alexandra.; Hill, A.V.S. 2003: CR1 Knops blood group alleles are not associated with severe malaria in the Gambia. Genes and Immunity 4(5): 368-373
Seregin, S.S.; Aldhamen, Y.A.; Appledorn, D.M.; Schuldt, N.J.; McBride, A.J.; Bujold, M.; Godbehere, S.S.; Amalfitano, A. 2009: CR1/2 is an important suppressor of Adenovirus-induced innate immune responses and is required for induction of neutralizing antibodies. Gene Therapy 16(10): 1245-1259
Galimberti, C.; Piepoli, T.; Letari, O.; Artusi, R.; Persiani, S.; Caselli, G.; Rovati, L.C. 2021: CR13626: a novel oral brain penetrant tyrosine kinase inhibitor that reduces tumor growth and prolongs survival in a mouse model of glioblastoma. American Journal of Cancer Research 11(7): 3558-3574
Cosgrove, L.J.; d'Apice, A.J.; Haddad, A.; Pedersen, J.; McKenzie, I.F. 1987: CR3 receptor on platelets and its role in the prostaglandin metabolic pathway. Immunology and Cell Biology 65: 453-460
Lee, I.; Kim, S.; Nagar, H.; Choi, S-Jeong.; Jeon, B.Hwa.; Piao, S.; Kim, C-Seong. 2020: CR6-interacting factor 1 deficiency reduces endothelial nitric oxide synthase activity by inhibiting biosynthesis of tetrahydrobiopterin. Scientific Reports 10(1): 842
Byun, J.; Son, S.M.; Cha, M-Y.; Shong, M.; Hwang, Y.J.; Kim, Y.; Ryu, H.; Moon, M.; Kim, K-S.; Mook-Jung, I. 2015: CR6-interacting factor 1 is a key regulator in Aβ-induced mitochondrial disruption and pathogenesis of Alzheimer's disease. Cell Death and Differentiation 22(6): 959-973
Kabadi, S.V.; Stoica, B.A.; Loane, D.J.; Luo, T.; Faden, A.I. 2014: CR8, a novel inhibitor of CDK, limits microglial activation, astrocytosis, neuronal loss, and neurologic dysfunction after experimental traumatic brain injury. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 34(3): 502-513
Bettayeb, K.; Oumata, N.; Echalier, A.; Ferandin, Y.; Endicott, J.A.; Galons, H.; Meijer, L. 2008: CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases. Oncogene 27(44): 5797-5807
Chhakchhuak, M.; Bajpai, N.; Purohit, A. 2020: CRAB Positive Acute Lymphoblastic Leukemia, Masquerader of Multiple Myeloma. Indian Journal of Hematology and Blood Transfusion: An Official Journal of Indian Society of Hematology and Blood Transfusion 36(2): 417-418
Enikeev, A.D.; Komelkov, A.V.; Axelrod, M.E.; Galetsky, S.A.; Kuzmichev, S.A.; Tchevkina, E.M. 2021: CRABP1 and CRABP2 Protein Levels Correlate with Each other but do not Correlate with Sensitivity of Breast Cancer Cells to Retinoic Acid. BIOCHEMISTRY. Biokhimiia 86(2): 217-229
Hughes, C.S.; ChinAleong, J.-A.; Kocher, H.M. 2020: CRABP2 and FABP5 expression levels in diseased and normal pancreas. Annals of Diagnostic Pathology 47: 151557
Vaeth, M.; Kahlfuss, S.; Feske, S. 2020: CRAC Channels and Calcium Signaling in T Cell-Mediated Immunity. Trends in Immunology 41(10): 878-901
Liu, S.; Sahid, M.Novrizal.Abdi.; Takemasa, E.; Kiyoi, T.; Kuno, M.; Oshima, Y.; Maeyama, K. 2016: CRACM3 regulates the stability of non-excitable exocytotic vesicle fusion pores in a Ca(2+)-independent manner via molecular interaction with syntaxin4. Scientific Reports 6: 28133
Eng, G.; Braverman, J.; Yilmaz, Ömer.H. 2018: CRAD as a cytoskeletal tumour suppressor. Nature Cell Biology 20(11): 1232-1233
Koprulu, M.; Shabbir, R.M.K.; Zaman, Q.; Nalbant, G.ök.; Malik, S.; Tolun, A.ıh. 2021: CRADD and USP44 mutations in intellectual disability, mild lissencephaly, brain atrophy, developmental delay, strabismus, behavioural problems and skeletal anomalies. European Journal of Medical Genetics 64(4): 104181
Atefi, M.; Titz, B.; Tsoi, J.; Avramis, E.; Le, A.; Ng, C.; Lomova, A.; Lassen, A.; Friedman, M.; Chmielowski, B.; Ribas, A.; Graeber, T.G. 2016: CRAF R391W is a melanoma driver oncogene. Scientific Reports 6: 27454
Jain, P.; Fierst, T.M.; Han, H.J.; Smith, T.E.; Vakil, A.; Storm, P.B.; Resnick, A.C.; Waanders, A.J. 2017: CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles. Oncogene 36(45): 6348-6358
Smalley, K.S.M.; Xiao, M.; Villanueva, J.; Nguyen, T.K.; Flaherty, K.T.; Letrero, R.; Van Belle, P.; Elder, D.E.; Wang, Y.; Nathanson, K.L.; Herlyn, M. 2009: CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations. Oncogene 28(1): 85-94
Noeparast, A.; Giron, P.; Noor, A.; Bahadur Shahi, R.; De Brakeleer, S.; Eggermont, C.; Vandenplas, H.; Boeckx, B.; Lambrechts, D.; De Grève, J.; Teugels, E. 2019: CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition. Oncogene 38(31): 5933-5941
Sundquist, S.; Batist, G.; Brodeur-Robb, K.; Dyck, K.; Eigl, B.J.; Lee, D.K.; Limoges, J.; Longstaff, H.; Pankovich, J.; Sadura, A.; Sullivan, P.; Dancey, J.E. 2021: CRAFT-A Proposed Framework for Decentralized Clinical Trials Participation in Canada. Current Oncology 28(5): 3857-3865
Wang, G.; Zhao, Z.; Ke, J.; Engel, Y.; Shi, Y-Ming.; Robinson, D.; Bingol, K.; Zhang, Z.; Bowen, B.; Louie, K.; Wang, B.; Evans, R.; Miyamoto, Y.; Cheng, K.; Kosina, S.; De Raad, M.; Silva, L.; Luhrs, A.; Lubbe, A.; Hoyt, D.W.; Francavilla, C.; Otani, H.; Deutsch, S.; Washton, N.M.; Rubin, E.M.; Mouncey, N.J.; Visel, A.; Northen, T.; Cheng, J-Fang.; Bode, H.B.; Yoshikuni, Y. 2019: CRAGE enables rapid activation of biosynthetic gene clusters in undomesticated bacteria. Nature Microbiology 4(12): 2498-2510
Wang, B.; Zhao, Z.; Jabusch, L.K.; Chiniquy, D.M.; Ono, K.; Conway, J.M.; Zhang, Z.; Wang, G.; Robinson, D.; Cheng, J.-F.; Dangl, J.L.; Northen, T.R.; Yoshikuni, Y. 2020: CRAGE-Duet Facilitates Modular Assembly of Biological Systems for Studying Plant-Microbe Interactions. Acs Synthetic Biology 9(9): 2610-2615
Noonan, A.J.C.; Qiu, Y.; Ho, J.C.H.; Ocampo, J.; Vreugdenhil, K.A.; Marr, R.A.; Zhao, Z.; Yoshikuni, Y.; Hallam, S.J. 2020: CRAGE-mediated insertion of fluorescent chromosomal markers for accurate and scalable measurement of co-culture dynamics in Escherichia coli. Synthetic Biology 5(1): Ysaa 015
Pearce, B.K.D.; Ayers, P.W.; Pudritz, R.E. 2020: CRAHCN-O: a Consistent Reduced Atmospheric Hybrid Chemical Network Oxygen Extension for Hydrogen Cyanide and Formaldehyde Chemistry in CO2-, N2-, H2O-, CH4-, and H2-Dominated Atmospheres. Journal of Physical Chemistry. a 124(41): 8594-8606
Engman, L.T.; Spriestersbach, D.C.; Moll, K.L. 1965: Cranial Base Angle and Nasopharyngeal Depth. Journal of the Colorado Dental Association 43: 25-29
Sirko, A.; Chekha, K.; Mizyakina, K. 2020: Cranial Nerve Hyperfunction Syndromes. Modern Approaches to Diagnosis and Treatment (Review). Georgian Medical News 303: 113-120
Muñoz, N.; Galvis, S.; Patiño, O.; Moneriz, C. 2021: Cranial Osteomyelitis as a Complication of Furuncular Myiasis. Revista Paulista de Pediatria: Orgao Oficial da Sociedade de Pediatria de Sao Paulo 39: E2020105
Eliachar, E.; Bret, A.J.; Bardiaux, M.; Tassy, R.; Pheulpin, J.; Schneider, M. 1963: Cranial Subcutaneous Hematoma in the Newborn. Archives Francaises de Pediatrie 20: 1105-1111
Shopfner, C.E.; Jabbour, J.T.; Vallion, R.M. 1965: Craniolacunia. American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine 93: 343-349
Rubasheva, A.E.; Burkovskaia, A.P. 1965: Craniolacunia. Vestnik Rentgenologii i Radiologii 40: 46-51
Kumar, S.; Nath, K. 1963: Craniostenosis. Journal of the All-India Ophthalmological Society 11: 43-50
Andreyev, O.A.; Skobska, O.E.; Andreyev, A.E.; Kajaya, N.V. 2016: Cranio—cerebral Trauma with Estimated Severity of 13—15 Points in Accordance to Glasgow Scale — a Light Trauma. Klinichna Khirurhiia 2016(11): 55-57
Phadtare, C.V.; Deora, H.; Sadashiva, N. 2021: CRASH 3: a monumental effort with minimal gain. European Journal of Trauma and Emergency Surgery: Official Publication of the European Trauma Society 47(1): 269-271
Lee, J.C.; Özer, B.üm.R.; Schultz, T. 2021: CRASY: correlated rotational alignment spectroscopy of pyridine. the rotational Raman spectrum of pyridine and asymmetric fragmentation of pyridine dimer cations. Physical Chemistry Chemical Physics: Pccp 23(17): 10621-10628
Kaliberova, L.N.; Krendelchtchikova, V.; Harmon, D.K.; Stockard, C.R.; Petersen, A.S.; Markert, J.M.; Gillespie, G.Y.; Grizzle, W.E.; Buchsbaum, D.J.; Kaliberov, S.A. 2009: CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma. Cancer Gene Therapy 16(10): 794-805
Grudzinska Pechhacker, M.K.; Di Scipio, M.; Vig, A.; Tumber, A.; Roslin, N.; Tavares, E.; Vincent, A.; Hèon, E. 2020: CRB1 -related retinopathy overlapping the ocular phenotype of S-adenosylhomocysteine hydrolase deficiency. Ophthalmic Genetics 41(5): 457-464
Paniagua, A.E.; Herranz-Martín, Súl.; Jimeno, D.; Jimeno, Ángela.M.; López-Benito, S.; Carlos Arévalo, J.; Velasco, A.; Aijón, Jé.; Lillo, Cón. 2015: CRB2 completes a fully expressed Crumbs complex in the Retinal Pigment Epithelium. Scientific Reports 5: 14504
Li, P.; Wang, Y.; Mao, X.; Jiang, Y.; Liu, J.; Li, J.; Wang, J.; Wang, R.; She, J.; Zhang, J.; Yang, J.; Liu, Y.; Liu, P. 2017: CRB3 downregulation confers breast cancer stem cell traits through TAZ/β-catenin. Oncogenesis 6(4): E322
Mao, X.; Li, P.; Wang, Y.; Liang, Z.; Liu, J.; Li, J.; Jiang, Y.; Bao, G.; Li, L.; Zhu, B.; Ren, Y.; Zhao, X.; Zhang, J.; Liu, Y.; Yang, J.; Liu, P. 2017: CRB3 regulates contact inhibition by activating the Hippo pathway in mammary epithelial cells. Cell Death and Disease 8(1): E2546
Cachi, P.G.; Ventura, S.án.; Cios, K.J. 2021: CRBA: a Competitive Rate-Based Algorithm Based on Competitive Spiking Neural Networks. Frontiers in Computational Neuroscience 15: 627567
Kuppumbatti, Y.S.; Rexer, B.; Nakajo, S.; Nakaya, K.; Mira-y-Lopez, R. 2001: CRBP suppresses breast cancer cell survival and anchorage-independent growth. Oncogene 20(50): 7413-7419
Courtney, A.; Howell, A.-M.; Daulatzai, N.; Savva, N.; Warren, O.; Mills, S.; Rasheed, S.; Milind, G.; Tekkis, N.; Gardiner, M.; Dai, T.; Safar, B.; Efron, J.E.; Darzi, A.; Tekkis, P.; Kontovounisios, C. 2020: CRC COVID: Colorectal cancer services during COVID-19 pandemic. Study protocol for service evaluation. International Journal of Surgery Protocols 23: 15-19
Firn, D. 1998: CRC alone in efforts to teach British doctors about cancer genetics. Nature Medicine 4(10): 1096
Firn, D. 1999: CRC forced to compromise over tobacco funding ban. Nature Medicine 5(2): 129
Liu, X.; Zhang, X.; Chen, J.; Ye, B.; Ren, S.; Lin, Y.; Sun, X.-F.; Zhang, H.; Shen, B. 2020: CRC-EBD: Epigenetic Biomarker Database for Colorectal Cancer. Frontiers in Genetics 11: 907
Beijnen, J.H.; Flora, K.P.; Halbert, G.W.; Henrar, R.E.; Slack, J.A. 1995: CRC/EORTC/NCI Joint Formulation Working Party: experiences in the formulation of investigational cytotoxic drugs. British Journal of Cancer 72(1): 210-218
Noubissi, F.K.; Elcheva, I.; Bhatia, N.; Shakoori, A.; Ougolkov, A.; Liu, J.; Minamoto, T.; Ross, J.; Fuchs, S.Y.; Spiegelman, V.S. 2006: CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling. Nature 441(7095): 898-901
Rutberg, S.E.; Adams, T.L.; Olive, M.; Alexander, N.; Vinson, C.; Yuspa, S.H. 1999: CRE DNA binding proteins bind to the AP-1 target sequence and suppress AP-1 transcriptional activity in mouse keratinocytes. Oncogene 18(8): 1569-1579
Jorde, D.; Kriechbaumer, T.; Berger, T.; Zitzlsperger, S.; Jacobsen, H-Arno. 2020: CREAM, a component level coffeemaker electrical activity measurement dataset. Scientific Data 7(1): 441
Dai, E.; Lv, Y.; Meng, F.; Yu, X.; Zhang, Y.; Wang, S.; Liu, X.; Liu, D.; Wang, J.; Li, X.; Jiang, W. 2014: CREAM: a database for chemotherapy resistance-associated miRSNP. Cell Death and Disease 5: E1272
Burnside, M.; Lewis, D.; Crocket, H.; Wilson, R.; Williman, J.; Jefferies, C.; Paul, R.; Wheeler, B.J.; de Bock, M. 2020: CREATE (Community deRivEd AutomaTEd insulin delivery) trial. Randomised parallel arm open label clinical trial comparing automated insulin delivery using a mobile controller (AnyDANA-loop) with an open-source algorithm with sensor augmented pump therapy in type 1 diabetes. Journal of Diabetes and Metabolic Disorders 19(2): 1615-1629
Zujewski, J.Anne.; Rubinstein, L. 2017: CREATE-X a role for capecitabine in early-stage breast cancer: an analysis of available data. Npj Breast Cancer 3: 27
Lee, S.; Li, B.; Martin, E.A.; D'Souza, A.G.; Jiang, J.; Doktorchik, C.; Southern, D.A.; Lee, J.; Wiebe, N.; Quan, H.; Eastwood, C.A. 2021: CREATE: a new Data Resource to Support Cardiac Precision Health. Cjc Open 3(5): 639-645
Yonehara, K.; Roska, B. 2017: CREATEd viruses go global. Nature Neuroscience 20(8): 1041-1042
Scott, B.; Health, W. 2016: Creating An Access Point for Wellness. Hospitals and Health Networks 90(8): 30 32
Siu, E.; Sadasivam, K.; Christiansen, N. 2016: Creating and Auditing a new Electronic Continuous Infusion Prescription Chart for a Paediatric Critical Care Unit. Archives of Disease in Childhood 101(9): E2
Kanki, H.; Sasaki, T.; Matsumura, S.; Kawano, T.; Todo, K.; Okazaki, S.; Nishiyama, K.; Takemori, H.; Mochizuki, H. 2020: CREB Coactivator CRTC2 Plays a Crucial Role in Endothelial Function. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 40(49): 9533-9546
Templeman, N.M.; Cota, V.; Keyes, W.; Kaletsky, R.; Murphy, C.T. 2020: CREB Non-autonomously Controls Reproductive Aging through Hedgehog/Patched Signaling. Developmental Cell 54(1): 92-105.E5
Benchoula, K.; Parhar, I.S.; Madhavan, P.; Hwa, W.E. 2021: CREB nuclear transcription activity as a targeting factor in the treatment of diabetes and diabetes complications. Biochemical Pharmacology 188: 114531
Yang, Y.; Wen, J.; Zheng, B.; Wu, S.; Mao, Q.; Liang, L.; Li, Z.; Bachmann, T.; Bekker, A.; Tao, Y.-X. 2021: CREB Participates in Paclitaxel-Induced Neuropathic Pain Genesis Through Transcriptional Activation of Dnmt3a in Primary Sensory Neurons. Neurotherapeutics: the Journal of the American Society for Experimental Neurotherapeutics 18(1): 586-600
Chang, M.; Lin, H.; Fu, H.; Wang, J.; Yang, Y.; Wan, Z.; Han, G. 2020: CREB activation affects mesenchymal stem cell migration and differentiation in periodontal tissues due to orthodontic force. International Journal of Biochemistry and Cell Biology 129: 105862
Li, J.; Zhang, Y.; Zheng, N.; Li, B.; Yang, J.; Zhang, C.; Xia, G.; Zhang, M. 2020: CREB activity is required for mTORC1 signaling-induced primordial follicle activation in mice. Histochemistry and Cell Biology 154(3): 287-299
Ashok, C.; Selvam, M.; Ponne, S.; Parcha, P.K.; Raja, K.M.P.; Baluchamy, S. 2020: CREB acts as a common transcription factor for major epigenetic repressors; DNMT3B, EZH2, CUL4B and E2F6. Medical Oncology 37(8): 68
Noriega, L.G.; Feige, Jérôme.N.; Canto, C.; Yamamoto, H.; Yu, J.; Herman, M.A.; Mataki, C.; Kahn, B.B.; Auwerx, J. 2011: CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability. Embo Reports 12(10): 1069-1076
Altarejos, J.Y.; Montminy, M. 2011: CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nature Reviews. Molecular Cell Biology 12(3): 141-151
Saeki, K.; Yuo, A.; Koizumi, M.; Fujiwara, K.; Kaneko, M.; Takaku, F.; Yazaki, Y. 2001: CREB antisense oligonucleotides induce non-apoptotic cell death in proliferating leukemia cells, but not normal hematopoietic cells, by a bizarre non-antisense mechanism. Leukemia 15(2): 238-245
Herzig, S.; Hedrick, S.; Morantte, I.; Koo, S-Hoi.; Galimi, F.; Montminy, M. 2003: CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-gamma. Nature 426(6963): 190-193
Tregnago, C.; Manara, E.; Zampini, M.; Bisio, V.; Borga, C.; Bresolin, S.; Aveic, S.; Germano, G.; Basso, G.; Pigazzi, M. 2016: CREB engages C/EBPδ to initiate leukemogenesis. Leukemia 30(9): 1887-1896
Dawson, T.M.; Ginty, D.D. 2002: CREB family transcription factors inhibit neuronal suicide. Nature Medicine 8(5): 450-451
Park, J.; Oh, H.; Kim, D.-Y.; Cheon, Y.; Park, Y.-J.; Hwang, H.; Neal, S.J.; Dar, A.R.; Butcher, R.A.; Sengupta, P.; Kim, D.-W.; Kim, K. 2021: CREB mediates the C. elegans dauer polyphenism through direct and cell-autonomous regulation of TGF-β expression. Plos Genetics 17(7): E1009678
Dong, Y.; Green, T.; Saal, D.; Marie, H.; Neve, R.; Nestler, E.J.; Malenka, R.C. 2006: CREB modulates excitability of nucleus accumbens neurons. Nature Neuroscience 9(4): 475-477
Esparza, S.D.; Chang, J.; Shankar, D.B.; Zhang, B.; Nelson, S.F.; Sakamoto, K.M. 2008: CREB regulates Meis1 expression in normal and malignant hematopoietic cells. Leukemia 22(3): 665-667
Zhou, Y.; Won, J.; Karlsson, M.Guzman.; Zhou, M.; Rogerson, T.; Balaji, J.; Neve, R.; Poirazi, P.; Silva, A.J. 2009: CREB regulates excitability and the allocation of memory to subsets of neurons in the amygdala. Nature Neuroscience 12(11): 1438-1443
Herzig, S.; Long, F.; Jhala, U.S.; Hedrick, S.; Quinn, R.; Bauer, A.; Rudolph, D.; Schutz, G.; Yoon, C.; Puigserver, P.; Spiegelman, B.; Montminy, M. 2001: CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413(6852): 179-183
Wallace, D.L.; Han, M-Hu.; Graham, D.L.; Green, T.A.; Vialou, V.; Iñiguez, S.D.; Cao, J-Li.; Kirk, A.; Chakravarty, S.; Kumar, A.; Krishnan, V.; Neve, R.L.; Cooper, D.C.; Bolaños, C.A.; Barrot, M.; McClung, C.A.; Nestler, E.J. 2009: CREB regulation of nucleus accumbens excitability mediates social isolation-induced behavioral deficits. Nature Neuroscience 12(2): 200-209
Kida, S.; Josselyn, S.A.; Peña de Ortiz, S.; Kogan, J.H.; Chevere, I.; Masushige, S.; Silva, A.J. 2002: CREB required for the stability of new and reactivated fear memories. Nature Neuroscience 5(4): 348-355
Armandari, I.; Zomerman, W.W.; Plasschaert, S.L.A.; Smit, M.J.; Martini, T.E.I.; de Camargo Magalhães, E.S.; Hogeling, S.M.; Rozema-Huizinga, G.C.; Lourens, H.J.; Meeuwsen-de Boer, T.G.J.; Scherpen, F.J.G.; de Bont, E.S.J.M.; Bruggeman, S.W.M. 2021: CREB signaling activity correlates with differentiation and survival in medulloblastoma. Scientific Reports 11(1): 16077
Lee, Y.Y.; Moujalled, D.; Doerflinger, M.; Gangoda, L.; Weston, R.; Rahimi, A.; de Alboran, I.; Herold, M.; Bouillet, P.; Xu, Q.; Gao, X.; Du, X-J.; Puthalakath, H. 2013: CREB-binding protein (CBP) regulates β-adrenoceptor (β-AR)-mediated apoptosis. Cell Death and Differentiation 20(7): 941-952
Xu, J.; Roy, A.; Palli, S.Reddy. 2018: CREB-binding protein plays key roles in juvenile hormone action in the red flour beetle, Tribolium Castaneum. Scientific Reports 8(1): 1426
Meller, R.; Minami, M.; Cameron, J.A.; Impey, S.; Chen, D.; Lan, J-Quan.; Henshall, D.C.; Simon, R.P. 2005: CREB-mediated Bcl-2 protein expression after ischemic preconditioning. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 25(2): 234-246
Zhang, J.; Cai, C-Yun.; Wu, H-Yin.; Zhu, L-Juan.; Luo, C-Xia.; Zhu, D-Ya. 2016: CREB-mediated synaptogenesis and neurogenesis is crucial for the role of 5-HT1a receptors in modulating anxiety behaviors. Scientific Reports 6: 29551
Tooley, J.G.; Catlin, J.P.; Schaner Tooley, C.E. 2021: CREB-mediated transcriptional activation of NRMT1 drives muscle differentiation. Transcription 2021: 1-17
Chen, W.-J.; Lai, Y.-J.; Lee, J.-L.; Wu, S.-T.; Hsu, Y.-J. 2020: CREB/ATF3 signaling mediates indoxyl sulfate-induced vascular smooth muscle cell proliferation and neointimal formation in uremia. Atherosclerosis 315: 43-54
Xia, T.; Zhang, Q.; Xiao, Y.; Wang, C.; Yu, J.; Liu, H.; Liu, B.; Zhang, Y.; Chen, S.; Liu, Y.; Chen, Y.; Guo, F. 2015: CREB/TRH pathway in the central nervous system regulates energy expenditure in response to deprivation of an essential amino acid. International Journal of Obesity 39(1): 105-113
Huang, X.; Liu, F.; Jiang, Z.; Guan, H.; Jia, Q. 2020: CREB1 Suppresses Transcription of microRNA-186 to Promote Growth, Invasion and Epithelial-Mesenchymal Transition of Gastric Cancer Cells Through the KRT8/HIF-1α Axis. Cancer Management and Research 12: 9097-9111
Zhao, L.; Xia, W.; Jiang, P. 2021: CREB1 and ATF1 Negatively Regulate Glutathione Biosynthesis Sensitizing Cells to Oxidative Stress. Frontiers in Cell and Developmental Biology 9: 698264
Yang, J.; Li, S.; Lv, H.; Wang, W.; Zhang, J.; Chu, L.; Zhang, Y. 2021: CREB1 and BDNF gene polymorphisms are associated with early treatment response to escitalopram in panic disorder. Journal of Affective Disorders 278: 536-541
Ray, R.; Jepson, C.; Wileyto, P.; Patterson, F.; Strasser, A.A.; Rukstalis, M.; Perkins, K.; Blendy, J.; Lerman, C. 2007: CREB1 haplotypes and the relative reinforcing value of nicotine. Molecular Psychiatry 12(7): 615-617
Friedrich, M.; Heimer, N.; Stoehr, C.; Steven, Aé.; Wach, S.; Taubert, H.; Hartmann, A.; Seliger, B. 2020: CREB1 is affected by the micro RNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma. Scientific Reports 10(1): 6499
Yu, L.; Gan, X.; Bai, Y.; An, R. 2021: CREB1 protects against the renal injury in a rat model of kidney stone disease and calcium oxalate monohydrate crystals-induced injury in NRK-52E cells. Toxicology and Applied Pharmacology 413: 115394
Sampieri, L.; Funes Chabán, M.; Di Giusto, P.; Rozés-Salvador, V.; Alvarez, C. 2021: CREB3L2 Modulates Nerve Growth Factor-Induced Cell Differentiation. Frontiers in Molecular Neuroscience 14: 650338
Tomoishi, S.; Fukushima, S.; Shinohara, K.; Katada, T.; Saito, K. 2017: CREB3L2-mediated expression of Sec23A/Sec24D is involved in hepatic stellate cell activation through ER-Golgi transport. Scientific Reports 7(1): 7992
Nakagawa, Y.; Satoh, A.; Tezuka, H.; Han, S-Iee.; Takei, K.; Iwasaki, H.; Yatoh, S.; Yahagi, N.; Suzuki, H.; Iwasaki, Y.; Sone, H.; Matsuzaka, T.; Yamada, N.; Shimano, H. 2016: CREB3L3 controls fatty acid oxidation and ketogenesis in synergy with PPARα. Scientific Reports 6: 39182
Wang, S.; Qiu, J.; Liu, L.; Su, C.; Qi, L.; Huang, C.; Chen, X.; Zhang, Y.; Ye, Y.; Ding, Y.; Liang, L.; Liao, W. 2020: CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET. Journal of Experimental and Clinical Cancer Research: Cr 39(1): 168
Inthal, A.; Zeitlhofer, P.; Zeginigg, M.; Morak, M.; Grausenburger, R.; Fronkova, E.; Fahrner, B.; Mann, G.; Haas, O.A.; Panzer-Grümayer, R. 2012: CREBBP HAT domain mutations prevail in relapse cases of high hyperdiploid childhood acute lymphoblastic leukemia. Leukemia 26(8): 1797-1803
Xian, R.R.; Xie, Y.; Haley, L.M.; Yonescu, R.; Pallavajjala, A.; Pittaluga, S.; Jaffe, E.S.; Duffield, A.S.; McCall, C.M.; Gheith, S.M.F.; Gocke, C.D. 2020: CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma. Blood Cancer Journal 10(6): 69
Fogelholm, J.; Henriksen, R.; Höglund, A.; Huq, N.; Johnsson, M.; Lenz, R.; Jensen, P.; Wright, D. 2020: CREBBP and WDR 24 Identified as Candidate Genes for Quantitative Variation in Red-Brown Plumage Colouration in the Chicken. Scientific Reports 10(1): 1161
Hu, H.; Yin, S.; Ma, R.; Chen, R.; Li, S.; Chen, Y.; Fei, H.; Yang, L. 2021: CREBBP knockdown suppressed proliferation and promoted chemo-sensitivity via PERK-mediated unfolded protein response in ovarian cancer. Journal of Cancer 12(15): 4595-4603
Mullighan, C.G.; Zhang, J.; Kasper, L.H.; Lerach, S.; Payne-Turner, D.; Phillips, L.A.; Heatley, S.L.; Holmfeldt, L.; Collins-Underwood, J.Racquel.; Ma, J.; Buetow, K.H.; Pui, C-Hon.; Baker, S.D.; Brindle, P.K.; Downing, J.R. 2011: CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 471(7337): 235-239
Huang, Y-Hui.; Cai, K.; Xu, P-Peng.; Wang, L.; Huang, C-Xin.; Fang, Y.; Cheng, S.; Sun, X-Jian.; Liu, F.; Huang, J-Yan.; Ji, M-Meng.; Zhao, W-Li. 2021: CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis. Signal Transduction and Targeted Therapy 6(1): 10
Li, G.; Zhang, J.; Jiang, Q.; Liu, B.; Xu, K. 2020: CREBH knockout accelerates hepatic fibrosis in mouse models of diet-induced nonalcoholic fatty liver disease. Life Sciences 254: 117795
Park, J-Gil.; Xu, X.; Cho, S.; Hur, K.Yeon.; Lee, M-Shik.; Kersten, S.; Lee, A-Hwee. 2016: CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis. Scientific Reports 6: 27938
Wade, H.; Pan, K.; Su, Q. 2021: CREBH: a Complex Array of Regulatory Mechanisms in Nutritional Signaling, Metabolic Inflammation, and Metabolic Disease. Molecular Nutrition and Food Research 65(1): E2000771
Loos, R.J.F. 2016: CREBRF variant increases obesity risk and protects against diabetes in Samoans. Nature Genetics 48(9): 976-978
Mousavi, S.Mostafa.; Zhu, W.; Sheng, Y.; Beroza, G.C. 2019: CRED: A Deep Residual Network of Convolutional and Recurrent Units for Earthquake Signal Detection. Scientific Reports 9(1): 10267
Wanner, C.; Brenner, S. 2019: CREDENCE and DELIGHT deliver on renal benefits. Nature Reviews. Nephrology 15(8): 459-460
Liu, D.; Tian, X.; Liu, Y.; Song, H.; Cheng, X.; Zhang, X.; Yan, C.; Han, Y. 2021: CREG ameliorates the phenotypic switching of cardiac fibroblasts after myocardial infarction via modulation of CDC42. Cell Death and Disease 12(4): 355
Tai, T.-T.; Zhou, Y.; Xu, G.-X.; Wu, T.; Huang, Z.-X.; Zhao, F.-F. 2020: CREG improves cardiac function by regulating cardiomyocytes' autophagy in diabetic myocardial infarction rats. European Review for Medical and Pharmacological Sciences 24(21): 11233-11242
Liu, J.; Qi, Y.; Chao, J.; Sathuvalli, P.; Y Lee, L.; Li, S. 2021: CREG1 promotes lysosomal biogenesis and function. Autophagy 2021: 1-17
Gounari, F. 2020: CRELD1 controls T cell homeostasis. Nature Immunology 21(12): 1480-1482
Bonaguro, L.; Köhne, M.; Schmidleithner, L.; Schulte-Schrepping, J.; Warnat-Herresthal, S.; Horne, A.; Kern, P.; Günther, P.; Ter Horst, R.; Jaeger, M.; Rahmouni, S.; Georges, M.; Falk, C.S.; Li, Y.; Mass, E.; Beyer, M.; Joosten, L.A.B.; Netea, M.G.; Ulas, T.; Schultze, J.L.; Aschenbrenner, A.C. 2020: CRELD1 modulates homeostasis of the immune system in mice and humans. Nature Immunology 21(12): 1517-1527
Cai, F.; Burns, R.Nicholas.; Kelly, B.; Hampton, B.Star. 2020: CREOGs Over Coffee: Feasibility of an Ob-Gyn Medical Education Podcast by Residents. Journal of Graduate Medical Education 12(3): 340-343
Zhang, Y.; Wang, S.; Kang, W.; Liu, C.; Dong, Y.; Ren, F.; Wang, Y.; Zhang, J.; Wang, G.; To, K.Fai.; Zhang, X.; Sung, J.Jy.; Chang, Z.; Yu, J. 2018: CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation. Oncogene 37(26): 3485-3500
Yang, L.; Yang, H.; Chu, Y.; Song, Y.; Ding, L.; Zhu, B.; Zhai, W.; Wang, X.; Kuang, Y.; Ren, F.; Jia, B.; Wu, W.; Ye, X.; Wang, Y.; Chang, Z. 2021: CREPT is required for murine stem cell maintenance during intestinal regeneration. Nature Communications 12(1): 270
Ding, L.; Yang, L.; He, Y.; Zhu, B.; Ren, F.; Fan, X.; Wang, Y.; Li, M.; Li, J.; Kuang, Y.; Liu, S.; Zhai, W.; Ma, D.; Ju, Y.; Liu, Q.; Jia, B.; Sheng, J.; Chang, Z. 2018: CREPT/RPRD1B associates with Aurora B to regulate Cyclin B1 expression for accelerating the G2/M transition in gastric cancer. Cell Death and Disease 9(12): 1172
Wang, J.; Mullighan, C.G.; Easton, J.; Roberts, S.; Heatley, S.L.; Ma, J.; Rusch, M.C.; Chen, K.; Harris, C.C.; Ding, L.; Holmfeldt, L.; Payne-Turner, D.; Fan, X.; Wei, L.; Zhao, D.; Obenauer, J.C.; Naeve, C.; Mardis, E.R.; Wilson, R.K.; Downing, J.R.; Zhang, J. 2011: CREST maps somatic structural variation in cancer genomes with base-pair resolution. Nature Methods 8(8): 652-654
Renton, A.E.; Traynor, B.J. 2013: CRESTing the ALS mountain. Nature Neuroscience 16(7): 774-775
Pacheco-Lugo, L.A.; Sáenz-García, J.é L.; Díaz-Olmos, Y.; Netto-Costa, R.; Brant, R.S.C.; DaRocha, W.D. 2020: CREditing: a tool for gene tuning in Trypanosoma cruzi. International Journal for Parasitology 50(13): 1067-1077
Reis-Silva, L.L.; Barretto-de-Souza, L.; Benini, R.; Crestani, C.C. 2021: CRF1 and CRF2 receptors in the lateral hypothalamus differently modulate the baroreflex function in unanesthetized rats. Brain Research 1751: 147195
Wanat, M.J.; Bonci, A.; Phillips, P.E.M. 2013: CRF acts in the midbrain to attenuate accumbens dopamine release to rewards but not their predictors. Nature Neuroscience 16(4): 383-385
Walker, L.C.; Lawrence, A.J. 2017: CRF and the nucleus incertus: a node for integration of stress signals. Nature Reviews. Neuroscience 18(2): 158
Beckstead, M.J.; Gantz, S.C.; Ford, C.P.; Stenzel-Poore, M.P.; Phillips, P.Em.; Mark, G.P.; Williams, J.T. 2009: CRF enhancement of GIRK channel-mediated transmission in dopamine neurons. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 34(8): 1926-1935
Dore, R.; Iemolo, A.; Smith, K.L.; Wang, X.; Cottone, P.; Sabino, V. 2013: CRF mediates the anxiogenic and anti-rewarding, but not the anorectic effects of PACAP. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 38(11): 2160-2169
Magalhaes, A.C.; Holmes, K.D.; Dale, L.B.; Comps-Agrar, L.; Lee, D.; Yadav, P.N.; Drysdale, L.; Poulter, M.O.; Roth, B.L.; Pin, J-Philippe.; Anisman, H.; Ferguson, S.S.G. 2010: CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling. Nature Neuroscience 13(5): 622-629
Lowery, E.G.; Spanos, M.; Navarro, M.; Lyons, A.M.; Hodge, C.W.; Thiele, T.E. 2010: CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 35(6): 1241-1252
Iemolo, A.; Blasio, A.; St Cyr, S.A.; Jiang, F.; Rice, K.C.; Sabino, V.; Cottone, P. 2013: CRF-CRF1 receptor system in the central and basolateral nuclei of the amygdala differentially mediates excessive eating of palatable food. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 38(12): 2456-2466
Li, L.-F.; Zhang, L.-Z.; He, Z.-X.; Yuan, W.; Ma, H.; Xun, Y.-F.; Zhang, J.; Hou, W.-J.; Zhang, X.-N.; Cai, W.-Q.; Guo, Q.-Q.; Jia, R.; Tai, F.-D. 2021: CRF-CRFR1 system within the dorsal medial prefrontal cortex are involved in consolation deficits under acute restraint stress in mandarin voles. Psychoneuroendocrinology 132: 105353
June, H.L.; Liu, J.; Warnock, K.T.; Bell, K.A.; Balan, I.; Bollino, D.; Puche, A.; Aurelian, L. 2015: CRF-amplified neuronal TLR4/MCP-1 signaling regulates alcohol self-administration. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 40(6): 1549-1559
Risbrough, V.B.; Geyer, M.A.; Hauger, R.L.; Coste, S.; Stenzel-Poore, M.; Wurst, W.; Holsboer, F. 2009: CRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cues. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 34(6): 1494-1503
Taché, Y.; Martinez, V.; Wang, L.; Million, M. 2004: CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome. British Journal of Pharmacology 141(8): 1321-1330
Ingallinesi, M.; Rouibi, K.; Le Moine, C.; Papaleo, F.; Contarino, A. 2012: CRF2 receptor-deficiency eliminates opiate withdrawal distress without impairing stress coping. Molecular Psychiatry 17(12): 1283-1294
Wiley, K.E.; Davenport, A.P. 2004: CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators. British Journal of Pharmacology 143(4): 508-514
Drechsler, Y.; Vasconcelos, E.J.R.; Griggs, L.M.; Diniz, P.P.P.V. 2020: CRFK and Primary Macrophages Transcriptomes in Response to Feline Coronavirus Infection Differ Significantly. Frontiers in Genetics 11: 584744
Zbytek, B.; Slominski, A.T. 2007: CRH mediates inflammation induced by lipopolysaccharide in human adult epidermal keratinocytes. Journal of Investigative Dermatology 127(3): 730-732
Yusibova, M.; Hasman, H.; Clausen, P.T.L.C.; Imkamp, F.; Wagner, K.; Andersen, L.P. 2020: CRHP Finder, a webtool for the detection of clarithromycin resistance in Helicobacter pylori from whole-genome sequencing data. Helicobacter 25(6): E12752
Rogers, J.; Raveendran, M.; Fawcett, G.L.; Fox, A.S.; Shelton, S.E.; Oler, J.A.; Cheverud, J.; Muzny, D.M.; Gibbs, R.A.; Davidson, R.J.; Kalin, N.H. 2013: CRHR1 genotypes, neural circuits and the diathesis for anxiety and depression. Molecular Psychiatry 18(6): 700-707
Sun, J.; Wang, J.; Xiong, D.; Hu, J.; Liu, R. 2016: CRHunter: integrating multifaceted information to predict catalytic residues in enzymes. Scientific Reports 6: 34044
Eddy, J.A.; Thorsson, V.és.; Lamb, A.E.; Gibbs, D.L.; Heimann, C.; Yu, J.X.; Chung, V.; Chae, Y.; Dang, K.; Vincent, B.G.; Shmulevich, I.; Guinney, J. 2020: CRi iAtlas: an interactive portal for immuno-oncology research. F1000research 9: 1028
Chen, Y.-Q.; Wang, S.-N.; Shi, Y.-J.; Chen, J.; Ding, S.-Q.; Tang, J.; Shen, L.; Wang, R.; Ding, H.; Hu, J.-G.; Lü, H.-Z. 2020: CRID3, a blocker of apoptosis associated speck like protein containing a card, ameliorates murine spinal cord injury by improving local immune microenvironment. Journal of Neuroinflammation 17(1): 255
Nagar, H.; Kim, S.; Lee, I.; Choi, S.-J.; Piao, S.; Jeon, B.H.; Shong, M.; Kim, C.-S. 2021: CRIF1 deficiency suppresses endothelial cell migration via upregulation of RhoGDI2. Plos one 16(8): E0256646
Chang, H.; Li, J.; Qu, K.; Wan, Y.; Liu, S.; Zheng, W.; Zhang, Z.; Liu, C. 2020: CRIF1 overexpression facilitates tumor growth and metastasis through inducing ROS/NFκB pathway in hepatocellular carcinoma. Cell Death and Disease 11(5): 332
Brandt, G.; Zimolong, A.; Carrat, L.; Merloz, P.; Staudte, H.W.; Lavallée, S.; Radermacher, K.; Rau, G. 1999: CRIGOS: a compact robot for image-guided orthopedic surgery. IEEE Transactions on Information Technology in Biomedicine: a Publication of the IEEE Engineering in Medicine and Biology Society 3(4): 252-260
Brandt, G.; Radermacher, K.; Zimolong, A.; Rau, G.; Merloz, P.; Klos, T.V.; Robb, J.; Staudte, H.W. 2000: CRIGOS: development of a compact robot for image-guided orthopedic surgery. Der Orthopade 29(7): 645-649
Berrier, K.L.; Kazi, Z.B.; Prater, S.N.; Bali, D.S.; Goldstein, J.; Stefanescu, M.C.; Rehder, C.W.; Botha, E.G.; Ellaway, C.; Bhattacharya, K.; Tylki-Szymanska, A.; Karabul, N.; Rosenberg, A.S.; Kishnani, P.S. 2015: CRIM-negative infantile Pompe disease: characterization of immune responses in patients treated with ERT monotherapy. Genetics in Medicine: Official Journal of the American College of Medical Genetics 17(11): 912-918
Petrović, B. 2021: Criminal Aspect of the Covid-19 Pandemic in Bosnia and Herzegovina and the Region. Psychiatria Danubina 33(Suppl 3): S352-S360
Arthurs, C.J.; Khlebnikov, R.; Melville, A.; Marčan, M.; Gomez, A.; Dillon-Murphy, D.; Cuomo, F.; Silva Vieira, M.; Schollenberger, J.; Lynch, S.R.; Tossas-Betancourt, C.; Iyer, K.; Hopper, S.; Livingston, E.; Youssefi, P.; Noorani, A.; Ben Ahmed, S.; Nauta, F.J.H.; van Bakel, T.M.J.; Ahmed, Y.; van Bakel, P.A.J.; Mynard, J.; Di Achille, P.; Gharahi, H.; Lau, K.D.; Filonova, V.; Aguirre, M.; Nama, N.; Xiao, N.; Baek, S.; Garikipati, K.; Sahni, O.; Nordsletten, D.; Figueroa, C.A. 2021: CRIMSON: An open-source software framework for cardiovascular integrated modelling and simulation. Plos Computational Biology 17(5): E1008881
Zoni, E.; Chen, L.; Karkampouna, S.; Granchi, Z.; Verhoef, E.I.; La Manna, F.; Kelber, J.; Pelger, R.C.M.; Henry, M.D.; Snaar-Jagalska, E.; van Leenders, G.J.L.H.; Beimers, L.; Kloen, P.; Gray, P.C.; van der Pluijm, G.; Kruithof-de Julio, M. 2017: CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer. Oncogene 36(33): 4739-4749
Balcioglu, O.; Heinz, R.E.; Freeman, D.W.; Gates, B.L.; Hagos, B.M.; Booker, E.; Mirzaei Mehrabad, E.; Diesen, H.T.; Bhakta, K.; Ranganathan, S.; Kachi, M.; Leblanc, M.; Gray, P.C.; Spike, B.T. 2020: CRIPTO antagonist ALK4L75A-Fc inhibits breast cancer cell plasticity and adaptation to stress. Breast Cancer Research: Bcr 22(1): 125
Talukder, A.H.; Meng, Q.; Kumar, R. 2006: CRIPak, a novel endogenous Pak1 inhibitor. Oncogene 25(9): 1311-1319
Wittayarat, M.; Pukazhenthi, B.S.; Tipkantha, W.; Techakumphu, M.; Srisuwatanasagul, S.; Panyaboriban, S. 2021: CRISP protein expression in semen of the endangered Malayan tapir (Tapirus indicus). Theriogenology 172: 106-115
Kurgan, G.; Turk, R.; Li, H.; Roberts, N.; Rettig, G.R.; Jacobi, A.M.; Tso, L.; Sturgeon, M.; Mertens, M.; Noten, R.; Florus, K.; Behlke, M.A.; Wang, Y.; McNeill, M.S. 2021: CRISPAltRations: a validated cloud-based approach for interrogation of double-strand break repair mediated by CRISPR genome editing. Molecular Therapy. Methods and Clinical Development 21: 478-491
Amit, I.; Iancu, O.; Levy-Jurgenson, A.; Kurgan, G.; McNeill, M.S.; Rettig, G.R.; Allen, D.; Breier, D.; Ben Haim, N.; Wang, Y.; Anavy, L.; Hendel, A.; Yakhini, Z. 2021: CRISPECTOR provides accurate estimation of genome editing translocation and off-target activity from comparative NGS data. Nature Communications 12(1): 3042
Neela, P.K.; Gosla, S.R.; Husain, A.; Mohan, V. 2020: CRISPLD2 Gene Polymorphisms with Nonsyndromic Cleft Lip Palate in Indian Population. Global Medical Genetics 7(1): 22-25
Zhang, S.; Pei, L.; Qu, J.; Sun, L.; Jiang, W.; Li, W.; Lin, Z.; Chen, D. 2021: CRISPLD2 attenuates pro-inflammatory cytokines production in HMGB1-stimulated monocytes and septic mice. American Journal of Translational Research 13(5): 4080-4091
Wisittipanit, N.; Pulsrikarn, C.; Srisong, S.; Srimora, R.; Kittiwan, N.; Poonchareon, K. 2020: CRISPR 2 PCR and high resolution melting profiling for identification and characterization of clinically-relevant Salmonella enterica subsp. enterica. Peerj 8: E9113
Gao, C.; Chen, J. 2021: CRISPR Adventures in China. Crispr Journal 4(3): 304-306
Shmakov, S.A.; Utkina, I.; Wolf, Y.I.; Makarova, K.S.; Severinov, K.V.; Koonin, E.V. 2020: CRISPR Arrays Away from cas Genes. Crispr Journal 3(6): 535-549
Akhtar, M.; Jamal, T.; Khan, M.; Khan, S.R.; Haider, S.; Jalil, F. 2021: CRISPR Cas System: An efficient tool for cancer modelling. JPMA. Journal of the Pakistan Medical Association 71(2(B): 718-724
Bansal, M.; Acharya, S.; Sharma, S.; Phutela, R.; Rauthan, R.; Maiti, S.; Chakraborty, D. 2021: CRISPR Cas9 based genome editing in inherited retinal dystrophies. Ophthalmic Genetics 2021: 1-10
Bodle, J.C.; Gersbach, C.A. 2021: CRISPR Clocks: the Times they Are a-Changin'. Crispr Journal 4(2): 160-163
Coelho, M.A.; De Braekeleer, E.; Firth, M.; Bista, M.; Lukasiak, S.; Cuomo, M.Emanuela.; Taylor, B.J.M. 2020: CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs. Nature Communications 11(1): 4132
Uddin, F.; Rudin, C.M.; Sen, T. 2020: CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future. Frontiers in Oncology 10: 1387
Wong, P.K.; Cheah, F.C.; Syafruddin, S.E.; Mohtar, M.A.; Azmi, N.; Ng, P.Y.; Chua, E.W. 2021: CRISPR Gene-Editing Models Geared Toward Therapy for Hereditary and Developmental Neurological Disorders. Frontiers in Pediatrics 9: 592571
Panfil, A.R.; Green, P.L.; Yoder, K.E. 2020: CRISPR Genome Editing Applied to the Pathogenic Retrovirus HTLV-1. Frontiers in Cellular and Infection Microbiology 10: 580371
Knott, G.J.; Lapinaite, A. 2021: CRISPR Gets its Origin Story. Crispr Journal 4(5): 631-633
Musunuru, K. 2021: CRISPR Hits Home in a First-in-Human Study. Crispr Journal 4(4): 460-461
Morelli, E.; Gulla', A.; Amodio, N.; Taiana, E.; Neri, A.; Fulciniti, M.; Munshi, N.C. 2021: CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA Network. Methods in Molecular Biology 2348: 189-204
Wong, A.I.; Rock, J.M. 2021: CRISPR Interference (CRISPRi) for Targeted Gene Silencing in Mycobacteria. Methods in Molecular Biology 2314: 343-364
Misa, J.; Schwartz, C. 2021: CRISPR Interference and Activation to Modulate Transcription in Yarrowia lipolytica. Methods in Molecular Biology 2307: 95-109
Nadolinskaia, N.I.; Zamakhaev, M.V.; Shumkov, M.S.; Armianinova, D.K.; Karpov, D.S.; Goncharenko, A.V. 2021: CRISPR Interference of Adenylate Cyclases from Mycobacterium tuberculosis. Applied Biochemistry and Microbiology 57(4): 421-425
Flotte, T.R. 2021: CRISPR Keeps Things Fresh: Next-Generation Tools for Gene Editing. Human Gene Therapy 32(5-6): 235-236
Stincic, T.L.; Bosch, M.A.; Hunker, A.C.; Juarez, B.; Connors, A.M.; Zweifel, L.S.; Rønnekleiv, O.K.; Kelly, M.J. 2021: CRISPR knockdown of Kcnq3 attenuates the M-current and increases excitability of NPY/AgRP neurons to alter energy balance. Molecular Metabolism 49: 101218
Kerek, E.M.; Cromwell, C.R.; Hubbard, B.P. 2020: CRISPR Lights up in Situ Protein Evolution. Cell Chemical Biology 27(5): 475-478
Dai, Y.; Wu, Y.; Liu, G.; Gooding, J.J. 2020: CRISPR Mediated Biosensing Toward Understanding Cellular Biology and Point-of-Care Diagnosis. Angewandte Chemie 59(47): 20754-20766
Choi, C.Q. 2021: CRISPR Meets its Match. Acs Central Science 7(5): 699-701
Kuroda, K.; Ueda, M. 2021: CRISPR Nickase-Mediated Base Editing in Yeast. Methods in Molecular Biology 2196: 27-37
Jordan, B. 2021: CRISPR Nobel, at last…. Medecine Sciences: M/S 37(1): 77-80
Deltcheva, E.; Chylinski, K.; Sharma, C.M.; Gonzales, K.; Chao, Y.; Pirzada, Z.A.; Eckert, M.R.; Vogel, Jörg.; Charpentier, E. 2011: CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471(7340): 602-607
Pan, Y.; Shen, N.; Jung-Klawitter, S.; Betzen, C.; Hoffmann, G.F.; Hoheisel, Jörg.D.; Blau, N. 2016: CRISPR RNA-guided FokI nucleases repair a PAH variant in a phenylketonuria model. Scientific Reports 6: 35794
Maeder, M.L.; Linder, S.J.; Cascio, V.M.; Fu, Y.; Ho, Q.H.; Joung, J.Keith. 2013: CRISPR RNA-guided activation of endogenous human genes. Nature Methods 10(10): 977-979
Wilkinson, R.A.; Martin, C.; Nemudryi, A.A.; Wiedenheft, B. 2019: CRISPR RNA-guided autonomous delivery of Cas9. Nature Structural and Molecular Biology 26(1): 14-24
Wu, W-Hsuan.; Tsai, Y-Ting.; Justus, S.; Lee, T-Ting.; Zhang, L.; Lin, C-Sheng.; Bassuk, A.G.; Mahajan, V.B.; Tsang, S.H. 2016: CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa. Molecular Therapy: the Journal of the American Society of Gene Therapy 24(8): 1388-1394
Carey, C.M.; Gagnon, J.A. 2020: CRISPR Rube Goldberg machines for visualizing cell lineage. Nature Neuroscience 23(12): 1469-1471
Li, Z.; Wang, B.; Gu, S.; Jiang, P.; Sahu, A.; Chen, C.-H.; Han, T.; Shi, S.; Wang, X.; Traugh, N.; Liu, H.; Liu, Y.; Wu, Q.; Brown, M.; Xiao, T.; Boland, G.M.; Shirley Liu, X. 2020: CRISPR Screens Identify Essential Cell Growth Mediators in BRAF Inhibitor-resistant Melanoma. Genomics Proteomics and Bioinformatics 18(1): 26-40
Sobh, A.; Russo, M.; Vulpe, C.D. 2021: CRISPR Screens in Toxicology Research: An Overview. Current Protocols 1(5): E136
Chen, S.; Xie, W.; Liu, Z.; Shan, H.; Chen, M.; Song, Y.; Yu, H.; Lai, L.; Li, Z. 2020: CRISPR Start-Loss: a Novel and Practical Alternative for Gene Silencing through Base-Editing-Induced Start Codon Mutations. Molecular Therapy. Nucleic Acids 21: 1062-1073
Manriquez-Roman, C.; Siegler, E.L.; Kenderian, S.S. 2021: CRISPR Takes the Front Seat in CART-Cell Development. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 35(2): 113-124
Kenderian, S.S.; Badley, A.D. 2020: CRISPR Taking the Front Seat in Immunotherapy. Journal of Cellular Immunology 2(4): 143-148
Mertz, L. 2021: CRISPR Tech Behind Super-Sensitive, Smartphone COVID Test. IEEE Pulse 12(2): 8-11
Choi, E.; Koo, T. 2021: CRISPR technologies for the treatment of Duchenne muscular dystrophy. Molecular Therapy: the Journal of the American Society of Gene Therapy 29(11): 3179-3191
Yamashita, K.; Iriki, H.; Kamimura, Y.; Muramoto, T. 2021: CRISPR Toolbox for Genome Editing in Dictyostelium. Frontiers in Cell and Developmental Biology 9: 721630
Breunig, C.T.; Köferle, A.; Neuner, A.M.; Wiesbeck, M.F.; Baumann, V.; Stricker, S.H. 2021: CRISPR Tools for Physiology and Cell State Changes: Potential of Transcriptional Engineering and Epigenome Editing. Physiological Reviews 101(1): 177-211
Beauruelle, C.ém.; Treluyer, L.; Pastuszka, A.; Cochard, T.; Lier, C.ém.; Mereghetti, L.; Glaser, P.; Poyart, C.; Lanotte, P. 2021: CRISPR Typing Increases the Discriminatory Power of Streptococcus agalactiae Typing Methods. Frontiers in Microbiology 12: 675597
Shariat, N.; Dudley, E. 2021: CRISPR Typing of Salmonella Isolates. Methods in Molecular Biology 2182: 39-44
Li, Q. 2021: CRISPR Typing of Salmonella Isolates from Different Resources. Methods in Molecular Biology 2182: 45-50
Nguyen, N.T.K.; Chang, Y.-H.; Truong, V.A.; Hsu, M.-N.; Pham, N.N.; Chang, C.-W.; Wu, Y.-H.; Chang, Y.-H.; Li, H.; Hu, Y.-C. 2021: CRISPR activation of long non-coding RNA DANCR promotes bone regeneration. Biomaterials 275: 120965
van der Weyden, L.; Harle, V.; Turner, G.; Offord, V.; Iyer, V.; Droop, A.; Swiatkowska, A.; Rabbie, R.; Campbell, A.D.; Sansom, O.J.; Pardo, M.; Choudhary, J.S.; Ferreira, I.; Tullett, M.; Arends, M.J.; Speak, A.O.; Adams, D.J. 2021: CRISPR activation screen in mice identifies novel membrane proteins enhancing pulmonary metastatic colonisation. Communications Biology 4(1): 395
Sasnauskas, G.; Siksnys, V. 2020: CRISPR adaptation from a structural perspective. Current Opinion in Structural Biology 65: 17-25
Duan, D. 2018: CRISPR alleviates muscular dystrophy in dogs. Nature Biomedical Engineering 2(11): 795-796
Díez-Villaseñor, César.; Rodriguez-Valera, F. 2019: CRISPR analysis suggests that small circular single-stranded DNA smacoviruses infect Archaea instead of humans. Nature Communications 10(1): 294
Mack, S.; Russell, I.A. 2021: CRISPR and Chromothripsis: Proceed with Caution. Crispr Journal 4(3): 309-312
Noorani, I.; Bradley, A.; de la Rosa, J. 2020: CRISPR and transposon in vivo screens for cancer drivers and therapeutic targets. Genome Biology 21(1): 204
Du, M.; Jillette, N.; Zhu, J.Jufen.; Li, S.; Cheng, A.Wu. 2020: CRISPR artificial splicing factors. Nature Communications 11(1): 2973
Medhi, D.; Jasin, M. 2020: CRISPR at lightning speeds. Science 368(6496): 1180-1181
Ledford, H. 2019: CRISPR babies: when will the world be ready?. Nature 570(7761): 293-296
Abdullah; Jiang, Z.; Hong, X.; Zhang, S.; Yao, R.; Xiao, Y. 2020: CRISPR base editing and prime editing: DSB and template-free editing systems for bacteria and plants. Synthetic and Systems Biotechnology 5(4): 277-292
Jothi, R.; Karthika, C.; Kamaladevi, A.; Satish, L.; Pandian, S.K.; Gowrishankar, S. 2021: CRISPR based bacterial genome editing and removal of pathogens. Progress in Molecular Biology and Translational Science 179: 77-92
Satish, L.; Lavanya, G.; Kasthuri, T.; Kalaivaani, A.; Shamili, S.; Muthuramalingam, P.; Gowrishankar, S.; Pandian, S.K.; Singh, V.; Sitrit, Y.; Kushmaro, A. 2021: CRISPR based development of RNA editing and the diagnostic platform. Progress in Molecular Biology and Translational Science 179: 117-159
Mancuso, P.; Chen, C.; Kaminski, R.; Gordon, J.; Liao, S.; Robinson, J.A.; Smith, M.D.; Liu, H.; Sariyer, I.K.; Sariyer, R.; Peterson, T.A.; Donadoni, M.; Williams, J.B.; Siddiqui, S.; Bunnell, B.A.; Ling, B.; MacLean, A.G.; Burdo, T.H.; Khalili, K. 2020: CRISPR based editing of SIV proviral DNA in ART treated non-human primates. Nature Communications 11(1): 6065
Chen, Y.-C. 2021: CRISPR based genome editing and removal of human viruses. Progress in Molecular Biology and Translational Science 179: 93-116
Wiedenheft, B.; Bondy-Denomy, J. 2017: CRISPR control of virulence in Pseudomonas aeruginosa. Cell Research 27(2): 163-164
Ledford, H. 2019: CRISPR conundrum: Strict European court ruling leaves food-testing labs without a plan. Nature 572(7767): 15
Callaway, E. 2019: CRISPR cuts turn gels into biological watchdogs. Nature 572(7771): 574
Pickles, S.; Petrucelli, L. 2018: CRISPR expands insight into the mechanisms of ALS and FTD. Nature Reviews. Neurology 14(6): 321-323
Ledford, H. 2017: CRISPR fixes disease gene in viable human embryos. Nature 548(7665): 13-14
Keatinge, M.; Tsarouchas, T.M.; Munir, T.; Porter, N.J.; Larraz, J.; Gianni, D.; Tsai, H.-H.; Becker, C.G.; Lyons, D.A.; Becker, T. 2021: CRISPR gRNA phenotypic screening in zebrafish reveals pro-regenerative genes in spinal cord injury. Plos Genetics 17(4): E1009515
Reardon, S. 2019: CRISPR gene-editing creates wave of exotic model organisms. Nature 568(7753): 441-442
Cyranoski, D. 2016: CRISPR gene-editing tested in a person for the first time. Nature 539(7630): 479
Asokan, A. 2019: CRISPR genome editing in stem cells turns to gold. Nature Materials 18(10): 1038-1039
Kantor, A.; McClements, M.E.; Peddle, C.F.; Fry, L.E.; Salman, A.; Cehajic-Kapetanovic, J.; Xue, K.; MacLaren, R.E. 2021: CRISPR genome engineering for retinal diseases. Progress in Molecular Biology and Translational Science 182: 29-79
Sheridan, C. 2015: CRISPR germline editing reverberates through biotech industry. Nature Biotechnology 33(5): 431-432
Bosley, K.S.; Botchan, M.; Bredenoord, A.L.; Carroll, D.; Charo, R.Alta.; Charpentier, E.; Cohen, R.; Corn, J.; Doudna, J.; Feng, G.; Greely, H.T.; Isasi, R.; Ji, W.; Kim, J-Soo.; Knoppers, B.; Lanphier, E.; Li, J.; Lovell-Badge, R.; Martin, G.Steven.; Moreno, J.; Naldini, L.; Pera, M.; Perry, A.C.F.; Venter, J.Craig.; Zhang, F.; Zhou, Q. 2015: CRISPR germline engineering--the community speaks. Nature Biotechnology 33(5): 478-486
Ledford, H. 2018: CRISPR hack transforms cells into data recorders. Nature 554(7693): 414-415
Ledford, H. 2018: CRISPR hack transforms cells into data recorders. Nature 554(7693): 414-415
Dolgin, E. 2017: CRISPR hacks enable pinpoint repairs to genome. Nature 550(7677): 439-440
Reardon, S. 2016: CRISPR heavyweights battle in US patent court. Nature 540(7633): 326-327
Fran 2016: CRISPR helps evo-devo scientists to unpick the origins of adaptions. Nature 536(7616): 249
Larson, M.H.; Gilbert, L.A.; Wang, X.; Lim, W.A.; Weissman, J.S.; Qi, L.S. 2013: CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nature Protocols 8(11): 2180-2196
Ghavami, S.; Pandi, A. 2021: CRISPR interference and its applications. Progress in Molecular Biology and Translational Science 180: 123-140
Noirot-Gros, M-Francoise.; Forrester, S.; Malato, G.; Larsen, P.E.; Noirot, P. 2019: CRISPR interference to interrogate genes that control biofilm formation in Pseudomonas fluorescens. Scientific Reports 9(1): 15954
Zheng, Y.; Shen, W.; Zhang, J.; Yang, B.; Liu, Y-Nan.; Qi, H.; Yu, X.; Lu, S-Yao.; Chen, Y.; Xu, Y-Zhou.; Li, Y.; Gage, F.H.; Mi, S.; Yao, J. 2018: CRISPR interference-based specific and efficient gene inactivation in the brain. Nature Neuroscience 21(3): 447-454
Li, Q.; Zhao, P.; Yin, H.; Liu, Z.; Zhao, H.; Tian, P. 2020: CRISPR interference-guided modulation of glucose pathways to boost aconitic acid production in Escherichia coli. Microbial Cell Factories 19(1): 174
Hsu, M.-N.; Yu, F.-J.; Chang, Y.-H.; Huang, K.-L.; Pham, N.N.; Truong, V.A.; Lin, M.-W.; Kieu Nguyen, N.T.; Hwang, S.-M.; Hu, Y.-C. 2020: CRISPR interference-mediated noggin knockdown promotes BMP2-induced osteogenesis and calvarial bone healing. Biomaterials 252: 120094
Marraffini, L.A.; Sontheimer, E.J. 2010: CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nature Reviews. Genetics 11(3): 181-190
Rahman, M.R.; Hossain, M.A.; Mozibullah, M.; Mujib, F.A.; Afrose, A.; Shahed-Al-Mahmud, M.; Apu, M.A.I. 2021: CRISPR is a useful biological tool for detecting nucleic acid of SARS-CoV-2 in human clinical samples. Biomedicine and PharmacoTherapy 140: 111772
Lu, J.; Shao, Y.; Qin, X.; Liu, D.; Chen, A.; Li, D.; Liu, M.; Wang, X. 2017: CRISPR knockout rat cytochrome P450 3A1/2 model for advancing drug metabolism and pharmacokinetics research. Scientific Reports 7: 42922
Lenk, G.M.; Park, Y.N.; Lemons, R.; Flynn, E.; Plank, M.; Frei, C.M.; Davis, M.J.; Gregorka, B.; Swanson, J.A.; Meisler, M.H.; Kitzman, J.O. 2019: CRISPR knockout screen implicates three genes in lysosome function. Scientific Reports 9(1): 9609
Evers, B.; Jastrzebski, K.; Heijmans, J.P.M.; Grernrum, W.; Beijersbergen, R.L.; Bernards, R. 2016: CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes. Nature Biotechnology 34(6): 631-633
Pickerill, E.S.; Bernstein, D.A. 2021: CRISPR mediated genome editing, a tool to dissect RNA modification processes. Methods in Enzymology 658: 435-452
Das, S.; Chadwick, B.P. 2021: CRISPR mediated targeting of DUX4 distal regulatory element represses DUX4 target genes dysregulated in Facioscapulohumeral muscular dystrophy. Scientific Reports 11(1): 12598
Maxmen, A. 2019: CRISPR might be the banana's only hope against a deadly fungus. Nature 574(7776): 15
Smalley, E. 2016: CRISPR mouse model boom, rat model renaissance. Nature Biotechnology 34(9): 893-894
Serebrenik, Y.V.; Shalem, O. 2018: CRISPR mutagenesis screening of mice. Nature Cell Biology 20(11): 1235-1237
Anderson, K.R.; Haeussler, M.; Watanabe, C.; Janakiraman, V.; Lund, J.; Modrusan, Z.; Stinson, J.; Bei, Q.; Buechler, A.; Yu, C.; Thamminana, S.R.; Tam, L.; Sowick, M-Anne.; Alcantar, T.; O'Neil, N.; Li, J.; Ta, L.; Lima, L.; Roose-Girma, M.; Rairdan, X.; Durinck, S.; Warming, Søren. 2018: CRISPR off-target analysis in genetically engineered rats and mice. Nature Methods 15(7): 512-514
Sheridan, C. 2017: CRISPR patent estate splinters. Nature Biotechnology 35(9): 808-809
Callaway, E. 2018: CRISPR plants now subject to tough GM laws in European Union. Nature 560(7716): 16
Zhang, Y.; Iaffaldano, B.; Qi, Y. 2021: CRISPR ribonucleoprotein-mediated genetic engineering in plants. Plant Communications 2(2): 100168
He, C.; Han, S.; Chang, Y.; Wu, M.; Zhao, Y.; Chen, C.; Chu, X. 2021: CRISPR screen in cancer: status quo and future perspectives. American Journal of Cancer Research 11(4): 1031-1050
Cortez, J.T.; Montauti, E.; Shifrut, E.; Gatchalian, J.; Zhang, Y.; Shaked, O.; Xu, Y.; Roth, T.L.; Simeonov, D.R.; Zhang, Y.; Chen, S.; Li, Z.; Woo, J.M.; Ho, J.; Vogel, I.A.; Prator, G.Y.; Zhang, B.; Lee, Y.; Sun, Z.; Ifergan, I.; Van Gool, Fédéric.; Hargreaves, D.C.; Bluestone, J.A.; Marson, A.; Fang, D. 2020: CRISPR screen in regulatory T cells reveals modulators of Foxp3. Nature 582(7812): 416-420
Sangaré, L.O.; Wang, Y.; Arranz-Solís, D.; Saeij, J.P.J. 2021: CRISPR screen to determine the in vivo fitness of Toxoplasma genes. Star Protocols 2(2): 100520
Lei, H.; Wang, Z.; Jiang, D.; Liu, F.; Liu, M.; Lei, X.; Yang, Y.; He, B.; Yan, M.; Huang, H.; Liu, Q.; Pang, J. 2021: CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer. Cell Death and Disease 12(8): 740
Neely, G. 2020: CRISPR screening used to identify an effective antidote for box jellyfish venom. Toxicon: Official Journal of the International Society on Toxinology 177 Suppl. 1: S9
Burgess, D.J. 2020: CRISPR screens beyond Cas9. Nature Reviews. Genetics 21(5): 273
Burgess, D.J. 2020: CRISPR screens come into sight. Nature Reviews. Genetics 21(1): 1
Zimmermann, M.; Murina, O.; Reijns, M.A.M.; Agathanggelou, A.; Challis, R.; Tarnauskaitė, Žygimantė.; Muir, M.; Fluteau, A.; Aregger, M.; McEwan, A.; Yuan, W.; Clarke, M.; Lambros, M.B.; Paneesha, S.; Moss, P.; Chandrashekhar, M.; Angers, S.; Moffat, J.; Brunton, V.G.; Hart, T.; de Bono, J.; Stankovic, T.; Jackson, A.P.; Durocher, D. 2018: CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions. Nature 559(7713): 285-289
Gautron, A.; Bachelot, L.; Aubry, M.; Leclerc, D.; Quéméner, A.ïs.M.; Corre, S.éb.; Rambow, F.; Paris, A.ïs.; Tardif, N.; Leclair, H.él.ïs.M.; Marin-Bejar, O.; Coulouarn, C.éd.; Marine, J.-C.; Galibert, M.-D.; Gilot, D. 2021: CRISPR screens identify tumor-promoting genes conferring melanoma cell plasticity and resistance. Embo Molecular Medicine 13(5): E13466
Han, K.; Pierce, S.E.; Li, A.; Spees, K.; Anderson, G.R.; Seoane, J.A.; Lo, Y-Hung.; Dubreuil, M.; Olivas, M.; Kamber, R.A.; Wainberg, M.; Kostyrko, K.; Kelly, M.R.; Yousefi, M.; Simpkins, S.W.; Yao, D.; Lee, K.; Kuo, C.J.; Jackson, P.K.; Sweet-Cordero, A.; Kundaje, A.; Gentles, A.J.; Curtis, C.; Winslow, M.M.; Bassik, M.C. 2020: CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities. Nature 580(7801): 136-141
Rousset, F.ço.; Bikard, D. 2020: CRISPR screens in the era of microbiomes. Current Opinion in Microbiology 57: 70-77
Safari, F.; Afarid, M.; Rastegari, B.; Borhani-Haghighi, A.; Barekati-Mowahed, M.; Behzad-Behbahani, A. 2021: CRISPR systems: Novel approaches for detection and combating COVID-19. Virus Research 294: 198282
Neff, E.P. 2020: CRISPR takes genetic screens forward. Lab Animal 49(1): 13-16
Eisenstein, M. 2018: CRISPR takes on Huntington's disease. Nature 557(7707): S42-S43
Hodgson, J. 2019: CRISPR target prediction remains blunt tool for clinical applications. Nature Biotechnology 37(3): 204-205
Collias, D.; Beisel, C.L. 2021: CRISPR technologies and the search for the PAM-free nuclease. Nature Communications 12(1): 555
Nakamura, M.; Gao, Y.; Dominguez, A.A.; Qi, L.S. 2021: CRISPR technologies for precise epigenome editing. Nature Cell Biology 23(1): 11-22
High, K.; Gregory, P.D.; Gersbach, C. 2014: CRISPR technology for gene therapy. Nature Medicine 20(5): 476-477
Feng, W.; Newbigging, A.M.; Tao, J.; Cao, Y.; Peng, H.; Le, C.; Wu, J.; Pang, B.; Li, J.; Tyrrell, D.L.; Zhang, H.; Le, X.C. 2021: CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules. Chemical Science 12(13): 4683-4698
Zhang, M.; Eshraghian, E.A.; Jammal, O.A.; Zhang, Z.; Zhu, X. 2021: CRISPR technology: the engine that drives cancer therapy. Biomedicine and PharmacoTherapy 133: 111007
Sheridan, C. 2017: CRISPR therapeutics push into human testing. Nature Biotechnology 35(1): 3-5
Ridler, C. 2018: CRISPR therapy shows promise in Duchenne muscular dystrophy. Nature Reviews. Neurology 14(11): 632-633
Lambert, L.J.; Lambert, L. 2020: CRISPR to the Core. Crispr Journal 3(6): 433
Platt, R.J. 2019: CRISPR tool modifies genes precisely by copying RNA into the genome. Nature 576(7785): 48-49
Storch, G.A. 2020: CRISPR tool scales up to interrogate a huge line-up of viral suspects. Nature 582(7811): 188-189
Kiani, S.; Beal, J.; Ebrahimkhani, M.R.; Huh, J.; Hall, R.N.; Xie, Z.; Li, Y.; Weiss, R. 2014: CRISPR transcriptional repression devices and layered circuits in mammalian cells. Nature Methods 11(7): 723-726
Ledford, H. 2020: CRISPR treatment inserted directly into the body for first time. Nature 579(7798): 185
Van Orden, M.J.; Newsom, S.; Rajan, R. 2020: CRISPR type II-A subgroups exhibit phylogenetically distinct mechanisms for prespacer insertion. Journal of Biological Chemistry 295(32): 10956-10968
Straiton, J. 2020: CRISPR vs COVID-19: how can gene editing help beat a virus?. Biotechniques 69(5): 327-329
Callow, M.G.; Watanabe, C.; Wickliffe, K.E.; Bainer, R.; Kummerfield, S.; Weng, J.; Cuellar, T.; Janakiraman, V.; Chen, H.; Chih, B.; Liang, Y.; Haley, B.; Newton, K.; Costa, M.R. 2018: CRISPR whole-genome screening identifies new necroptosis regulators and RIPK1 alternative splicing. Cell Death and Disease 9(3): 261
Finger-Bou, M.; Orsi, E.; van der Oost, J.; Staals, R.H.J. 2020: CRISPR with a Happy Ending: Non-Templated DNA Repair for Prokaryotic Genome Engineering. Biotechnology Journal 15(7): E1900404
Khan, S.H.; Zaidi, S.K. 2021: CRISPR, cell lines and organoids: new entrants in next generational lab medicine. JPMA. Journal of the Pakistan Medical Association 71(7): 1714-1715
Ledford, H. 2015: CRISPR, the disruptor. Nature 522(7554): 20-24
Gholizadeh, P.; Aghazadeh, M.; Ghotaslou, R.; Ahangarzadeh Rezaee, M.; Pirzadeh, T.; Köse, Şükran.; Ganbarov, K.; Yousefi, M.; Kafil, H.Samadi. 2020: CRISPR- cas system in the acquisition of virulence genes in dental-root canal and hospital-acquired isolates of Enterococcus faecalis. Virulence 11(1): 1257-1267
Sorek, R.; Kunin, V.; Hugenholtz, P. 2008: CRISPR--a widespread system that provides acquired resistance against phages in bacteria and archaea. Nature Reviews. Microbiology 6(3): 181-186
Xu, X.; Luo, T.; Gao, J.; Lin, N.; Li, W.; Xia, X.; Wang, J. 2020: CRISPR-Assisted DNA Detection: a Novel dCas9-Based DNA Detection Technique. Crispr Journal 3(6): 487-502
Sun, J.; Lu, L.-B.; Liang, T.-X.; Yang, L.-R.; Wu, J.-P. 2020: CRISPR-Assisted Multiplex Base Editing System in Pseudomonas putida KT2440. Frontiers in Bioengineering and Biotechnology 8: 905
Ye, Q.; Zhao, X.; Liu, J.; Zeng, Z.; Zhang, Z.; Liu, T.; Li, Y.; Han, W.; Peng, N. 2020: CRISPR-Associated Factor Csa3b Regulates CRISPR Adaptation and Cmr-Mediated RNA Interference in Sulfolobus islandicus. Frontiers in Microbiology 11: 2038
Zabrady, K.; Zabrady, M.; Kolesar, P.; Li, A.W.H.; Doherty, A.J. 2021: CRISPR-Associated Primase-Polymerases are implicated in prokaryotic CRISPR-Cas adaptation. Nature Communications 12(1): 3690
Chen, X.; Tian, X.; Xue, L.; Zhang, X.; Yang, S.; Traw, M.Brian.; Huang, J. 2019: CRISPR-Based Assessment of Gene Specialization in the Gibberellin Metabolic Pathway in Rice. Plant Physiology 180(4): 2091-2105
Abbasi, J. 2021: CRISPR-Based COVID-19 Smartphone Test in Development. JAMA 325(6): 522
Ganbaatar, U.; Liu, C. 2021: CRISPR-Based COVID-19 Testing: Toward Next-Generation Point-of-Care Diagnostics. Frontiers in Cellular and Infection Microbiology 11: 663949
Jolany Vangah, S.; Katalani, C.; Booneh, H.A.; Hajizade, A.; Sijercic, A.; Ahmadian, G. 2020: CRISPR-Based Diagnosis of Infectious and Noninfectious Diseases. Biological Procedures Online 22: 22
Newsham, E.; Richards-Kortum, R. 2021: CRISPR-Based Electrochemical Sensor Permits Sensitive and Specific Viral Detection in Low-Resource Settings. Acs Central Science 7(6): 926-928
Ramachandran, V.; Weiland, J.J.; Bolton, M.D. 2021: CRISPR-Based Isothermal Next-Generation Diagnostic Method for Virus Detection in Sugarbeet. Frontiers in Microbiology 12: 679994
Cencic, R.; Naineni, S.K.; Pugsley, L.; Senéchal, P.; Sahni, A.; Pelletier, J. 2020: CRISPR-Based Screen Links an Inhibitor of Nonsense-Mediated Decay to eIF4A3 Target Engagement. Acs Chemical Biology 15(6): 1621-1629
Moreb, E.A.; Hutmacher, M.; Lynch, M.D. 2020: CRISPR-Cas "Non-Target" Sites Inhibit On-Target Cutting Rates. Crispr Journal 3(6): 550-561
Casas-Mollano, J.A.; Zinselmeier, M.H.; Erickson, S.E.; Smanski, M.J. 2020: CRISPR-Cas Activators for Engineering Gene Expression in Higher Eukaryotes. Crispr Journal 3(5): 350-364
Sharma, V.; Zheng, W.; Huang, J.; Cook, D.E. 2021: CRISPR-Cas RNA Targeting Using Transient Cas13a Expression in Nicotiana benthamiana. Methods in Molecular Biology 2170: 1-18
Kumar, P.; Malik, Y.S.; Ganesh, B.; Rahangdale, S.; Saurabh, S.; Natesan, S.; Srivastava, A.; Sharun, K.; Yatoo, M.I.; Tiwari, R.; Singh, R.K.; Dhama, K. 2020: CRISPR-Cas System: An Approach with Potentials for COVID-19 Diagnosis and Therapeutics. Frontiers in Cellular and Infection Microbiology 10: 576875
Butiuc-Keul, A.; Farkas, A.; Carpa, R.; Iordache, D. 2022: CRISPR-Cas System: the Powerful Modulator of Accessory Genomes in Prokaryotes. Microbial Physiology 32(1-2): 2-17
Hendriks, D.; Clevers, H.; Artegiani, B. 2020: CRISPR-Cas Tools and their Application in Genetic Engineering of Human Stem Cells and Organoids. Cell Stem Cell 27(5): 705-731
Amitai, G.; Sorek, R. 2016: CRISPR-Cas adaptation: insights into the mechanism of action. Nature Reviews. Microbiology 14(2): 67-76
Dupuis, M-Ève.; Villion, M.; Magadán, A.H.; Moineau, S. 2013: CRISPR-Cas and restriction-modification systems are compatible and increase phage resistance. Nature Communications 4: 2087
Yin, L.; Man, S.; Ye, S.; Liu, G.; Ma, L. 2021: CRISPR-Cas based virus detection: Recent advances and perspectives. Biosensors and Bioelectronics 193: 113541
Shipman, S.L.; Nivala, J.; Macklis, J.D.; Church, G.M. 2017: CRISPR-Cas encoding of a digital movie into the genomes of a population of living bacteria. Nature 547(7663): 345-349
Verosloff, M.S.; Shapiro, S.J.; Hawkins, E.M.; Alpay, E.; Verma, D.; Stanfield, E.G.; Kreindler, L.; Jain, S.; McKay, B.; Hubbell, S.A.; Hendriks, C.G.; Blizard, B.A.; Broughton, J.P.; Chen, J.S. 2022: CRISPR-Cas enzymes: the toolkit revolutionizing diagnostics. Biotechnology Journal 17(7): E2100304
Kanitchinda, S.; Srisala, J.; Suebsing, R.; Prachumwat, A.; Chaijarasphong, T. 2020: CRISPR-Cas fluorescent cleavage assay coupled with recombinase polymerase amplification for sensitive and specific detection of Enterocytozoon hepatopenaei. Biotechnology Reports 27: E00485
Marraffini, L.A. 2015: CRISPR-Cas immunity in prokaryotes. Nature 526(7571): 55-61
Fineran, P.C. 2019: CRISPR-Cas impedes archaeal mating. Nature Microbiology 4(1): 2-3
Zlotorynski, E. 2019: CRISPR-Cas in its prime. Nature Reviews. Molecular Cell Biology 20(12): 718-719
Faure, G.; Shmakov, S.A.; Yan, W.X.; Cheng, D.R.; Scott, D.A.; Peters, J.E.; Makarova, K.S.; Koonin, E.V. 2019: CRISPR-Cas in mobile genetic elements: counter-defence and beyond. Nature Reviews. Microbiology 17(8): 513-525
Trudel, L.; Frenette, M.; Moineau, S. 2017: CRISPR-Cas in the laboratory classroom. Nature Microbiology 2: 17018
Stovicek, V.; Borodina, I.; Forster, J. 2015: CRISPR-Cas system enables fast and simple genome editing of industrial Saccharomyces cerevisiae strains. Metabolic Engineering Communications 2: 13-22
Roy, S.; Naha, S.; Rao, A.; Basu, S. 2021: CRISPR-Cas system, antibiotic resistance and virulence in bacteria: Through a common lens. Progress in Molecular Biology and Translational Science 178: 123-174
Aslam, B.; Rasool, M.; Idris, A.; Muzammil, S.; Alvi, R.F.; Khurshid, M.; Rasool, M.H.; Zhang, D.; Ma, Z.; Baloch, Z. 2020: CRISPR-Cas system: a potential alternative tool to cope antibiotic resistance. Antimicrobial Resistance and Infection Control 9(1): 131
Modell, J.W.; Jiang, W.; Marraffini, L.A. 2017: CRISPR-Cas systems exploit viral DNA injection to establish and maintain adaptive immunity. Nature 544(7648): 101-104
Sander, J.D.; Joung, J.Keith. 2014: CRISPR-Cas systems for editing, regulating and targeting genomes. Nature Biotechnology 32(4): 347-355
Mani, I.; Arazoe, T.; Singh, V. 2021: CRISPR-Cas systems for genome editing of mammalian cells. Progress in Molecular Biology and Translational Science 181: 15-30
Fallah, M.S.; Mohebbi, A.; Yasaghi, M.; Ghaemi, E.A. 2021: CRISPR-Cas systems in Proteus mirabilis. Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 92: 104881
Gohil, N.; Bhattacharjee, G.; Lam, N.L.; Perli, S.D.; Singh, V. 2021: CRISPR-Cas systems: Challenges and future prospects. Progress in Molecular Biology and Translational Science 180: 141-151
Xu, Y.; Li, Z. 2020: CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy. Computational and Structural Biotechnology Journal 18: 2401-2415
Westra, E.R.; Buckling, A.; Fineran, P.C. 2014: CRISPR-Cas systems: beyond adaptive immunity. Nature Reviews. Microbiology 12(5): 317-326
Miri, S.M.; Tafsiri, E.; Cho, W.C.S.; Ghaemi, A. 2020: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy. Cancer Cell International 20: 456
Song, X.; Zhang, X.-Y.; Xiong, Z.-Q.; Liu, X.-X.; Xia, Y.-J.; Wang, S.-J.; Ai, L.-Z. 2020: CRISPR-Cas-mediated gene editing in lactic acid bacteria. Molecular Biology Reports 47(10): 8133-8144
Broughton, J.P.; Deng, X.; Yu, G.; Fasching, C.L.; Servellita, V.; Singh, J.; Miao, X.; Streithorst, J.A.; Granados, A.; Sotomayor-Gonzalez, A.; Zorn, K.; Gopez, A.; Hsu, E.; Gu, W.; Miller, S.; Pan, C-Yang.; Guevara, H.; Wadford, D.A.; Chen, J.S.; Chiu, C.Y. 2020: CRISPR-Cas12-based detection of SARS-CoV-2. Nature Biotechnology 38(7): 870-874
Bandyopadhyay, A.; Kancharla, N.; Javalkote, V.S.; Dasgupta, S.; Brutnell, T.P. 2020: CRISPR-Cas12a (Cpf1): a Versatile Tool in the Plant Genome Editing Tool Box for Agricultural Advancement. Frontiers in Plant Science 11: 584151
Qian, W.; Huang, J.; Wang, X.; Wang, T.; Li, Y. 2021: CRISPR-Cas12a combined with reverse transcription recombinase polymerase amplification for sensitive and specific detection of human norovirus genotype GII.4. Virology 564: 26-32
Sun, W.; Wang, J.; Hu, Q.; Zhou, X.; Khademhosseini, A.; Gu, Z. 2020: CRISPR-Cas12a delivery by DNA-mediated bioresponsive editing for cholesterol regulation. Science Advances 6(21): Eaba 2983
Li, S-Yuan.; Cheng, Q-Xiang.; Liu, J-Kun.; Nie, X-Qun.; Zhao, G-Ping.; Wang, J. 2018: CRISPR-Cas12a has both cis- and trans-cleavage activities on single-stranded DNA. Cell Research 28(4): 491-493
Murugan, K.; Seetharam, A.S.; Severin, A.J.; Sashital, D.G. 2020: CRISPR-Cas12a has widespread off-target and dsDNA-nicking effects. Journal of Biological Chemistry 295(17): 5538-5553
Li, Y.; Li, T.; Liu, B.-F.; Hu, R.; Zhu, J.; He, T.; Zhou, X.; Li, C.; Yang, Y.; Liu, M. 2020: CRISPR-Cas12a trans-cleaves DNA G-quadruplexes. Chemical Communications 56(83): 12526-12529
Zhou, Y.; Liu, X.; Wu, J.; Zhao, G.; Wang, J. 2020: CRISPR-Cas12a-Assisted Genome Editing in Amycolatopsis mediterranei. Frontiers in Bioengineering and Biotechnology 8: 698
Li, S-Yuan.; Cheng, Q-Xiang.; Wang, J-Man.; Li, X-Yan.; Zhang, Z-Long.; Gao, S.; Cao, R-Bing.; Zhao, G-Ping.; Wang, J. 2018: CRISPR-Cas12a-assisted nucleic acid detection. Cell Discovery 4: 20
Ming, M.; Ren, Q.; Pan, C.; He, Y.; Zhang, Y.; Liu, S.; Zhong, Z.; Wang, J.; Malzahn, A.A.; Wu, J.; Zheng, X.; Zhang, Y.; Qi, Y. 2020: CRISPR-Cas12b enables efficient plant genome engineering. Nature Plants 6(3): 202-208
Zhang, Y. 2020: CRISPR-Cas13 as an Antiviral Strategy for Coronavirus Disease 2019. Crispr Journal 3(3): 140-142
Yin, L.; Zhao, F.; Sun, H.; Wang, Z.; Huang, Y.; Zhu, W.; Xu, F.; Mei, S.; Liu, X.; Zhang, D.; Wei, L.; Cen, S.; Hu, S.; Liang, C.; Guo, F. 2020: CRISPR-Cas13a Inhibits HIV-1 Infection. Molecular Therapy. Nucleic Acids 21: 147-155
Che, W.; Ye, S.; Cai, A.; Cui, X.; Sun, Y. 2020: CRISPR-Cas13a Targeting the Enhancer RNA-SMAD7e Inhibits Bladder Cancer Development Both in vitro and in vivo. Frontiers in Molecular Biosciences 7: 607740
Zhou, J.; Yin, L.; Dong, Y.; Peng, L.; Liu, G.; Man, S.; Ma, L. 2020: CRISPR-Cas13a based bacterial detection platform: Sensing pathogen Staphylococcus aureus in food samples. Analytica Chimica Acta 1127: 225-233
Ashraf, M.U.; Salman, H.M.; Khalid, M.F.; Khan, M.H.F.; Anwar, S.; Afzal, S.; Idrees, M.; Chaudhary, S.U. 2021: CRISPR-Cas13a mediated targeting of hepatitis C virus internal-ribosomal entry site (IRES) as an effective antiviral strategy. Biomedicine and PharmacoTherapy 136: 111239
Yao, R.; Xu, Y.; Wang, L.; Wang, D.; Ren, L.; Ren, C.; Li, C.; Li, X.; Ni, W.; He, Y.; Hu, R.; Guo, T.; Li, Y.; Li, L.; Wang, X.; Hu, S. 2021: CRISPR-Cas13a-Based Detection for Bovine Viral Diarrhea Virus. Frontiers in Veterinary Science 8: 603919
Kushawah, G.; Hernandez-Huertas, L.; Abugattas-Nuñez Del Prado, J.; Martinez-Morales, J.R.; DeVore, M.L.; Hassan, H.; Moreno-Sanchez, I.; Tomas-Gallardo, L.; Diaz-Moscoso, A.; Monges, D.E.; Guelfo, J.R.; Theune, W.C.; Brannan, E.O.; Wang, W.; Corbin, T.J.; Moran, A.M.; Sánchez Alvarado, A.; Málaga-Trillo, E.; Takacs, C.M.; Bazzini, A.A.; Moreno-Mateos, M.A. 2020: CRISPR-Cas13d Induces Efficient mRNA Knockdown in Animal Embryos. Developmental Cell 54(6): 805-817.E7
Shen, C.-C.; Lin, M.-W.; Nguyen, B.K.T.; Chang, C.-W.; Shih, J.-R.; Nguyen, M.T.T.; Chang, Y.-H.; Hu, Y.-C. 2020: CRISPR-Cas13d for Gene Knockdown and Engineering of CHO Cells. Acs Synthetic Biology 9(10): 2808-2818
Morisaka, H.; Yoshimi, K.; Okuzaki, Y.; Gee, P.; Kunihiro, Y.; Sonpho, E.; Xu, H.; Sasakawa, N.; Naito, Y.; Nakada, S.; Yamamoto, T.; Sano, S.; Hotta, A.; Takeda, J.; Mashimo, T. 2019: CRISPR-Cas3 induces broad and unidirectional genome editing in human cells. Nature Communications 10(1): 5302
Khouzam, J.P.S.; Tivakaran, V.S. 2021: CRISPR-Cas9 Applications in Cardiovascular Disease. Current Problems in Cardiology 46(3): 100652
Smedley, M.A.; Hayta, S.; Clarke, M.; Harwood, W.A. 2021: CRISPR-Cas9 Based Genome Editing in Wheat. Current Protocols 1(3): E65
Wang, G.; Zhao, N.; Berkhout, B.; Das, A.T. 2016: CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape. Molecular Therapy: the Journal of the American Society of Gene Therapy 24(3): 522-526
Fenner, A. 2020: CRISPR-Cas9 ERβ deletion reveals roles in prostate. Nature Reviews. Urology 17(4): 192-193
Gažová, I.; Lefevre, L.; Bush, S.J.; Rojo, R.; Hume, D.A.; Lengeling, A.; Summers, K.M. 2021: CRISPR-Cas9 Editing of Human Histone Deubiquitinase Gene USP16 in Human Monocytic Leukemia Cell Line THP-1. Frontiers in Cell and Developmental Biology 9: 679544
Meisel, R. 2021: CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. New England Journal of Medicine 384(23): E91
Mehta, J. 2021: CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. New England Journal of Medicine 384(23): E91
Rocca, C.J.; Rainaldi, J.N.; Sharma, J.; Shi, Y.; Haquang, J.H.; Luebeck, J.; Mali, P.; Cherqui, S. 2020: CRISPR-Cas9 Gene Editing of Hematopoietic Stem Cells from Patients with Friedreich's Ataxia. Molecular Therapy. Methods and Clinical Development 17: 1026-1036
Khan, A.H.; Tye, G.J.; Noordin, R. 2020: CRISPR-Cas9 Genome Editing Tool for the Production of Industrial Biopharmaceuticals. Molecular Biotechnology 62(9): 401-411
Mohring, F.; Hart, M.N.; Patel, A.; Baker, D.A.; Moon, R.W. 2020: CRISPR-Cas9 Genome Editing of Plasmodium knowlesi. Bio-Protocol 10(4):E3522
Peng, P.; Wang, X.; Shen, D.; Sun, J.; Jia, Y.; Xu, R-Gang.; Zhu, L-Fei.; Ni, J-Quan. 2019: CRISPR-Cas9 Mediated Genome Editing in Drosophila. Bio-Protocol 9(2):E3141
Khan, A.O.; Simms, V.A.; Pike, J.A.; Thomas, S.G.; Morgan, N.V. 2017: CRISPR-Cas9 Mediated Labelling Allows for Single Molecule Imaging and Resolution. Scientific Reports 7(1): 8450
Riggan, L.; Hildreth, A.D.; Rolot, M.; Wong, Y.-Y.; Satyadi, W.; Sun, R.; Huerta, C.; O'Sullivan, T.E. 2020: CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Mature Primary Innate Immune Cells. Cell Reports 31(7): 107651
Hildreth, A.D.; Riggan, L.; O'Sullivan, T.E. 2020: CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells. Star Protocols 1(3): 100113
Wang, X.; Huang, X.; Fang, X.; Zhang, Y.; Wang, W. 2016: CRISPR-Cas9 System as a Versatile Tool for Genome Engineering in Human Cells. Molecular Therapy. Nucleic Acids 5(11): E388
Vuelta, E.; Ordoñez, J.é L.; Alonso-Pérez, V.ón.; Méndez, L.ía.; Hernández-Carabias, P.; Saldaña, R.; Sevilla, J.án.; Sebastián, E.; Muntión, S.; Sánchez-Guijo, F.ín.; Hernández-Rivas, J.ús.M.ía.; García-Tuñón, I.; Sánchez-Martín, M. 2021: CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and new Opportunities to Treat Chronic Myeloid Leukemia. Crispr Journal 4(4): 519-535
Alsomali, N.; Hussein, G. 2021: CRISPR-Cas9 and he Jiankui's Case: an Islamic Bioethics Review using Maqasid al-Shari'a and Qawaid Fighiyyah. Asian Bioethics Review 13(2): 149-165
Urnov, F.D. 2021: CRISPR-Cas9 can cause chromothripsis. Nature Genetics 53(6): 768-769
Gray, B.N.; Spruill, W.Murray. 2017: CRISPR-Cas9 claim sets and the potential to stifle innovation. Nature Biotechnology 35(7): 630-633
Xu, X.; Duan, D.; Chen, S-Jie. 2017: CRISPR-Cas9 cleavage efficiency correlates strongly with target-sgRNA folding stability: from physical mechanism to off-target assessment. Scientific Reports 7(1): 143
Kluesner, M.G.; Lahr, W.S.; Lonetree, C-Lin.; Smeester, B.A.; Qiu, X.; Slipek, N.J.; Claudio Vázquez, P.N.; Pitzen, S.P.; Pomeroy, E.J.; Vignes, M.J.; Lee, S.C.; Bingea, S.P.; Andrew, A.A.; Webber, B.R.; Moriarity, B.S. 2021: CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells. Nature Communications 12(1): 2437
Schick, J.A.; Seisenberger, C.; Beig, J.; Bürger, A.; Iyer, V.; Maier, V.; Perera, S.; Rosen, B.; Skarnes, W.C.; Wurst, W. 2016: CRISPR-Cas9 enables conditional mutagenesis of challenging loci. Scientific Reports 6: 32326
Klann, T.S.; Black, J.B.; Chellappan, M.; Safi, A.; Song, L.; Hilton, I.B.; Crawford, G.E.; Reddy, T.E.; Gersbach, C.A. 2017: CRISPR-Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome. Nature Biotechnology 35(6): 561-568
Dai, W-Jing.; Zhu, L-Yao.; Yan, Z-Yi.; Xu, Y.; Wang, Q-Long.; Lu, X-Jie. 2016: CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles. Molecular Therapy. Nucleic Acids 5: E349
Mani, I. 2021: CRISPR-Cas9 for treating hereditary diseases. Progress in Molecular Biology and Translational Science 181: 165-183
Jayavaradhan, R.; Pillis, D.M.; Goodman, M.; Zhang, F.; Zhang, Y.; Andreassen, P.R.; Malik, P. 2019: CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites. Nature Communications 10(1): 2866
Zhang, Q.; Fu, Y.; Thakur, C.; Bi, Z.; Wadgaonkar, P.; Qiu, Y.; Xu, L.; Rice, M.'K.; Zhang, W.; Almutairy, B.; Chen, F. 2020: CRISPR-Cas9 gene editing causes alternative splicing of the targeting mRNA. Biochemical and Biophysical Research Communications 528(1): 54-61
Stone, D.; Long, K.R.; Loprieno, M.A.; De Silva Feelixge, H.S.; Kenkel, E.J.; Liley, R.M.; Rapp, S.; Roychoudhury, P.; Nguyen, T.; Stensland, L.; Colón-Thillet, R.; Klouser, L.M.; Weber, N.D.; Le, C.; Wagoner, J.; Goecker, E.A.; Li, A.Z.; Eichholz, K.; Corey, L.; Tyrrell, D.L.; Greninger, A.L.; Huang, M.-L.; Polyak, S.J.; Aubert, M.; Sagartz, J.E.; Jerome, K.R. 2021: CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice. Molecular Therapy. Methods and Clinical Development 20: 258-275
Huang, J.Y.; Kan, S-Hsin.; Sandfeld, E.K.; Dalton, N.D.; Rangel, A.D.; Chan, Y.; Davis-Turak, J.; Neumann, J.; Wang, R.Y. 2020: CRISPR-Cas9 generated Pompe knock-in murine model exhibits early-onset hypertrophic cardiomyopathy and skeletal muscle weakness. Scientific Reports 10(1): 10321
Richardson, C.D.; Kazane, K.R.; Feng, S.J.; Zelin, E.; Bray, N.L.; Schäfer, A.J.; Floor, S.N.; Corn, J.E. 2018: CRISPR-Cas9 genome editing in human cells occurs via the Fanconi anemia pathway. Nature Genetics 50(8): 1132-1139
Cullot, Gégoire.; Boutin, J.; Toutain, Jérôme.; Prat, F.; Pennamen, P.; Rooryck, C.; Teichmann, M.; Rousseau, E.; Lamrissi-Garcia, I.; Guyonnet-Duperat, Véronique.; Bibeyran, A.; Lalanne, M.; Prouzet-Mauléon, Vérie.; Turcq, Béatrice.; Ged, Cécile.; Blouin, J-Marc.; Richard, E.; Dabernat, S.; Moreau-Gaudry, Fçois.; Bedel, Aélie. 2019: CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations. Nature Communications 10(1): 1136
Hultquist, J.F.; Hiatt, J.; Schumann, K.; McGregor, M.J.; Roth, T.L.; Haas, P.; Doudna, J.A.; Marson, A.; Krogan, N.J. 2019: CRISPR-Cas9 genome engineering of primary CD4 + T cells for the interrogation of HIV-host factor interactions. Nature Protocols 14(1): 1-27
Boutin, J.; Rosier, J.; Cappellen, D.; Prat, F.; Toutain, J.; Pennamen, P.; Bouron, J.; Rooryck, C.; Merlio, J.P.; Lamrissi-Garcia, I.; Cullot, G.; Amintas, S.; Guyonnet-Duperat, V.; Ged, C.; Blouin, J.M.; Richard, E.; Dabernat, S.; Moreau-Gaudry, F.; Bedel, A. 2021: CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells. Nature Communications 12(1): 4922
Randhawa, S. 2021: CRISPR-Cas9 in cancer therapeutics. Progress in Molecular Biology and Translational Science 181: 129-163
Su, S.; Hu, B.; Shao, J.; Shen, B.; Du, J.; Du, Y.; Zhou, J.; Yu, L.; Zhang, L.; Chen, F.; Sha, H.; Cheng, L.; Meng, F.; Zou, Z.; Huang, X.; Liu, B. 2016: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Scientific Reports 6: 20070
Song, C.W.; Rathnasingh, C.; Park, J.M.; Kwon, M.; Song, H. 2021: CRISPR-Cas9 mediated engineering of Bacillus licheniformis for industrial production of (2R,3S)-butanediol. Biotechnology Progress 37(1): E3072
Wu, J.; Vilarino, M.; Suzuki, K.; Okamura, D.; Bogliotti, Y.Soledad.; Park, I.; Rowe, J.; McNabb, B.; Ross, P.Juan.; Belmonte, J.Carlos.Izpisua. 2017: CRISPR-Cas9 mediated one-step disabling of pancreatogenesis in pigs. Scientific Reports 7(1): 10487
Zhang, Y.; Held, M.A.; Kaur, D.; Showalter, A.M. 2021: CRISPR-Cas9 multiplex genome editing of the hydroxyproline-O-galactosyltransferase gene family alters arabinogalactan-protein glycosylation and function in Arabidopsis. Bmc Plant Biology 21(1): 16
Tsui, C.Kimberly.; Barfield, R.M.; Fischer, C.R.; Morgens, D.W.; Li, A.; Smith, B.A.H.; Gray, M.Anne.; Bertozzi, C.R.; Rabuka, D.; Bassik, M.C. 2019: CRISPR-Cas9 screens identify regulators of antibody-drug conjugate toxicity. Nature Chemical Biology 15(10): 949-958
Kramer, N.J.; Haney, M.S.; Morgens, D.W.; Jovičić, A.; Couthouis, J.; Li, A.; Ousey, J.; Ma, R.; Bieri, G.; Tsui, C.Kimberly.; Shi, Y.; Hertz, N.T.; Tessier-Lavigne, M.; Ichida, J.K.; Bassik, M.C.; Gitler, A.D. 2018: CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity. Nature Genetics 50(4): 603-612
Hoppe, C.; Ashe, H.L. 2021: CRISPR-Cas9 strategies to insert MS2 stem-loops into endogenous loci in Drosophila embryos. Star Protocols 2(1): 100380
Rybicki, E.P. 2019: CRISPR-Cas9 strikes out in cassava. Nature Biotechnology 37(7): 727-728
Heinze, S.D.; Kohlbrenner, T.; Ippolito, D.; Meccariello, A.; Burger, A.; Mosimann, C.; Saccone, G.; Bopp, D. 2017: CRISPR-Cas9 targeted disruption of the yellow ortholog in the housefly identifies the brown body locus. Scientific Reports 7(1): 4582
Strzyz, P. 2020: CRISPR-Cas9 wins Nobel. Nature Reviews. Molecular Cell Biology 21(12): 714
Chiang, T-Wei.Will.; le Sage, C.; Larrieu, D.; Demir, M.; Jackson, S.P. 2016: CRISPR-Cas9(D10A) nickase-based genotypic and phenotypic screening to enhance genome editing. Scientific Reports 6: 24356
Tong, Y.; Whitford, C.M.; Blin, K.; Jørgensen, T.S.; Weber, T.; Lee, S.Yup. 2020: CRISPR-Cas9, CRISPRi and CRISPR-BEST-mediated genetic manipulation in streptomycetes. Nature Protocols 15(8): 2470-2502
Wang, Y.; Wang, Z.; Ji, Q. 2020: CRISPR-Cas9-Based Genome Editing and Cytidine Base Editing in Acinetobacter baumannii. Star Protocols 1(1): 100025
Mertaoja, A.; Nowakowska, M.B.; Mascher, G.; Heljanko, V.; Groothuis, D.; Minton, N.P.; Lindström, M. 2021: CRISPR-Cas9-Based Toolkit for Clostridium botulinum Group Ii Spore and Sporulation Research. Frontiers in Microbiology 12: 617269
Amini, L.; Wagner, D.L.; Rössler, U.; Zarrinrad, G.; Wagner, L.F.; Vollmer, T.; Wendering, D.és.ée.J.; Kornak, U.; Volk, H.-D.; Reinke, P.; Schmueck-Henneresse, M. 2021: CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients. Molecular Therapy: the Journal of the American Society of Gene Therapy 29(1): 32-46
Neequaye, M.; Stavnstrup, S.; Harwood, W.; Lawrenson, T.; Hundleby, P.; Irwin, J.; Troncoso-Rey, P.; Saha, S.; Traka, M.H.; Mithen, R.; Østergaard, L. 2021: CRISPR-Cas9-Mediated Gene Editing of MYB28 Genes Impair Glucoraphanin Accumulation of Brassica oleracea in the Field. Crispr Journal 4(3): 416-426
Gago, S.; Overton, N.L.D.; Bowyer, P. 2021: CRISPR-Cas9-Mediated Gene Silencing in Cultured Human Epithelia. Methods in Molecular Biology 2260: 37-47
Pippin, J.A.; Chesi, A.; Wagley, Y.; Su, C.; Pahl, M.C.; Hodge, K.M.; Johnson, M.E.; Wells, A.D.; Hankenson, K.D.; Grant, S.F.A. 2021: CRISPR-Cas9-Mediated Genome Editing Confirms EPDR1 as an Effector Gene at the BMD GWAS-Implicated ' STARD3NL ' Locus. Jbmr Plus 5(9): E10531
Wilson, A.M.; Wingfield, B.D. 2020: CRISPR-Cas9-Mediated Genome Editing in the Filamentous Ascomycete Huntiella omanensis. Journal of Visualized Experiments: Jove 2020(160)
Amorim, J.ão.P.; Bordeira-Carriço, R.; Gali-Macedo, A.; Perrod, C.; Bessa, J.é 2020: CRISPR-Cas9-Mediated Genomic Deletions Protocol in Zebrafish. Star Protocols 1(3): 100208
Kaeuferle, T.; Deisenberger, L.; Jablonowski, L.; Stief, T.A.; Blaeschke, F.; Willier, S.; Feuchtinger, T. 2020: CRISPR-Cas9-Mediated Glucocorticoid Resistance in Virus-Specific T Cells for Adoptive T Cell Therapy Posttransplantation. Molecular Therapy: the Journal of the American Society of Gene Therapy 28(9): 1965-1973
Sami, A.; Xue, Z.; Tazein, S.; Arshad, A.; He Zhu, Z.; Ping Chen, Y.; Hong, Y.; Tian Zhu, X.; Jin Zhou, K. 2021: CRISPR-Cas9-based genetic engineering for crop improvement under drought stress. Bioengineered 12(1): 5814-5829
Sidik, S.M.; Huet, D.; Lourido, S. 2018: CRISPR-Cas9-based genome-wide screening of Toxoplasma gondii. Nature Protocols 13(1): 307-323
Tuladhar, R.; Yeu, Y.; Tyler Piazza, J.; Tan, Z.; Rene Clemenceau, J.; Wu, X.; Barrett, Q.; Herbert, J.; Mathews, D.H.; Kim, J.; Hyun Hwang, T.; Lum, L. 2019: CRISPR-Cas9-based mutagenesis frequently provokes on-target mRNA misregulation. Nature Communications 10(1): 4056
Nihongaki, Y.; Furuhata, Y.; Otabe, T.; Hasegawa, S.; Yoshimoto, K.; Sato, M. 2017: CRISPR-Cas9-based photoactivatable transcription systems to induce neuronal differentiation. Nature Methods 14(10): 963-966
Wanzel, M.; Vischedyk, J.B.; Gittler, M.P.; Gremke, N.; Seiz, J.R.; Hefter, M.; Noack, M.; Savai, R.; Mernberger, M.; Charles, Jël.P.; Schneikert, J.; Bretz, A.Catherine.; Nist, A.; Stiewe, T. 2016: CRISPR-Cas9-based target validation for p53-reactivating model compounds. Nature Chemical Biology 12(1): 22-28
Li, Q.; Li, Y.; Yang, S.; Huang, S.; Yan, M.; Ding, Y.; Tang, W.; Lou, X.; Yin, Q.; Sun, Z.; Lu, L.; Shi, H.; Wang, H.; Chen, Y.; Li, J. 2018: CRISPR-Cas9-mediated base-editing screening in mice identifies DND1 amino acids that are critical for primordial germ cell development. Nature Cell Biology 20(11): 1315-1325
Chu, H.W.; Rios, C.; Huang, C.; Wesolowska-Andersen, A.; Burchard, E.G.; O'Connor, B.P.; Fingerlin, T.E.; Nichols, D.; Reynolds, S.D.; Seibold, M.A. 2015: CRISPR-Cas9-mediated gene knockout in primary human airway epithelial cells reveals a proinflammatory role for MUC18. Gene Therapy 22(10): 822-829
Osakabe, Y.; Liang, Z.; Ren, C.; Nishitani, C.; Osakabe, K.; Wada, M.; Komori, S.; Malnoy, M.; Velasco, R.; Poli, M.; Jung, M-Hee.; Koo, O-Jae.; Viola, R.; Nagamangala Kanchiswamy, C. 2018: CRISPR-Cas9-mediated genome editing in apple and grapevine. Nature Protocols 13(12): 2844-2863
Wang, L.; Li, M-Yin.; Qu, C.; Miao, W-Ying.; Yin, Q.; Liao, J.; Cao, H-Teng.; Huang, M.; Wang, K.; Zuo, E.; Peng, G.; Zhang, S-Xin.; Chen, G.; Li, Q.; Tang, K.; Yu, Q.; Li, Z.; Wong, C.Cl.; Xu, G.; Jing, N.; Yu, X.; Li, J. 2017: CRISPR-Cas9-mediated genome editing in one blastomere of two-cell embryos reveals a novel Tet3 function in regulating neocortical development. Cell Research 27(6): 815-829
Beying, N.; Schmidt, C.; Pacher, M.; Houben, A.; Puchta, H. 2020: CRISPR-Cas9-mediated induction of heritable chromosomal translocations in Arabidopsis. Nature Plants 6(6): 638-645
Liu, X.; Zhang, Y.; Cheng, C.; Cheng, A.W.; Zhang, X.; Li, N.; Xia, C.; Wei, X.; Liu, X.; Wang, H. 2017: CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells. Cell Research 27(1): 154-157
Manglekar, R.R.; Geng, A. 2020: CRISPR-Cas9-mediated seb1 disruption in Talaromyces pinophilus EMU for its enhanced cellulase production. Enzyme and Microbial Technology 140: 109646
Shin, G.; Grimes, S.M.; Lee, H.; Lau, B.T.; Xia, L.C.; Ji, H.P. 2017: CRISPR-Cas9-targeted fragmentation and selective sequencing enable massively parallel microsatellite analysis. Nature Communications 8: 14291
Hashemi, A. 2020: CRISPR-Cas9/CRISPRi tools for cell factory construction in E. coli. World Journal of Microbiology and Biotechnology 36(7): 96
Hirsch, Fçois.; Lévy, Y.; Chneiweiss, Hé. 2017: CRISPR-Cas9: A European position on genome editing. Nature 541(7635): 30
Sharma, G.; Sharma, A.R.; Bhattacharya, M.; Lee, S.-S.; Chakraborty, C. 2021: CRISPR-Cas9: a Preclinical and Clinical Perspective for the Treatment of Human Diseases. Molecular Therapy: the Journal of the American Society of Gene Therapy 29(2): 571-586
Barman, N.C.; Khan, N.M.; Islam, M.; Nain, Z.; Roy, R.K.; Haque, A.; Barman, S.K. 2020: CRISPR-Cas9: a Promising Genome Editing Therapeutic Tool for Alzheimer's Disease-A Narrative Review. Neurology and Therapy 9(2): 419-434
Hossain, M.A. 2021: CRISPR-Cas9: a fascinating journey from bacterial immune system to human gene editing. Progress in Molecular Biology and Translational Science 178: 63-83
Yin, H.; Xue, W.; Anderson, D.G. 2019: CRISPR-Cas: a tool for cancer research and therapeutics. Nature Reviews. Clinical Oncology 16(5): 281-295
Li, C.; Cao, Y.; Zhang, L.; Li, J.; Wang, J.; Zhou, Y.; Wei, H.; Guo, M.; Liu, L.; Liu, C.; Zhang, S.; Liu, G. 2021: CRISPR-CasRx Targeting LncRNA LINC00341 Inhibits Tumor Cell Growth in vitro and in vivo. Frontiers in Molecular Biosciences 8: 638995
Moreno-Mateos, M.A.; Fernandez, J.P.; Rouet, R.; Vejnar, C.E.; Lane, M.A.; Mis, E.; Khokha, M.K.; Doudna, J.A.; Giraldez, A.J. 2017: CRISPR-Cpf1 mediates efficient homology-directed repair and temperature-controlled genome editing. Nature Communications 8(1): 2024
Papa, G.; Venditti, L.; Braga, L.; Schneider, E.; Giacca, M.; Petris, G.; Burrone, O.R. 2020: CRISPR-Csy4-Mediated Editing of Rotavirus Double-Stranded RNA Genome. Cell Reports 32(13): 108205
Liu, H.; Wang, X. 2021: CRISPR-ERA: a Webserver for Guide RNA Design of Gene Editing and Regulation. Methods in Molecular Biology 2189: 65-69
Swings, T.; Marciano, D.C.; Atri, B.; Bosserman, R.E.; Wang, C.; Leysen, M.; Bonte, C.; Schalck, T.; Furey, I.; Van den Bergh, B.; Verstraeten, N.; Christie, P.J.; Herman, C.; Lichtarge, O.; Michiels, J. 2018: CRISPR-FRT targets shared sites in a knock-out collection for off-the-shelf genome editing. Nature Communications 9(1): 2231
Wallace, D.C. 2020: CRISPR-Free Mitochondrial DNA Base Editing. Crispr Journal 3(4): 228-230
Wang, G.; Chow, R.D.; Zhu, L.; Bai, Z.; Ye, L.; Zhang, F.; Renauer, P.A.; Dong, M.B.; Dai, X.; Zhang, X.; Du, Y.; Cheng, Y.; Niu, L.; Chu, Z.; Kim, K.; Liao, C.; Clark, P.; Errami, Y.; Chen, S. 2020: CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade. Cancer Discovery 10(12): 1912-1933
Preece, R.; Pavesi, A.; Gkazi, S.A.; Stegmann, K.A.; Georgiadis, C.; Tan, Z.M.; Aw, J.Y.J.; Maini, M.K.; Bertoletti, A.; Qasim, W. 2020: CRISPR-Mediated Base Conversion Allows Discriminatory Depletion of Endogenous T Cell Receptors for Enhanced Synthetic Immunity. Molecular Therapy. Methods and Clinical Development 19: 149-161
Siddique, A.; Suckow, G.; Head, S.; Ordoukhanian, P.; Sussman, H.; Ramachandran, D.; Homer, N.; Bajena, J.; Brown, K.; Chittur, S.; Knudtson, K.; Kermack, J. 2020: CRISPR-Mediated Depletion of Ribosomal RNA-Derived DNA from RNA-Seq NGS Libraries. Journal of Biomolecular Techniques: Jbt 31(Suppl): S26
Russo, G.L.; Sonsalla, G.; Natarajan, P.; Breunig, C.T.; Bulli, G.; Merl-Pham, J.; Schmitt, S.; Giehrl-Schwab, J.; Giesert, F.; Jastroch, M.; Zischka, H.; Wurst, W.; Stricker, S.H.; Hauck, S.M.; Masserdotti, G.; Götz, M. 2021: CRISPR-Mediated Induction of Neuron-Enriched Mitochondrial Proteins Boosts Direct Glia-to-Neuron Conversion. Cell Stem Cell 28(3): 584
Rosch, J.C.; Neal, E.H.; Balikov, D.A.; Rahim, M.; Lippmann, E.S. 2020: CRISPR-Mediated Isogenic Cell-SELEX Approach for Generating Highly Specific Aptamers Against Native Membrane Proteins. Cellular and Molecular Bioengineering 13(5): 559-574
Yamazaki, T.; Hirose, T. 2021: CRISPR-Mediated Mutagenesis of Long Noncoding RNAs. Methods in Molecular Biology 2254: 283-303
Kitagawa, A.; Kizub, I.; Jacob, C.; Michael, K.; D'Alessandro, A.; Reisz, J.A.; Grzybowski, M.; Geurts, A.M.; Rocic, P.; Gupte, R.; Miano, J.M.; Gupte, S.A. 2020: CRISPR-Mediated Single Nucleotide Polymorphism Modeling in Rats Reveals Insight into Reduced Cardiovascular Risk Associated with Mediterranean G6PD Variant. Hypertension 76(2): 523-532
Markus, B.M.; Boydston, E.A.; Lourido, S. 2021: CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii. Msphere 6(5): E0047421
Schokrpur, S.; Hu, J.; Moughon, D.L.; Liu, P.; Lin, L.C.; Hermann, K.; Mangul, S.; Guan, W.; Pellegrini, M.; Xu, H.; Wu, L. 2016: CRISPR-Mediated VHL Knockout Generates an Improved Model for Metastatic Renal Cell Carcinoma. Scientific Reports 6: 29032
Sasano, Y.; Nagasawa, K.; Kaboli, S.; Sugiyama, M.; Harashima, S. 2016: CRISPR-PCS: a powerful new approach to inducing multiple chromosome splitting in Saccharomyces cerevisiae. Scientific Reports 6: 30278
Li, B.; Chen, P.B.; Diao, Y. 2021: CRISPR-SE: a brute force search engine for CRISPR design. Nar Genomics and Bioinformatics 3(1): Lqab 013
Kuscu, C.; Parlak, M.; Tufan, T.; Yang, J.; Szlachta, K.; Wei, X.; Mammadov, R.; Adli, M. 2017: CRISPR-STOP: gene silencing through base-editing-induced nonsense mutations. Nature Methods 14(7): 710-712
Ma, H.; Tu, L-Chun.; Naseri, A.; Chung, Y-Chieh.; Grunwald, D.; Zhang, S.; Pederson, T. 2018: CRISPR-Sirius: RNA scaffolds for signal amplification in genome imaging. Nature Methods 15(11): 928-931
Sun, N.-H.; Chen, D.-Y.; Ye, L.-P.; Sheng, G.; Gong, J.-J.; Chen, B.-H.; Lu, Y.-M.; Han, F. 2020: CRISPR-Sunspot: Imaging of endogenous low-abundance RNA at the single-molecule level in live cells. Theranostics 10(24): 10993-11012
Anderson, D.P.; Benns, H.J.; Tate, E.W.; Child, M.A. 2020: CRISPR-TAPE: protein-centric CRISPR guide design for targeted proteome engineering. Molecular Systems Biology 16(6): E9475
Decaestecker, W.; Buono, R.Andrade.; Pfeiffer, M.L.; Vangheluwe, N.; Jourquin, J.; Karimi, M.; Van Isterdael, G.; Beeckman, T.; Nowack, M.K.; Jacobs, T.B. 2019: CRISPR-TSKO: A Technique for Efficient Mutagenesis in Specific Cell Types, Tissues, or Organs in Arabidopsis. Plant Cell 31(12): 2868-2887
Michlits, G.; Hubmann, M.; Wu, S-Hsien.; Vainorius, G.; Budusan, E.; Zhuk, S.; Burkard, T.R.; Novatchkova, M.; Aichinger, M.; Lu, Y.; Reece-Hoyes, J.; Nitsch, R.; Schramek, D.; Hoepfner, D.; Elling, U. 2017: CRISPR-UMI: single-cell lineage tracing of pooled CRISPR-Cas9 screens. Nature Methods 14(12): 1191-1197
Yi, W.; Li, J.; Zhu, X.; Wang, X.; Fan, L.; Sun, W.; Liao, L.; Zhang, J.; Li, X.; Ye, J.; Chen, F.; Taipale, J.; Chan, K.Ming.; Zhang, L.; Yan, J. 2020: CRISPR-assisted detection of RNA-protein interactions in living cells. Nature Methods 17(7): 685-688
Cyranoski, D. 2018: CRISPR-baby scientist fails to satisfy critics. Nature 564(7734): 13-14
Palacios Araya, D.; Palmer, K.L.; Duerkop, B.A. 2021: CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria. Plos Pathogens 17(7): E1009672
Lyu, C.; Shi, H.; Cui, Y.; Li, M.; Yan, Z.; Yan, L.; Jiang, Y. 2020: CRISPR-based biosensing is prospective for rapid and sensitive diagnosis of pediatric tuberculosis. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 101: 183-187
Vatankhah, M.; Azizi, A.; Sanajouyan Langeroudi, A.; Ataei Azimi, S.; Khorsand, I.; Kerachian, M.Amin.; Motaei, J. 2020: CRISPR-based biosensing systems: a way to rapidly diagnose COVID-19. Critical Reviews in Clinical Laboratory Sciences 2020: 1-27
Zainuddin, H.S.; Bai, Y.; Mansell, T.J. 2019: CRISPR-based curing and analysis of metabolic burden of cryptic plasmids in Escherichia coli Nissle 1917. Engineering in Life Sciences 19(6): 478-485
Qiu, E.; Jin, S.; Xiao, Z.; Chen, Q.; Wang, Q.; Liu, H.; Xie, C.; Chen, C.; Li, Z.; Han, S. 2021: CRISPR-based detection of Helicobacter pylori in stool samples. Helicobacter 26(4): E12828
Nouri, R.; Tang, Z.; Dong, M.; Liu, T.; Kshirsagar, A.; Guan, W. 2021: CRISPR-based detection of SARS-CoV-2: a review from sample to result. Biosensors and Bioelectronics 178: 113012
Stower, H. 2018: CRISPR-based diagnostics. Nature Medicine 24(6): 702
Kaminski, M.M.; Abudayyeh, O.O.; Gootenberg, J.S.; Zhang, F.; Collins, J.J. 2021: CRISPR-based diagnostics. Nature Biomedical Engineering 5(7): 643-656
Bhattacharjee, G.; Gohil, N.; Lam, N.L.; Singh, V. 2021: CRISPR-based diagnostics for detection of pathogens. Progress in Molecular Biology and Translational Science 181: 45-57
Xia, B.; Amador, G.; Viswanatha, R.; Zirin, J.; Mohr, S.E.; Perrimon, N. 2020: CRISPR-based engineering of gene knockout cells by homology-directed insertion in polyploid Drosophila S2R+ cells. Nature Protocols 15(10): 3478-3498
Schultzhaus, Z.; Wang, Z.; Stenger, D. 2021: CRISPR-based enrichment strategies for targeted sequencing. Biotechnology Advances 46: 107672
Kampmann, M. 2020: CRISPR-based functional genomics for neurological disease. Nature Reviews. Neurology 16(9): 465-480
Goodwin, M.; Lee, E.; Lakshmanan, U.; Shipp, S.; Froessl, L.; Barzaghi, F.; Passerini, L.; Narula, M.; Sheikali, A.; Lee, C.M.; Bao, G.; Bauer, C.S.; Miller, H.K.; Garcia-Lloret, M.; Butte, M.J.; Bertaina, A.; Shah, A.; Pavel-Dinu, M.; Hendel, A.; Porteus, M.; Roncarolo, M.G.; Bacchetta, R. 2020: CRISPR-based gene editing enables FOXP3 gene repair in IPEX patient cells. Science Advances 6(19): Eaaz 0571
Santos-Moreno, J.; Schaerli, Y. 2020: CRISPR-based gene expression control for synthetic gene circuits. Biochemical Society Transactions 48(5): 1979-1993
Rathore, A.; Iketani, S.; Wang, P.; Jia, M.; Sahi, V.; Ho, D.D. 2020: CRISPR-based gene knockout screens reveal deubiquitinases involved in HIV-1 latency in two Jurkat cell models. Scientific Reports 10(1): 5350
Bevacqua, R.J.; Dai, X.; Lam, J.Y.; Gu, X.; Friedlander, M.S.H.; Tellez, K.; Miguel-Escalada, I.; Bonàs-Guarch, S.; Atla, G.; Zhao, W.; Kim, S.Hyun.; Dominguez, A.A.; Qi, L.S.; Ferrer, J.; MacDonald, P.E.; Kim, S.K. 2021: CRISPR-based genome editing in primary human pancreatic islet cells. Nature Communications 12(1): 2397
Sharma, P.; Sharma, B.S.; Verma, R.J. 2021: CRISPR-based genome editing of zebrafish. Progress in Molecular Biology and Translational Science 180: 69-84
Shapiro, R.S.; Chavez, A.; Collins, J.J. 2018: CRISPR-based genomic tools for the manipulation of genetically intractable microorganisms. Nature Reviews. Microbiology 16(6): 333-339
Sabzehzari, M.; Zeinali, M.; Naghavi, M.R. 2020: CRISPR-based metabolic editing: Next-generation metabolic engineering in plants. Gene 759: 144993
Arazoe, T. 2021: CRISPR-based pathogenic fungal genome editing for control of infection and disease. Progress in Molecular Biology and Translational Science 179: 161-196
Curti, L.Ana.; Pereyra-Bonnet, F.; Repizo, G.Daniel.; Fay, J.Vannina.; Salvatierra, K.; Blariza, Mía.José.; Ibañez-Alegre, D.; Rinflerch, A.Raquel.; Miretti, M.; Gimenez, C.Alejandra. 2020: CRISPR-based platform for carbapenemases and emerging viruses detection using Cas12a (Cpf1) effector nuclease. Emerging Microbes and Infections 9(1): 1140-1148
Karah, N.; Wai, S.N.; Uhlin, B.E. 2021: CRISPR-based subtyping to track the evolutionary history of a global clone of Acinetobacter baumannii. Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 90: 104774
Mózsik, László.; Hoekzema, M.; de Kok, N.A.W.; Bovenberg, R.A.L.; Nygård, Y.; Driessen, A.J.M. 2021: CRISPR-based transcriptional activation tool for silent genes in filamentous fungi. Scientific Reports 11(1): 1118
Xiang, X.; Qian, K.; Zhang, Z.; Lin, F.; Xie, Y.; Liu, Y.; Yang, Z. 2020: CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia. Journal of Drug Targeting 28(7-8): 727-731
Sun, X.; Wang, Z.; Chen, X.; Shen, K. 2021: CRISPR-cas9 Screening Identified Lethal Genes Enriched in Cell Cycle Pathway and of Prognosis Significance in Breast Cancer. Frontiers in Cell and Developmental Biology 9: 646774
Ghaemi, A.; Bagheri, E.; Abnous, K.; Taghdisi, S.M.; Ramezani, M.; Alibolandi, M. 2021: CRISPR-cas9 genome editing delivery systems for targeted cancer therapy. Life Sciences 267: 118969
Xing, H.; Meng, L-Hua. 2020: CRISPR-cas9: a powerful tool towards precision medicine in cancer treatment. Acta Pharmacologica Sinica 41(5): 583-587
Yu, S.; Price, M.A.; Wang, Y.; Liu, Y.; Guo, Y.; Ni, X.; Rosser, S.J.; Bi, C.; Wang, M. 2020: CRISPR-dCas9 Mediated Cytosine Deaminase Base Editing in Bacillus subtilis. Acs Synthetic Biology 9(7): 1781-1789
Fu, Y.; Rocha, P.P.; Luo, V.M.; Raviram, R.; Deng, Y.; Mazzoni, E.O.; Skok, J.A. 2016: CRISPR-dCas9 and sgRNA scaffolds enable dual-colour live imaging of satellite sequences and repeat-enriched individual loci. Nature Communications 7: 11707
Uygun, Z.O.; Yeniay, L.; Gi Rgi N Sağın, F. 2020: CRISPR-dCas9 powered impedimetric biosensor for label-free detection of circulating tumor DNAs. Analytica Chimica Acta 1121: 35-41
Martinez-Escobar, A.; Luna-Callejas, B.ín.; Ramón-Gallegos, E. 2020: CRISPR-dCas9-Based Artificial Transcription Factors to Improve Efficacy of Cancer Treatment with Drug Repurposing: Proposal for Future Research. Frontiers in Oncology 10: 604948
Xiang, L.; Qi, F.; Jiang, L.; Tan, J.; Deng, C.; Wei, Z.; Jin, S.; Huang, G. 2020: CRISPR-dCas9-mediated knockdown of prtR, an essential gene in Pseudomonas aeruginosa. Letters in Applied Microbiology 71(4): 386-393
Rees, H.A.; Minella, A.C.; Burnett, C.A.; Komor, A.C.; Gaudelli, N.M. 2021: CRISPR-derived genome editing therapies: Progress from bench to bedside. Molecular Therapy: the Journal of the American Society of Gene Therapy 29(11): 3125-3139
Yi, Y.; Chai, X.; Zheng, L.; Zhang, Y.; Shen, J.; Hu, B.; Tao, G. 2021: CRISPR-edited CART with GM-CSF knockout and auto secretion of IL6 and IL1 blockers in patients with hematologic malignancy. Cell Discovery 7(1): 27
Opar, A. 2019: CRISPR-edited babies arrived, and regulators are still racing to catch up. Nature Medicine 25(11): 1634-1636
Waltz, E. 2016: CRISPR-edited crops free to enter market, skip regulation. Nature Biotechnology 34(6): 582
Montenont, E.; Bhatlekar, S.; Jacob, S.; Kosaka, Y.; Manne, B.K.; Lee, O.; Parra-Izquierdo, I.; Tugolukova, E.; Tolley, N.D.; Rondina, M.T.; Bray, P.F.; Rowley, J.W. 2021: CRISPR-edited megakaryocytes for rapid screening of platelet gene functions. Blood Advances 5(9): 2362-2374
Zhong, H.; Chen, Y.; Li, Y.; Chen, R.; Mardon, G. 2015: CRISPR-engineered mosaicism rapidly reveals that loss of Kcnj13 function in mice mimics human disease phenotypes. Scientific Reports 5: 8366
Halperin, S.O.; Tou, C.J.; Wong, E.B.; Modavi, C.; Schaffer, D.V.; Dueber, J.E. 2018: CRISPR-guided DNA polymerases enable diversification of all nucleotides in a tunable window. Nature 560(7717): 248-252
Limsirichai, P.; Gaj, T.; Schaffer, D.V. 2016: CRISPR-mediated Activation of Latent HIV-1 Expression. Molecular Therapy: the Journal of the American Society of Gene Therapy 24(3): 499-507
Xu, L.; Park, K.Ho.; Zhao, L.; Xu, J.; El Refaey, M.; Gao, Y.; Zhu, H.; Ma, J.; Han, R. 2016: CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice. Molecular Therapy: the Journal of the American Society of Gene Therapy 24(3): 564-569
Yamagata, M.; Sanes, J.R. 2021: CRISPR-mediated Labeling of Cells in Chick Embryos Based on Selectively Expressed Genes. Bio-Protocol 11(15):E4105
Liu, C.; Grote, A.; Ghedin, E.; Unnasch, T.R. 2020: CRISPR-mediated Transfection of Brugia malayi. Plos Neglected Tropical Diseases 14(8): E0008627
Liu, B.; Diaz Arguello, O.A.; Chen, D.; Chen, S.; Saber, A.; Haisma, H.J. 2020: CRISPR-mediated ablation of overexpressed EGFR in combination with sunitinib significantly suppresses renal cell carcinoma proliferation. Plos one 15(5): E0232985
Zhang, Y.; Ozono, S.; Yao, W.; Tobiume, M.; Yamaoka, S.; Kishigami, S.; Fujita, H.; Tokunaga, K. 2019: CRISPR-mediated activation of endogenous BST-2/tetherin expression inhibits wild-type HIV-1 production. Scientific Reports 9(1): 3134
Xue, W.; Chen, S.; Yin, H.; Tammela, T.; Papagiannakopoulos, T.; Joshi, N.S.; Cai, W.; Yang, G.; Bronson, R.; Crowley, D.G.; Zhang, F.; Anderson, D.G.; Sharp, P.A.; Jacks, T. 2014: CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature 514(7522): 380-384
Gabr, H.; El Ghamrawy, M.K.; Almaeen, A.H.; Abdelhafiz, A.S.; Hassan, A.O.S.; El Sissy, M.H. 2020: CRISPR-mediated gene modification of hematopoietic stem cells with beta-thalassemia IVS-1-110 mutation. Stem Cell Research and Therapy 11(1): 390
Guillen, R.X.; Beckley, J.R.; Chen, J-Song.; Gould, K.L. 2020: CRISPR-mediated gene targeting of CK1δ/ε leads to enhanced understanding of their role in endocytosis via phosphoregulation of GAPVD1. Scientific Reports 10(1): 6797
Li, M.; Lang, X.; Moran Cabrera, M.; De Keyser, S.; Sun, X.; Da Silva, N.; Wheeldon, I. 2021: CRISPR-mediated multigene integration enables Shikimate pathway refactoring for enhanced 2-phenylethanol biosynthesis in Kluyveromyces marxianus. Biotechnology for Biofuels 14(1): 3
Fabrick, J.A.; LeRoy, D.M.; Mathew, L.G.; Wu, Y.; Unnithan, G.C.; Yelich, A.J.; Carrière, Y.; Li, X.; Tabashnik, B.E. 2021: CRISPR-mediated mutations in the ABC transporter gene ABCA2 confer pink bollworm resistance to Bt toxin Cry2Ab. Scientific Reports 11(1): 10377
Sung, C.K.; Yim, H. 2020: CRISPR-mediated promoter de/methylation technologies for gene regulation. Archives of Pharmacal Research 43(7): 705-713
Xiao, D.; Zhang, W.; Wang, Q.; Li, X.; Zhang, Y.; Rasouli, J.; Casella, G.; Ciric, B.; Curtis, M.; Rostami, A.; Zhang, G.-X. 2021: CRISPR-mediated rapid generation of neural cell-specific knockout mice facilitates research in neurophysiology and pathology. Molecular Therapy. Methods and Clinical Development 20: 755-764
Strezoska, Ža.; Dickerson, S.M.; Maksimova, E.; Chou, E.; Gross, M.M.; Hemphill, K.; Hardcastle, T.; Perkett, M.; Stombaugh, J.; Miller, G.W.; Anderson, E.M.; Vermeulen, A.; Smith, A.v.B. 2020: CRISPR-mediated transcriptional activation with synthetic guide RNA. Journal of Biotechnology 319: 25-35
Giménez, C.A.; Ielpi, M.; Mutto, A.; Grosembacher, L.; Argibay, P.; Pereyra-Bonnet, F. 2016: CRISPR-on system for the activation of the endogenous human INS gene. Gene Therapy 23(6): 543-547
Bruch, R.; Johnston, M.; Kling, A.é; Mattmüller, T.; Baaske, J.; Partel, S.; Madlener, S.; Weber, W.; Urban, G.A.; Dincer, C. 2021: CRISPR-powered electrochemical microfluidic multiplexed biosensor for target amplification-free miRNA diagnostics. Biosensors and Bioelectronics 177: 112887
Hwang, G.-H.; Yu, J.; Yang, S.; Son, W.J.; Lim, K.; Kim, H.S.; Kim, J.-S.; Bae, S. 2020: CRISPR-sub: Analysis of DNA substitution mutations caused by CRISPR-Cas9 in human cells. Computational and Structural Biotechnology Journal 18: 1686-1694
Vinyard, M.E.; Su, C.; Siegenfeld, A.P.; Waterbury, A.L.; Freedy, A.M.; Gosavi, P.M.; Park, Y.; Kwan, E.E.; Senzer, B.D.; Doench, J.G.; Bauer, D.E.; Pinello, L.; Liau, B.B. 2019: CRISPR-suppressor scanning reveals a nonenzymatic role of LSD1 in AML. Nature Chemical Biology 15(5): 529-539
Wang, Q.; Zhang, B.; Xu, X.; Long, F.; Wang, J. 2018: CRISPR-typing PCR (ctPCR), a new Cas9-based DNA detection method. Scientific Reports 8(1): 14126
Slesarev, A.; Viswanathan, L.; Tang, Y.; Borgschulte, T.; Achtien, K.; Razafsky, D.; Onions, D.; Chang, A.; Cote, C. 2019: CRISPR/CAS9 targeted CAPTURE of mammalian genomic regions for characterization by NGS. Scientific Reports 9(1): 3587
Ashfaq, U.A.; Khalid, H. 2020: CRISPR/CAS9-Mediated Antiviral Activity: a Tool to Combat Viral Infection. Critical Reviews in Eukaryotic Gene Expression 30(1): 45-56
Miyata, H.; Abbasi, F.; Visconti, P.E.; Ikawa, M. 2020: CRISPR/CAS9-mediated amino acid substitution reveals phosphorylation residues of RSPH6A are not essential for male fertility in mice†. Biology of Reproduction 103(5): 912-914
Schweickert, P.G.; Wang, N.; Sandefur, S.L.; Lloyd, M.E.; Konieczny, S.F.; Frye, C.C.; Cheng, Z. 2021: CRISPR/Cas12a-mediated CHO genome engineering can be effectively integrated at multiple stages of the cell line generation process for bioproduction. Biotechnology Journal 16(4): E2000308
Değirmenci, L.; Geiger, D.; Rogé Ferreira, F.áb.L.; Keller, A.; Krischke, B.; Beye, M.; Steffan-Dewenter, I.; Scheiner, R. 2020: CRISPR/Cas 9-Mediated Mutations as a new Tool for Studying Taste in Honeybees. Chemical Senses 45(8): 655-666
Borca, M.V.; Berggren, K.A.; Ramirez-Medina, E.; Vuono, E.A.; Gladue, D.P. 2018: CRISPR/Cas Gene Editing of a Large DNA Virus: African Swine Fever Virus. Bio-Protocol 8(16):E2978
Rozhkova, A.M.; Kislitsin, V.Y. 2021: CRISPR/Cas Genome Editing in Filamentous Fungi. BIOCHEMISTRY. Biokhimiia 86(Suppl 1): S120-S139
Vitiello, M.; Poliseno, L. 2021: CRISPR/Cas Technologies Applied to Pseudogenes. Methods in Molecular Biology 2324: 265-284
Ahmed, M.Z.; Badani, P.; Reddy, R.; Mishra, G. 2021: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches. Journal of Molecular Diagnostics: Jmd 23(11): 1433-1442
Dara, M.; Talebzadeh, M. 2020: CRISPR/Cas as a Potential Diagnosis Technique for COVID-19. Avicenna Journal of Medical Biotechnology 12(3): 201-202
Dey, A. 2021: CRISPR/Cas genome editing to optimize pharmacologically active plant natural products. Pharmacological Research 164: 105359
Escalona-Noguero, C.; López-Valls, M.ía.; Sot, B.ña. 2021: CRISPR/Cas technology as a promising weapon to combat viral infections. Bioessays: News and Reviews in Molecular Cellular and Developmental Biology 43(4): E2000315
Feng, S.; Hu, L.; Zhang, Q.; Zhang, F.; Du, J.; Liang, G.; Li, A.; Song, G.; Liu, Y. 2020: CRISPR/Cas technology promotes the various application of Dunaliella salina system. Applied Microbiology and Biotechnology 104(20): 8621-8630
Leisen, T.; Bietz, F.; Werner, J.; Wegner, A.; Schaffrath, U.; Scheuring, D.; Willmund, F.; Mosbach, A.; Scalliet, G.; Hahn, M. 2020: CRISPR/Cas with ribonucleoprotein complexes and transiently selected telomere vectors allows highly efficient marker-free and multiple genome editing in Botrytis cinerea. Plos Pathogens 16(8): E1008326
Purusothaman, D-Kumar.; Shackleford, L.; Anderson, M.A.E.; Harvey-Samuel, T.; Alphey, L. 2021: CRISPR/Cas-9 mediated knock-in by homology dependent repair in the West Nile Virus vector Culex quinquefasciatus Say. Scientific Reports 11(1): 14964
Dasgupta, I.; Flotte, T.R.; Keeler, A.M. 2021: CRISPR/Cas-Dependent and Nuclease-Free in Vivo Therapeutic Gene Editing. Human Gene Therapy 32(5-6): 275-293
Gadwal, A.; Roy, D.; Khokhar, M.; Modi, A.; Sharma, P.; Purohit, P. 2021: CRISPR/Cas-New Molecular Scissors in Diagnostics and Therapeutics of COVID-19. Indian Journal of Clinical Biochemistry: Ijcb 36(4): 459-467
Zheng, X.; Zheng, P.; Sun, J. 2021: CRISPR/Cas-based genome editing in Aspergillus niger. Sheng Wu Gong Cheng Xue Bao 37(3): 980-990
Yu, C.; Mo, J.; Zhao, X.; Li, G.; Zhang, X. 2021: CRISPR/Cas-mediated DNA base editing technology and its application in biomedicine and agriculture. Sheng Wu Gong Cheng Xue Bao 37(9): 3071-3087
Shao, Y.; Guan, Y.; Wang, L.; Qiu, Z.; Liu, M.; Chen, Y.; Wu, L.; Li, Y.; Ma, X.; Liu, M.; Li, D. 2014: CRISPR/Cas-mediated genome editing in the rat via direct injection of one-cell embryos. Nature Protocols 9(10): 2493-2512
Dong, Z.; Qin, Q.; Hu, Z.; Zhang, X.; Miao, J.; Huang, L.; Chen, P.; Lu, C.; Pan, M. 2020: CRISPR/Cas12a Mediated Genome Editing Enhances Bombyx mori Resistance to BmNPV. Frontiers in Bioengineering and Biotechnology 8: 841
Kim, H.; Lee, S.; Yoon, J.; Song, J.; Park, H.G. 2021: CRISPR/Cas12a collateral cleavage activity for simple and rapid detection of protein/small molecule interaction. Biosensors and Bioelectronics 194: 113587
Wang, X.; Ji, P.; Fan, H.; Dang, L.; Wan, W.; Liu, S.; Li, Y.; Yu, W.; Li, X.; Ma, X.; Ma, X.; Zhao, Q.; Huang, X.; Liao, M. 2020: CRISPR/Cas12a technology combined with immunochromatographic strips for portable detection of African swine fever virus. Communications Biology 3(1): 62
Wang, D.-X.; Wang, J.; Du, Y.-C.; Ma, J.-Y.; Wang, S.-Y.; Tang, A.-N.; Kong, D.-M. 2020: CRISPR/Cas12a-based dual amplified biosensing system for sensitive and rapid detection of polynucleotide kinase/phosphatase. Biosensors and Bioelectronics 168: 112556
Yu, F.; Zhang, K.; Wang, Y.; Li, D.; Cui, Z.; Huang, J.; Zhang, S.; Li, X.; Zhang, L. 2021: CRISPR/Cas12a-based on-site diagnostics of Cryptosporidium parvum IId-subtype-family from human and cattle fecal samples. Parasites and Vectors 14(1): 208
Baldering, T.N.; Karathanasis, C.; Harwardt, M.-L.I.E.; Freund, P.; Meurer, M.; Rahm, J.V.; Knop, M.; Dietz, M.S.; Heilemann, M. 2021: CRISPR/Cas12a-mediated labeling of MET receptor enables quantitative single-molecule imaging of endogenous protein organization and dynamics. Iscience 24(1): 101895